dan 2163 has been researched along with sulpiride in 619 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 45 (7.27) | 18.7374 |
| 1990's | 59 (9.53) | 18.2507 |
| 2000's | 280 (45.23) | 29.6817 |
| 2010's | 224 (36.19) | 24.3611 |
| 2020's | 11 (1.78) | 2.80 |
| Authors | Studies |
|---|---|
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Baltrukevich, H; Czarnota, K; Handzlik, J; Kucwaj-Brysz, K | 1 |
| Miens, M; Renan, F | 1 |
| Allegre, G; Borenstein, P; Gekiere, F | 1 |
| Balthazard, C; Darondel, A | 1 |
| Hug, R; Richou, H | 1 |
| Dollfus, S; Lesieur, P; Menard, JF; Petit, M | 1 |
| Kakigi, T; Kaneda, H; Maeda, K; Shintani, T; Tanimoto, K | 1 |
| Chevallier, JC; Chiffoleau, A; Drouin, E; Gauthier, C; Godin, JF; Lande, G; Le Marec, H | 1 |
| Aymes, C; Delille, F; Harry, P; Hass, C; Montaz, L; Simonin, D; Turcant, A; Varache, N | 1 |
| Dufour, A; Grognet, JM; Istin, M; Moulin, A; Rauch-Desanti, C; Truffer, D | 1 |
| Arimoto, H; Inotsume, N; Kamizono, A; Miyakawa, T; Miyamoto, K; Nakano, M; Ueda, K | 1 |
| Aimard, G; Daléry, J; de Villard, R; Moreau, T; Trillet, M | 1 |
| Blaton, NM; De Ranter, CJ; De Winter, HL; Peeters, OM; Verlinde, CL | 1 |
| Boyer, P; Lecrubier, Y; Puech, AJ | 1 |
| Delcker, A; Gaertner, HJ; Oczkowski, B; Schoon, ML | 1 |
| Blin, O; Durup, M; Pailhous, J; Serratrice, G | 1 |
| Protais, P; Vasse, M | 1 |
| Chivers, JK; Jenner, P; Marsden, CD; Reavill, C | 1 |
| Carnoy, P; Puech, AJ; Simon, P; Soubrie, P | 1 |
| Cassan, P | 1 |
| Fujita, M; Horikomi, K | 1 |
| Boyer, P | 1 |
| Gaume, JY; Haumonte, MT; Hoffmann, E; Koriche, A; Leser, J; Vallindra, C | 1 |
| Bohbot, M; Diquet, B; Doare, L | 1 |
| Amore, M; Campanile, A; Campanile, S; Cerisoli, M | 1 |
| Gibbs, J; Schneider, LH; Smith, GP | 1 |
| Bourin, M; Colombel, MC; Larousse, C | 1 |
| Samouelian, J | 1 |
| Bucci, L | 1 |
| Bres, J; Bressolle, F | 1 |
| Kato, Y; Kobari, T; Namekawa, H; Yamada, S | 1 |
| Iguro, Y; Ito, T; Kato, Y; Kobari, T; Namekawa, H; Yamada, S | 1 |
| Jenner, P; Kilpatrick, GJ; Marsden, CD | 1 |
| Kitagawa, N; Miyachi, Y; Mizuchi, A; Saruta, S | 2 |
| Worms, P | 1 |
| Leclere, A; Plichart, P | 1 |
| Amedro, MJ; Couquiaud, FG | 1 |
| Bartels, M; Bauer, H; Gaertner, HJ; Mann, K | 1 |
| Lin, CW; Wilk, S | 1 |
| Blondel, F | 1 |
| Berger, M; Lang, F; Tamet, JY | 1 |
| Grivois, H; Kamal, S | 1 |
| Mohy, Y | 1 |
| Cornier, P | 1 |
| Anguera, P; Bulteau, J; Soubrier, JP | 1 |
| de Laitre, G | 1 |
| Morel, D | 2 |
| Kitagawa, N; Miyachi, Y; Mizuchi, A | 1 |
| Kitagawa, N; Miyachi, Y; Mizuchi, A; Saruta, S; Tokuda, H | 1 |
| Hamano, H; Miyachi, Y; Mizuchi, A; Sarai, K | 1 |
| Challier, JC; Nandakumaran, M; Olive, G; Rey, E; Richard, MO | 1 |
| Kohda, Y; Nishihara, K; Tamura, Z | 1 |
| Peselow, ED; Stanley, M | 1 |
| Fontaine, J; Reuse, J | 1 |
| Hugonenq, H; Uso, T | 1 |
| Kishioka, S; Masuda, Y; Miyamoto, Y; Ozaki, M; Yamamoto, H | 1 |
| Imazu, Y; Moriuchi, K; Yoneda, H | 1 |
| Berton, C; Kintz, P; Mangin, P; Mutter-Schmidt, C; Tracqui, A | 1 |
| Aubin, F; Lecrubier, Y; Martinot, JL; Paillère-Martinot, ML | 1 |
| Bailey, P; Castro, JO; Crocq, MA; Duval, F; Lataste, X; Macher, JP; Mokrani, MC | 1 |
| Aubin, F; Boyer, P; Dewailly, J; Lecrubier, Y; Puech, AJ | 1 |
| Fukushima, S; Inotsume, N; Kamizono, A; Nakano, M | 1 |
| Anderer, P; Földes, P; Grünberger, J; Küfferle, B; Saletu, B; Topitz, A | 1 |
| Nishi, S; Yamada, S; Yokoo, H | 1 |
| Campo, G; Castrillón, E; Conde, S; León, A; León, CA; Vigoya, J | 1 |
| Fukushima, S; Inotsume, N; Kamizono, A; Nakano, M; Okamoto, Y | 1 |
| Perrault, G; Scatton, B; Schoemaker, H | 1 |
| Ascalone, V; Malavasi, B; Ripamonti, M | 1 |
| Ascalone, V; Locatelli, M; Malavasi, B; Ripamonti, M | 1 |
| Jalava, ML; Kalska, H; Lavanant, C; Mattila, MJ; Patat, A; Seppälä, T; Vanakoski, J | 1 |
| Barik, S; de Beaurepaire, R | 2 |
| Dao-Castellana, MH; Loc'h, C; Martinot, JL; Mazière, B; Paillère-Martinot, ML; Poirier, MF | 1 |
| Depoortere, R; Morel, E; Perrault, G; Sanger, DJ; Scatton, B | 1 |
| Benavides, J; Carter, C; Chergui, K; Claustre, Y; Curet, O; Fage, D; Gonon, F; Oblin, A; Rouquier, L; Scatton, B; Schoemaker, H | 1 |
| Fleurot, O; Loo, H; Poirier-Littre, MF; Rein, W; Theron, M | 1 |
| Imamura, T; Jitsufuchi, N; Kudo, K; Tokunaga, H | 1 |
| Boyer, P; Lecrubier, Y; Rein, W; Turjanski, S | 1 |
| Freeman, HL | 1 |
| Rein, W; Turjanski, S | 1 |
| Claustre, Y; Cudennec, A; Oblin, A; Perrault, G; Sanger, DJ; Scatton, B; Schoemaker, H | 1 |
| Danion, JM; Grangé, D; Kauffmann-Muller, F; Patat, A; Peretti, CS; Rosenzweig, P | 1 |
| Boyer, P; Fleurot, O; Möller, HJ; Rein, W | 1 |
| Bénavidès, J; Cudennec, A; Fage, D; Scatton, B | 1 |
| Smeraldi, E | 1 |
| Alberts, JL; Barnes, TR; Curson, DA; Pantelis, C; Speller, JC | 1 |
| Attar-Levy, D; Martinot, JL; Monnet, F; Paillère-Martinot, ML; Recassens, C; Trichard, C | 1 |
| Laduron, PM | 1 |
| Adler, G; Benkert, O; Gattaz, WF; Gründer, G; Hillert, A; Philipp, M; Rein, W; Sauer, H; Schröder, J; Wetzel, H | 1 |
| Fleurot, O; Puech, A; Rein, W | 1 |
| Reid, S; Turner, J | 1 |
| Ahtoy, P; Canal, M; Chaufour, S; Chretien, P; Deschamps, C; Hamon-Vilcot, B; Nasr, A; Piette, F; Rosenzweig, P; Zieleniuk, I | 1 |
| Di Giovanni, G; Di Mascio, M; Di Matteo, V; Esposito, E | 1 |
| Boyer, P; Fleurot, O; Lecrubier, Y; Stalla-Bourdillon, A | 1 |
| Anghelescu, I; Benkert, O; Gründer, G; Hiemke, C; Hillert, A; Lange, K; Schlösser, R; Wetzel, H | 1 |
| Danion, JM; Fleurot, O; Rein, W | 1 |
| de Bie, A; Louwerens, JW; Milius, H; Muntjewerff, ND; O'Hanlon, JF; Patat, A; Ramaekers, JG; Rosenzweig, P | 1 |
| Coulouvrat, C; Dondey-Nouvel, L | 1 |
| Horikomi, K; Iizuka, K; Mita, N; Miwa, T; Nagase, H; Sakai, K; Sonehara, K; Takagi, K; Takahashi, S | 1 |
| Ravizza, L | 1 |
| Allain, H; Gandon, JM; Miget, N; Patat, A; Rosenzweig, P | 1 |
| Bayle, FJ; Ghaoui, S; Olie, JP | 1 |
| Bale, R; Bech, P; Fleurot, O; Möller, HJ; Peuskens, J; Rein, W | 1 |
| Papp, M; Wieronska, J | 1 |
| Darcourt, G | 1 |
| Möller, HJ | 4 |
| Coulouvrat, C; Dondey-Nouvel, L; Rein, W | 1 |
| Peuskens, J | 2 |
| Colonna, L; Dondey-Nouvel, L; Rein, W; Saleem, P | 1 |
| Naber, D | 1 |
| McAskill, R; Taylor, DM | 1 |
| Bergougnan, L; Canal, M; L'Heritier, C; Legangneux, E; McEwen, J; Miget, N; Pinquier, JL; Rosenzweig, P; Wesnes, KA | 1 |
| Bonhomme, D; Carrière, P; Lempérière, T | 1 |
| Bebbington, P; Freemantle, N; Geddes, J; Harrison, P | 1 |
| Braus, DF; Jatzko, A; Ries, S; Schreiner, A | 1 |
| Kapur, S; Remington, G | 2 |
| Agelink, MW; Klieser, E; Linka, T; Lukas, K; Majewski, T; Ullrich, H; Wurthmann, C | 1 |
| Hilger, E; Kasper, S | 1 |
| Kerwin, R | 1 |
| Lecrubier, Y | 2 |
| Azorin, JM | 1 |
| Artiges, E; Canal, M; Loc'h, C; Mallet, L; Martinot, JL; Mazière, B; Paillère-Martinot, ML; Xiberas, X | 1 |
| Blin, O | 1 |
| Cesková, E; Drybcák, P; Hrobar, P; Lorenc, M; Spacek, J | 1 |
| Funaoka, H; Ishii, H; Muratake, T; Nakajima, E; Shimoda, K; Shirai, A; Someya, T; Sunahara, N; Takahashi, S; Yashiki, T | 1 |
| Azorin, M; Bottai, T; Dalery, J; Garreau, G; Lecrubier, Y; Lempérière, T; Lisoprawski, A; Petitjean, F; Vanelle, JM | 1 |
| Cavagnini, F; Clemente, A; Ferrari, VM; Laini, V; Lugo, F; Mantero, M; Mauri, MC; Redaelli, G; Ruggiero, GM; Zappulli, D | 1 |
| Göpel, C; Marcus, A | 1 |
| Hardern, R; Page, AV; Teoh, R | 1 |
| Grohmann, R; Pedrosa Gil, F; Rüther, E; Schneider, C | 1 |
| Amore, M; Jori, MC | 1 |
| Curran, MP; Perry, CM | 2 |
| Castelli, MP; Gessa, GL; Mocci, I; Pani, L; Sanna, AM | 1 |
| Grohmann, R; Pedrosa Gil, F; Rüther, E | 1 |
| Cassano, GB; Jori, MC | 1 |
| Loo, H; Olié, JP; Saleem, P | 1 |
| Lewis, DA | 1 |
| Engel, RR; Kissling, W; Leucht, S; Pitschel-Walz, G | 1 |
| Bogetto, F; Gandolfo, S; Maina, G; Vitalucci, A | 1 |
| Gessa, GL; Pani, L | 1 |
| Bartholini, F; Casu, MA; Gessa, GL; Marchese, G; Pani, L; Ruiu, S; Saba, P | 1 |
| Züchner, H | 1 |
| Bayle, FJ; Chereau, I; Lancon, C; Llorca, PM | 1 |
| Haasen, C; Krausz, M; Naber, D; Nika, E; Yagdiran, O | 1 |
| Lima, MS; Mota, NE; Soares, BG | 1 |
| Green, B | 1 |
| Bartholini, F; Casti, P; Gessa, GL; Marchese, G; Pani, L; Ruiu, S; Saba, P | 1 |
| Bottlender, R; Dobmeier, P; Hofschuster, E; Jäger, M; Möller, HJ | 1 |
| Möller, HJ; Peuskens, J; Puech, A | 1 |
| Bogetto, F; Fonzo, V; Ravizza, L; Rocca, G; Rocca, P; Scotta, M; Zanalda, E | 1 |
| Casti, P; Gessa, GL; Marchese, G; Pani, L; Ruiu, S; Saba, P | 1 |
| Horikomi, K; Karasawa, J; Takagi, K; Takahashi, S | 1 |
| Cottencin, O; Devos, P; Dupont, S; Goudemand, M; Llorca, PM; Mazas, O; Rascle, C; Steinling, M; Thomas, P; Vaiva, G | 1 |
| Benkert, O; Müller, MJ; Wetzel, H | 1 |
| Bartholini, F; Casti, P; Gessa, G; Marchese, G; Pani, L; Ruiu, S; Saba, P | 1 |
| Burns, T; Chabannes, JP; Demyttenaere, K | 1 |
| Anghelescu, I; Benkert, O; Ewald-Gründer, S; Gründer, G; Hiemke, C; Hillert, A; Schlösser, R | 1 |
| Aubriot-Delmas, B; Benadhira, R; Januel, D; Kalalou, K; Plaze, M; Rocamora, JF; Saba, G | 1 |
| Aubin, HJ; Berlin, I; Dally, S; Hispard, E; Lépine, JP; Marra, D; Notides, C; Payan, C; Tilikete, S; Warot, D | 1 |
| Bergougnan, L; Bianchetti, G; Canal, M; Patat, A; Rosenzweig, P; Zieleniuk, I | 1 |
| Pani, L | 1 |
| Bogetto, F; Marchiaro, L; Rasetti, R; Rivoira, E; Rocca, P | 1 |
| Fleurot, O; Giudicelli, A; Lĵo, H; Martin, S; Peuskens, J; Rein, W; Thirumalai, S | 1 |
| Benkert, O; Eich, FX; Müller, MJ; Puech, A; Rein, W; Wetzel, H | 1 |
| Fleurot, O; Lecrubier, Y; Peuskens, J; Rein, W; Sechter, D | 1 |
| Barr, AM; Genn, RF; Phillips, AG | 1 |
| Goudie, AJ; Smith, JA | 1 |
| Härtter, S; Hiemke, C; Sachse, J; Weigmann, H | 1 |
| Laux, G; Livak, V; Neumann, M; Paul, HW | 1 |
| Braus, DF; Ries, S; Tost, H; Weimer, E | 1 |
| Biala, G; Duarte, C; Hamon, M; Le Bihan, C; Thiébot, MH | 1 |
| Danileviciūte, V | 1 |
| Chen, YS; Hwang, TJ; Lee, SM; Lee, YC; Lin, HN; Sun, HJ; Tsai, SJ | 1 |
| Gessa, GL; Kasper, S | 1 |
| Montgomery, SA | 1 |
| Kasper, S | 1 |
| Castle, DJ; Lambert, TJ | 1 |
| Bégaud, B; Ouariki, S; Péhourcq, F | 1 |
| Abou El Ela, A; Galla, HJ; Härtter, S; Hiemke, C; Hüwel, S; Langguth, P; Lohmann, T | 1 |
| Canal, M; Coulouvrat, C; Legangneux, E; van Lier, JJ; van Vliet, AA | 1 |
| Murphy, BP | 1 |
| Bressan, RA; Ell, PJ; Erlandsson, K; Flanagan, RJ; Jones, HM; Mulligan, R; Pilowsky, LS | 1 |
| Metin, O; Tot, S; Yazici, AE; Yazici, K | 1 |
| Arai, H; Kumagai, R; Nagata, T; Ohnuma, T | 1 |
| Fric, M; Laux, G | 1 |
| Eastwood, D; French, K | 1 |
| Backer, MM; Bloch, M; Pick, CG; Rigai, T; Schreiber, S; Weizman, T | 1 |
| Hamann, J; Kissling, W; Leucht, S; Wagenpfeil, S | 1 |
| Henn, FA; Knopf, U; Thome, J; Zink, M | 1 |
| Henn, FA; Thome, J; Zink, M | 1 |
| Leucht, S | 1 |
| Mortimer, AM | 1 |
| Correll, CU; Kane, JM; Leucht, S | 1 |
| Linden, M; Scheel, T; Xaver Eich, F | 1 |
| Bressan, RA; Ell, PJ; Erlandsson, K; Pilowsky, LS; Spencer, EP | 1 |
| Fountoulakis, KN; Iacovides, A; St Kaprinis, G | 1 |
| Bitter, I | 1 |
| Croissant, B; Heinz, A; Hermann, D; Mann, K | 1 |
| Bergemann, N; Frick, A; Kopitz, J; Kress, KR | 2 |
| Lôo, H; Martin, S; Mortimer, A; Peuskens, J | 1 |
| Agelink, MW; Ak, I; Kavuk, I | 1 |
| Huguelet, P; Perroud, N | 1 |
| Jagadheesan, K; Muirhead, D | 1 |
| Barrett, SL; Bell, R; King, DJ; Watson, D | 1 |
| Grigor'eva, EA; Ritskov, AS | 1 |
| El Ela, AA; Härtter, S; Hiemke, C; Langguth, P; Schmitt, U; Spahn-Langguth, H | 1 |
| Fleischhacker, WW; Hummer, M; Lechleitner, M; Rettenbacher, MA | 1 |
| Amore, M; Canonico, PL; Pani, L; Racagni, G; Ravizza, L | 1 |
| Freudenreich, O; Goff, D; Stahl, S | 1 |
| Beer, MD; Cobb, AM; Kerwin, R; Launer, M; Matthiasson, P; Munro, J; Osborne, S; Purcell, S; Travis, M | 1 |
| Bliesener, N; Klingmüller, D; Kühn, KU; Quednow, BB; Yokusoglu, H | 1 |
| Bryois, Ch; Sahli, Ch | 1 |
| Chen, CK; Chou, YH | 1 |
| McKeage, K; Plosker, GL | 1 |
| Amann, B; Hegerl, U; Juckel, G; Möller, HJ; Mulert, C; Pogarell, O | 1 |
| Lawrie, S; McIntosh, A; Nadeem, Z | 2 |
| Messer, T; Schmauss, M; Strasser, O | 1 |
| Kühn, KU; Maier, W; Quednow, BB; Schlaepfer, TE; Wagner, M; Westheide, J | 1 |
| Atbasoglu, EC; Can Saka, M; Goker, C; Ozguven, HD | 1 |
| Bares, M; Dockery, C; Horácek, J; Kopecek, M; Svarc, J | 1 |
| Cowan, C; George, S | 1 |
| Bartenstein, P; Buchholz, HG; Gründer, G; Härtter, S; Hiemke, C; Rösch, F; Siessmeier, T; Stoeter, P; Vernaleken, I | 1 |
| Croissant, B; Hermann, D; Olbrich, R | 1 |
| Agelink, MW; Kämpf, P; Naber, D | 1 |
| Cook, B; Hoogenboom, G | 1 |
| Bressan, RA; Ell, PJ; Erlandsson, K; Pilowsky, LS; Stone, JM | 1 |
| Dehning, S; Müller, N; Riedel, M | 1 |
| Charpiat, B; Cuilleret, FJ; Franchini, S; Henry, A; Milon, H; Vial, T | 1 |
| Borsos, K; Harangozó, J; Kukla, B; Németh, O; Slezák, A | 1 |
| Hajak, G; Müller, JL; Putzhammer, A | 1 |
| Okubo, Y; Takahashi, H; Yahata, N | 1 |
| Lawrie, S; McIntosh, A | 1 |
| Kerwin, RW; Knapp, M; Patel, A; Surguladze, S; Travis, MJ | 1 |
| Apiquian, R; Fresan, A; Herrera-Estrella, M; Sanchez-Torres, I | 1 |
| Benabarre, A; Capapey, J; Comes, M; Goikolea, JM; Popova, E; Ros, S; Sánchez-Moreno, J; Vieta, E | 1 |
| Dresel, S; Frodl, T; Hahn, K; la Fougère, C; Meisenzahl, E; Möller, HJ; Schmitt, G; Stauss, J; Tatsch, K | 1 |
| Ward, DI | 1 |
| Busch, R; Hamann, J; Kane, JM; Kissling, W; Leucht, S | 1 |
| Asai, K; Koeda, M; Okubo, Y; Suhara, T; Takahashi, H; Takano, A; Yahata, N | 1 |
| Liappas, J; Paparrigopoulos, T; Rabavilas, A; Tzavellas, E | 1 |
| Budin, R; Fleming, AS; Kapur, S; Li, M | 1 |
| Bannan, E; Brakoulias, V; Cohen, P; Geary, G | 1 |
| Cordonnier, L; Noble, F; Roques, BP; Sanchez, M | 2 |
| Berk, M; Bourin, M; Dodd, S; Ivanovski, B; Lagopoulos, J; Malhi, GS; Mitchell, PB | 1 |
| Bares, M; Horácek, J; Kopecek, M | 1 |
| Beckmann, K; Bliesener, N; Kühn, KU; Maier, W; Quednow, BB; Wagner, M; Westheide, J | 1 |
| Brown, D; Fraser, K; Martin, M; Taylor, M; Turner, M; Watt, L | 1 |
| Frecska, E | 1 |
| Bahk, WM; Kweon, YS; Lee, CT; Lee, HK; Lee, KU; Pae, CU; Won, WY | 1 |
| Engel, R; Etschel, E; Hamann, J; Kane, JM; Kissling, W; Leucht, S | 1 |
| Andrich, J; Kraus, PH; Przuntek, H; Saft, C | 1 |
| Lin, CL; Shiah, IS; Wan, FJ; Wang, TS; Yeh, CB | 1 |
| Abou El-Ela, A; Baron, JM; Glavinas, H; Guo, LJ; Härtter, S; Hiemke, C; Krajcsi, P; Langguth, P; Schmitt, U; Tillmann, C | 1 |
| Kusuhara, H; Lee, YJ; Morimoto, T; Okubo, Y; Sugiyama, Y; Suhara, T; Suzuki, K; Takahashi, H; Takano, A; Yasuno, F | 1 |
| Smeraldi, E; Zanardi, R | 1 |
| Eich, FX; Härtter, S; Hiemke, C; Müller, MJ; Regenbogen, B | 1 |
| Arnold, P; Gschwend, MH; Martin, W; Ring, J | 1 |
| Knecht, G; Naber, D; Veismann, S; Wolf, K | 1 |
| Eich, FX; Linden, M; Scheel, T | 1 |
| Kreinin, A; Novitski, D; Weizman, A | 1 |
| Murray, S; Olié, JP; Spina, E; Yang, R | 1 |
| Dikeos, DG; Papadimitriou, GN; Psarros, CJ; Soldatos, CR; Theleritis, CG | 1 |
| Ferentinos, PP; Havaki-Kontaxaki, BJ; Kontaxakis, VP; Paplos, KG; Soldatos, CR | 1 |
| Eich, FX; Härtter, S; Hiemke, C; Müller, MJ; Regenbogen, B; Sachse, J | 2 |
| Mavreas, V; Pappas, D; Peritogiannis, V; Tsouli, S; Zafiris, S | 1 |
| Daly, F; Gosselin, S; Hackett, LP; Haider, T; Isbister, GK; John, S; Murray, L; O'Mullane, P | 1 |
| Burlon, M; Göhring, K; Gruschka, P; Kaiser, S; Pfüller, U; Roesch-Ely, D; Weisbrod, M | 1 |
| Bradshaw, CM; Hou, RH; Langley, RW; Samuels, ER; Szabadi, E | 1 |
| Cipriani, A; Geddes, JR; Rendell, JM | 1 |
| Bono, G; Colombo, C; Corbetta, S; Mancioli, A; Mauri, M; Rebecchi, V | 1 |
| Braus, DF; Flor, H; Georgi, A; Heinz, A; Hermann, D; Klein, S; Mann, K; Nikitopoulos, J; Smolka, MN; Wrase, J | 1 |
| Bäuml, J; Davis, JM; Engel, RR; Leucht, S | 1 |
| Müller-Vahl, KR | 1 |
| Liappas, J; Mourikis, I; Paparrigopoulos, T; Soldatos, C; Tzavellas, E | 1 |
| Gründer, G; Paulzen, M | 1 |
| Fountoulakis, KN; Iacovides, A; Kantartzis, S; Kaprinis, G; Mavridis, T; Panagiotidis, P; Siamouli, M | 1 |
| Baumgartner, S; Ebenbichler, C; Edlinger, M; Fleischhacker, WW; Hofer, A; Hummer, M; Kemmler, G; Lechleitner, M; Rettenbacher, MA | 1 |
| Bouhassira, M; Lancrenon, S; Lecrubier, Y; Perrin, E; Quintin, P | 1 |
| Baumgartner, S; Ebenbichler, C; Edlinger, M; Hofer, A; Hummer, M; Kemmler, G; Lechleitner, M; Rettenbacher, MA; Wolfgang Fleischhacker, W | 1 |
| Cotton, S; McGorry, PD; Murphy, BP; Stuart, AH; Wade, D | 1 |
| Kovács, G; Kovács, L | 1 |
| Alonso, J; Haro, JM; Lépine, JP; Novick, D; Ratcliffe, M; Suarez, D | 1 |
| Douki, S; Vanelle, JM | 1 |
| Aldenhoff, JB; Boigs, M; Braun, S; Fritzer, G; Göder, R; Koch, J | 1 |
| Giailoglou, D; Kouzoupis, A; Masdrakis, VG; Papadimitriou, GN; Papageorgiou, C; Soldatos, CR | 1 |
| Dettling, M; Neuhaus, AH; Opgen-Rhein, C | 1 |
| Eich, FX; Lambert, M; Linden, M; Naber, D; Schacht, M; Schimmelmann, BG | 1 |
| Doraiswamy, PM; Edwards, R; Mueller-Oerlinghausen, B; Schott, G; Star, K | 1 |
| Carvalho, AF; Cavalcante, JL; Nunes-Neto, PR; Oliveira Lima, MC | 1 |
| Bodner, T; Edlinger, M; Fleischhacker, WW; Hofer, A; Huber, R; Kemmler, G; Rettenbacher, MA; Sachs, G | 1 |
| Lee, C; Lee, CU; Lim, HK; Pae, CU | 1 |
| Limosin, F | 1 |
| Benitez, J; Daskalakis, ZJ; Egan, GF; Fitzgerald, PB; Jackson, G; Kulkarni, J; Sritharan, A | 1 |
| Berra, C; Binaschi, L; Borio, R; Torta, R | 1 |
| Goulia, P; Hyphantis, T; Mavreas, V; Pappas, D; Peritogiannis, V | 1 |
| De Hert, M; Mortimer, A; Peuskens, J | 1 |
| Eich, FX; Linden, M; Pyrkosch, L | 1 |
| Hopkała, H; Komsta, Ł; Skibiński, R; Suchodolska, I | 1 |
| Hui, HY; Law, WL; You, JH; Young, WM | 1 |
| Friederich, M; Kozian, R | 1 |
| Fanali, S; Mandrioli, R; Morganti, E; Musenga, A; Raggi, MA | 1 |
| Bushe, C; Shaw, M | 1 |
| Bret, MC; Bret, P; Fourier-Réglat, A; Pariente, A | 1 |
| Altunay, IK; Kayaoğlu, S; Mercan, S; Ogutcen, O; Taskintuna, N | 1 |
| Balasubramaniam, K; Choudhary, PC; Joyce, E; Mortimer, AM; Saleem, PT | 1 |
| Hwang, MY; Kim, JM; Kim, SW; Lee, JH; Lee, SH; Shin, IS; Yang, SJ; Yoon, BH; Yoon, JS | 1 |
| Cazali, J; Dervaux, A | 1 |
| Abu-Tair, F; Bergemann, N; Kopitz, J; Kress, KR; Parzer, P | 1 |
| David, AS; Gibbs, AA; Naudts, KH; Spencer, EP | 2 |
| Druschky, KF; Eikelmann, B; Harter, C; Obier, C | 1 |
| Bazin, N; Chabannes, JP; Ferreri, M; Garay, RP; Hameg, A; Leguay, D; Nuss, P; Peretti, CS; Tatu, P | 1 |
| Bechdolf, A; Gaebel, W; Häfner, H; Janssen, B; Klosterkötter, J; Kühn, KU; Maier, W; Maurer, K; Möller, HJ; Ruhrmann, S; Schultze-Lutter, F; Wagner, M | 1 |
| Cejpková, A; Rodáková, I; Svestka, J; Synek, O; Tomanová, J | 1 |
| Abay, E; Kose, R | 1 |
| Assion, HJ; Basilowski, M; Juckel, G; Lemanski, S; Reinbold, H | 1 |
| Aydemir, MC; Goka, E; Kisa, C; Yalcin, DO | 1 |
| Lang, UE; Malte Tugtekin, S; Matschke, K; Schmeisser, A; von Golitschek, R; Willbring, M | 1 |
| Lawrie, SM; Shajahan, P; Taylor, M | 1 |
| Boter, H; Davidson, M; Dollfus, S; Fleischhacker, WW; Gaebel, W; Galderisi, S; Gheorghe, MD; Grobbee, DE; Hranov, LG; Hummer, M; Kahn, RS; Keet, IP; Libiger, J; Lindefors, N; López-Ibor, JJ; Peuskens, J; Riecher-Rössler, A; Rybakowski, JK; Vergouwe, Y | 1 |
| Papadimitriou, GN; Politis, AM; Psarros, C; Soldatos, CR; Theleritis, CG | 1 |
| Hwang, MY; Kim, JM; Kim, SW; Shin, IS; Yang, SJ; Yoon, JS | 1 |
| Das, PP; Grover, S; Sahoo, M | 1 |
| George, N; Gerostamoulos, D; Lynch, MJ; Woods, J | 1 |
| Agai Csongor, E; Domány, G; Elekes, O; Gémesi, LI; Gyertyán, I; Kapás, M; Kedves, R; Kiss, B; Laszy, J; Pásztor, G; Sághy, K; Szombathelyi, Z; Zájer-Balázs, M | 1 |
| Agai-Csongor, E; Bugovics, G; Domány, G; Fazekas, K; Gyertyán, I; Horváth, A; Kiss, B; Laszlovszky, I; Némethy, Z; Schmidt, E; Szombathelyi, Z | 1 |
| Chandran, M; El-Shazly, M | 1 |
| Akkaya, C; Ersoy, C; Kaya, B; Kirli, S; Kotan, Z; Sarandol, A | 1 |
| Chen, CK; Chen, HK; Tzeng, NS | 1 |
| Alptekin, K; Kontaxakis, VP; Pani, L; Villagrán, JM | 1 |
| Aggarwal, A; Mendhekar, DN; Yajuvendra, B | 1 |
| Lohia, D; Mendhekar, D | 2 |
| Ajjala, D; Bhyrapuneni, G; Kandikere, V; Mudigonda, K; Mukkanti, K; Nirogi, R; Suraneni, R | 1 |
| Bai, YM; Kuo, TB; Wang, YC; Yang, CC | 1 |
| Barlow, KB; Kapur, S; Natesan, S; Nobrega, JN; Reckless, GE | 1 |
| Aldenhoff, JB; Baier, PC; Hinze-Selch, D; Koch, JM; Ohlmeyer, K; Seeck-Hirschner, M; Wilms, S | 1 |
| Boerner, R; Dresel, S; Frodl, T; Gründer, G; Hahn, K; la Fougère, C; Meisenzahl, EM; Möller, HJ; Scheuerecker, J; Schmitt, G; Schwarz, M; Stauss, J | 1 |
| Endo, S; Hamamura, T; Ishihara, T; Kuroda, S; Miyata, S; Taoka, H; Toma, K | 1 |
| Akyildiz, U; Balci, V; Sevincok, L | 1 |
| Chen, YY; Huang, MC; Wu, KC | 1 |
| Katsigiannopoulos, K; Kouvelas, D; Papazisis, G; Saitis, M | 1 |
| Chua, SE; Chung, AK | 1 |
| Eich, FX; Möller, HJ; Riedel, M | 1 |
| Papadimitriou, GN; Paparrigopoulos, TJ; Politis, AM; Psarros, C; Theleritis, CG | 1 |
| Mendhekar, DN | 2 |
| Borsos, K; Csukly, G; Harangozó, J; Németh, O; Slezák, A | 1 |
| Chen, CK; Chen, CL; Chen, CY; Huang, SY; Kuo, SC; Yeh, YW | 1 |
| Dietrich-Muszalska, A; Olas, B | 1 |
| Adan-Manes, J; Garcia-Parajua, P | 1 |
| Ebenbichler, CF; Engl, J; Fleischhacker, WW; Kaser, S; Ott, HW; Patsch, JR; Rettenbacher, MA; Tschoner, A | 1 |
| Guvenir, T; Varol Tas, F | 1 |
| Abbas, AI; Hedlund, PB; Huang, XP; Meltzer, HY; Roth, BL; Tran, TB | 1 |
| Andrade, C; Mendhekar, DN | 2 |
| Barceló, B; Castanyer, B; Puiguriguer, J; Yates, C | 1 |
| Kumar, R; Sachdev, PS | 1 |
| Ayesa, R; Crespo-Facorro, B; Martínez-Garcia, O; Mata, I; Pérez-Iglesias, R; Ramirez-Bonilla, M; Rodríguez-Sánchez, JM; Vázquez-Barquero, JL | 1 |
| Chen, CL; Chen, CY; Kuo, SC; Yeh, YW | 1 |
| Goldberg, TE; Gomar, JJ | 1 |
| Ahn, YM; Choi, JS; Chung, IW; Hwang, SS; Jun, TY; Kang, DY; Kim, CE; Kim, JJ; Kim, SH; Kim, YS; Lee, KY | 1 |
| Praharaj, SK; Sarkar, S; Sinha, VK | 1 |
| Bhaumik, U; Bose, A; Chakrabarty, US; Chatterjee, B; Das, A; Ghosh, A; Pal, TK; Sarkar, AK | 1 |
| Ahn, YM; Chang, JS; Hwang, SS; Kim, SH; Kim, YS; Lee, KY | 1 |
| Kapur, S; Patel, MX; Sparshatt, A; Taylor, D | 1 |
| Barbui, C; Boso, M; Cipriani, A | 1 |
| Christodoulou, C; Douzenis, A; Gournellis, R; Lykouras, LP; Rizos, E | 1 |
| Bailles, E; Fuente, E; Matrai, S; Pintor, L | 1 |
| Bakhla, AK; Goyal, N; Nizamie, SH | 1 |
| Bhoopathi, PS; Hunger, H; Kissling, W; Komossa, K; Leucht, S; Rummel-Kluge, C; Schwarz, S | 1 |
| Hiranita, T; Nawata, Y; Yamamoto, T | 1 |
| Bai, YM; Chen, JY; Chen, SY; Chen, TT; Gau, SS; Lai, IC; Lin, CC; Liou, YJ; Wang, YC | 1 |
| Eich, FX; Huber, CG; Karow, A; Lambert, M; Naber, D; Schimmelmann, BG; Schulz, H | 1 |
| Ekinci, AE; Ekinci, O; Guriz, O; Orsel, S | 1 |
| Arturi, F; Grembiale, A; Succurro, E; Ursini, F | 1 |
| Bhowmick, S; Ghosh, M; Hazra, A | 1 |
| Ahn, YM; Hwang, SS; Jung, DC; Kim, SH; Kim, YS | 1 |
| Hunger, H; Kissling, W; Komossa, K; Leucht, S; Rummel-Kluge, C; Schmid, F; Schwarz, S; Silveira da Mota Neto, JI | 1 |
| Nuss, P; Tessier, C | 1 |
| Marti, M; Morari, M; Viaro, R | 1 |
| Hoyer, C; Klosterkötter, J; Koethe, D; Kranaster, L; Leweke, FM; Meyer-Lindenberg, A | 1 |
| Burns, T; Derks, EM; Fleischhacker, WW; Gaebel, W; Kahn, RS; Riesbeck, M; Rössler, W; von Wilmsdorff, M | 1 |
| Kastania, A; Katsafouros, K; Laskos, E; Lykouras, L; Michalopoulou, PG; Papadopoulou, A; Rizos, EN; Vasilopoulos, D | 1 |
| Duggan, L; Hunger, H; Kissling, W; Komossa, K; Leucht, S; Rummel-Kluge, C; Schmid, F; Schwarz, S | 1 |
| Goyal, N; Sinha, VK | 1 |
| Dabhi, D; Neog, M; Patel, H; Prajapati, V; Sharma, S | 1 |
| Barnas, C; Friedrich, F; Höfer, P; Lesch, OM; Schmook, M; Spindelegger, C; Vyssoki, B; Walter, H | 1 |
| Been, G; Garg, V; Magoulas, P; Yasugi, S | 1 |
| Chen, CC; Chen, YY; Hung, GC | 1 |
| Papadimitriou, GN; Pehlivanidis, A; Spyropoulou, AC; Tourkantonis, A | 1 |
| Abbott, S; Barnes, A; Bullmore, ET; Craig, KJ; Ersche, KD; Merlo-Pich, EV; Müller, U; Ooi, C; Robbins, TW; Sahakian, BJ; Shabbir, SS; Suckling, J | 1 |
| Balit, CR; Duffull, SB; Isbister, GK; Macleod, D | 1 |
| Groleger, U; Novak-Grubic, V | 1 |
| Dehning, S; Klauss, V; Krause, D; Möller, HJ; Müller, N; Musil, R; Obermeier, M; Riedel, M; Schennach-Wolff, R; Schwarz, MJ | 1 |
| Aggarwal, A; Sharma, DD | 1 |
| Stevenson, RJ | 1 |
| Chen, JH; Tzeng, NS | 1 |
| Chiu, HW; Li, TC; Liu, HH | 1 |
| Davis, JM; Hunger, H; Kissling, W; Komossa, K; Leucht, S; Lobos, CA; Rummel-Kluge, C; Schmid, F; Schwarz, S | 1 |
| Hackett, LP; Ilett, KF; Kohan, R; Teoh, S | 1 |
| Hackett, LP; Ilett, KF; Kohan, R; Teoh, S; Watt, F | 1 |
| Bergman, J; Kreinin, A; Lerner, V; Libov, I; Miodownik, C; Shestakova, D; Sokolik, S | 1 |
| Prikryl, R; Prikrylova-Kucerova, H; Ustohal, L | 1 |
| Eberle, MC; Fallgatter, AJ; Plewnia, C; Wasserka, B; Wildgruber, D | 1 |
| Claes, S; De Hert, M; Martens, GJ; Moons, T; Peuskens, J; Van Loo, KM; Van Schijndel, JE; van Winkel, R | 1 |
| Couchman, L; Flanagan, RJ; Morgan, PE | 1 |
| Chen, J; Gao, K; Kemp, DE | 1 |
| Cocito, L; Gialloreti, LE; Guida, S; Krueger, F; Pardini, M; Primavera, A | 1 |
| Depping, AM; Gaudchau, A; Kissling, W; Komossa, K; Leucht, S | 1 |
| Chand, P; Rehni, AK; Singh, TG | 1 |
| Hunger, H; Kissling, W; Komossa, K; Leucht, S; Rummel-Kluge, C; Schmid, F; Schwarz, S | 1 |
| Jocham, G; Klein, TA; Ullsperger, M | 2 |
| Barbudo, E; Ceverino, A; Correas Lauffer, J; Garcia-Resa, E; Molina, JD; Mur, C; Quintero, J | 1 |
| Dietrich-Muszalska, A; Kontek, B; Olas, B; Rabe-Jabłońska, J | 1 |
| Dadić-Hero, E; Grahovac, T; Graovac, M; Ružić, K; Sabljić, V; Sepić-Grahovac, D | 1 |
| Englisch, S; Esslinger, C; Meyer-Lindenberg, A; Rausch, F; Schirmbeck, F; Zink, M | 1 |
| Álvarez, S; Bobes, J; Flórez, G; García-Portilla, P; Nogueiras, L; Saiz, PA | 1 |
| Cho, HY; Kim, YH; Lee, BJ; Lee, JG; Park, SW; Seo, MK; Seol, W | 1 |
| Amorin-Díaz, M; Lerma-Carrillo, I; López-Muñoz, F; López-Rodríguez, E; Molina, JD; Toledo-Romero, F | 1 |
| Coulter, CV; Duffull, SB; Isbister, GK; Joy, JP | 1 |
| Punukollu, B; Rutherford, H | 1 |
| Ekström, J; Godoy, T; Riva, A | 2 |
| Bullmore, ET; Craig, KJ; Cumming, P; Ersche, KD; Fineberg, NA; Müller, U; Robbins, TW | 1 |
| Kymionis, GD; Peponis, VG; Portaliou, DM; Skouriotis, S; Stratos, AA; Stroubini, TE | 1 |
| Bitter, I; Czobor, P; Derks, EM; Fleischhacker, WW; Kahn, RS; Libiger, J; Volavka, J | 1 |
| Skibiński, R | 1 |
| Goswami, K; Saddichha, S; Vishnuvardhan, G | 1 |
| Chiu, HW; Huang, HT; Ku, YC; Li, TC | 1 |
| Abbott, S; Bullmore, ET; Clark, L; Craig, KJ; Ersche, KD; Fineberg, NA; Merlo-Pich, EV; Müller, U; Ooi, C; Robbins, TW; Roiser, JP; Sahakian, BJ; Shabbir, SS; Suckling, J | 1 |
| Body, S; Bradshaw, CM; de Bruin, N; den Boon, FS; Hampson, CL; Szabadi, E | 1 |
| Abaitua, I; Alonso-Ferreira, V; Hens, MJ; Posada de la Paz, M; Villaverde-Hueso, A | 1 |
| Cheung, PH; Ciallella, JR; DeCrescenzo, GA; Halse, R; Roix, JJ; Saha, S; Sulpice, T | 1 |
| Ceskova, E; Priborska, Z; Suchopar, J | 1 |
| Hamelijnck, J; Needham, E | 1 |
| Barkus, E; Craig, KJ; Dadhiwala, R; Dawson, GR; Deakin, JF; Dourish, CT; Ettinger, U; Grayson, L; Koychev, I; Lees, J; McMullen, K; Perry, C; Schmechtig, A; Walters, J; Wilkinson, L; Williams, S | 1 |
| Ahn, YM; Chang, JS; Chung, IW; Jun, TY; Kang, DY; Kim, CE; Kim, YS; Lee, KY; Seok, JH; Shin, YM | 1 |
| Katsu, K; Suzuki, A; Tatsumi, N; Tokumori, D; Yokouchi, Y | 1 |
| Czernikiewicz, A; Kucharska-Pietura, K; Mortimer, A; Tylec, A | 1 |
| Chung, YC; Huang, GB; Lee, KH; Park, CH; Park, MS; Park, TW; Tong, Z; Yang, JC | 1 |
| Kang, SG; Kim, TW; Lee, BH; Lee, HJ; Park, YM; Yoon, HK | 1 |
| Chang, YT; Chen, CC; Chen, WJ; Kuo, CJ; Lee, WC; Liao, YT; Shau, WY; Tsai, SY; Yang, SY | 1 |
| Han, C; Jeong, HG; Joe, SH; Ko, YH; Lee, HY; Lee, MS | 1 |
| Ahn, YM; Jung, DC; Kim, EY; Kim, SH; Kim, YS; Lee, NY | 1 |
| Deuschle, M; Gilles, M; Kopf, D; Lederbogen, F; Lehnert, H; Medlin, F; Paslakis, G | 1 |
| Dunn, G; French, P; Hutton, P; Morrison, AP; Taylor, PJ; Yung, AR | 1 |
| Leucht, S; Levine, SZ | 4 |
| Bitter, I; Bucci, P; Fleischhacker, WW; Galderisi, S; Kahn, RS; Libiger, J; Mucci, A | 1 |
| Calandre, EP; Hidalgo, J; Morillas-Arques, P; Rico-Villademoros, F; Rodriguez-Lopez, CM; Vilchez, JS | 1 |
| Ascher-Svanum, H; Bertsch, J; Brugnoli, R; Haro, JM; Hong, J; Novick, D | 1 |
| Gerth, CW; Hellmich, M; Hoyer, C; Klosterkötter, J; Koethe, D; Leweke, FM; Muhl, D; Pahlisch, F; Piomelli, D | 1 |
| Lee, BD; Yun, HW | 1 |
| Bicikova, M; Hampl, R; Hill, M; Mohr, P; Ripova, D | 1 |
| Bowskill, SV; Flanagan, RJ; Handley, SA; Patel, MX | 1 |
| Chung, YC; Han, EH; Huang, GB; Kang, NI; Li, CR; Sui, ZY; Zhao, T | 1 |
| Choi, TY; Jung, SW; Koo, BH; Lee, JH; Lee, KH; Lee, SJ | 1 |
| Bhatia, MS; Jhanjee, A; Srivastava, S | 2 |
| Blagojević, D; Lečić-Toševski, D; Miljević, Č; Niketić, V; Nikolić, M; Nikolić-Kokić, A; Spasić, MB | 1 |
| Chung, YC; Huang, GB; Kim, MG; Oh, KY; Park, TW; Yang, JC; Zhao, T | 1 |
| Agarwal, SM; Behere, RV; Gangadhar, BN; Rao, NP; Varambally, S; Venkatasubramanian, G | 1 |
| Lai, CH | 1 |
| D'iakonov, AL; Lobanova, IV | 1 |
| Flanagan, RJ | 1 |
| Buonaguro, EF; de Bartolomeis, A; Iasevoli, F; Marmo, F; Rossi, R; Tomasetti, C | 1 |
| Negi, JS; Singh, S | 1 |
| Craig, KJ; Dadhiwala, R; Dawson, GR; Deakin, JF; Dourish, CT; Ettinger, U; Grayson, L; Koychev, I; Lees, J; McMullen, K; Migo, EM; Morris, R; Perry, C; Schmechtig, A; Wilkinson, L; Williams, SC | 1 |
| Chang, CK; Hung, GC | 1 |
| Gazdag, G; Iványi, Z; Takács, R; Ungvari, GS | 1 |
| Birch, MA; Couchman, L; Flanagan, RJ; Karna, T; Marsh, A; McAllister, R; Paton, C; Pietromartire, S | 1 |
| Couchman, L; Fisher, DS; Flanagan, RJ; Handley, SA; Morgan, PE; Partridge, SJ | 1 |
| Akhtar, S; Praharaj, SK; Sarkhel, S | 1 |
| Doberentz, E; Madea, B; Musshoff, F | 1 |
| Al'perina, EL; Cheĭdo, MA; Idova, GV; Lobacheva, OA; Nikitina, VB; Semke, AV; Vetlugina, TP; Zhukova, EN | 1 |
| Behr, ER; De Ponti, F; Koci, A; Moretti, U; Poluzzi, E; Raschi, E; Spina, E; Sturkenboom, M | 1 |
| Fisher, DS; Flanagan, RJ; Handley, SA; Partridge, SJ | 1 |
| Abler, B; Graf, H; Viviani, R; Wiegers, M | 1 |
| Medvedovici, A; Rădulescu, FŞ; Ranetti, AE; Voicu, V | 1 |
| Nikiforuk, A; Popik, P | 1 |
| Hou, YC; Lai, CH | 3 |
| Bernacer, J; Clark, L; Corlett, PR; Fletcher, PC; McFarlane, B; Murray, GK; Ramachandra, P; Robbins, TW; Turner, DC | 1 |
| Tufan, AE; Yalug, I | 1 |
| Fijał, K; Hołuj, M; Kos, T; Nikiforuk, A; Popik, P; Rafa, D | 1 |
| Chen, CC; Huang, YH; Lane, HY; Lin, CH; Lin, SC; Wang, FC | 1 |
| Arvanitakis, P; Dimopoulou, K; Kalkavoura, CS; Lykouras, L; Michopoulos, I; Theodoropoulou, P; Tzebelikos, E | 1 |
| Bahk, WM; Wang, HR; Woo, YS | 1 |
| Bergis, M; Bouaziz, H; Chassard, D; Diemunsch, P; Eberhart, L; Fox, G; Gan, TJ; Keh, D; Kranke, P; Liu, N; Motsch, J; Wallenborn, J | 1 |
| Al'perina, EL; Cheĭdo, MA; Idova, GV; Lobacheva, OA; Meniavtseva, TA; Vetlugina, TP; Zhukova, EN | 1 |
| Berardelli, I; Biondi, M; Calabrò, F; Hefner, S; Pasquini, M; Roselli, V | 1 |
| Cantisani, A; Ferrari, G; Grassi, G; Pallanti, S; Poli, L; Righi, L | 1 |
| Deslauriers, J; Desmarais, C; Grignon, S; Sarret, P | 1 |
| Conti, G; Ekström, J; Godoy, T; Isola, M; Isola, R; Lilliu, MA; Loy, F; Riva, A; Solinas, P | 1 |
| Barr, JL; Forster, GL; Meyer, DL; Miiller, LC; Novick, AM; Renner, KJ; Roberts, CL; Scholl, JL; Watt, MJ | 1 |
| Citrome, L; Czobor, P; Van Dorn, RA; Volavka, J | 1 |
| Basu, A; Brooman-White, RS; Das, M; Gupta, N; Hotham, JE; Humphreys, SA; Larkin, F; Ross, CC; Simpson, PJ | 1 |
| Athanaselis, S; Nikolaou, P; Papoutsis, I; Pistos, C; Rizopoulou, A; Spiliopoulou, C | 1 |
| Abdelaghaffar, W; Bekri, I; El Hechmi, Z; Melki, W; Ouanes, S; Rafrafi, R | 1 |
| Baek, IW; Jang, YJ; Jeong, TC; Kang, W; Kim, E; Kwon, KI; Noh, K; Yoon, YR | 1 |
| Brownings, S; Clark-Papasavas, C; Cleij, M; Dunn, JT; Gomes, R; Greaves, S; Howard, R; Joemon, J; Kessler, R; Liu, K; Marsden, P; Mogg, A; Nwosu, B; Reeves, S | 1 |
| Hsieh, CY; Kao Yang, YH; Lai, EC; Lin, SJ | 1 |
| Jang, YJ; Jeong, TC; Kang, W; Kim, E; Kwon, KI; Noh, K; Yun, HY | 1 |
| Belal, F; Halawa, MI; Tolba, MM; Walash, MI | 1 |
| Aalouane, R; Berhili, N; Hlal, H; Kettani, N; Rammouz, I | 1 |
| De Oliveira, EO; Donahue, TJ; Hillhouse, TM; Porter, JH; Webster, KA; Young, R | 1 |
| Csomor, PA; Geyer, MA; Huber, T; Preller, KH; Studerus, E; Vollenweider, FX | 1 |
| Andersen, GS; Düring, S; Glenthøj, BY; Oranje, B | 1 |
| Calandre, EP; Rico-Villademoros, F; Slim, M | 1 |
| Gerlai, R; Muraleetharan, A; Nowicki, M; Tran, S | 1 |
| Abu Abed, M; Brockmöller, J; Couraud, PO; Dos Santos Pereira, JN; Romero, IA; Saadatmand, AR; Tadjerpisheh, S; Tzvetkov, MV; Weksler, B | 1 |
| Cheng, CM; Tsai, SJ | 1 |
| Seeman, P | 1 |
| Eifler, S; Englisch, S; Esslinger, C; Kirsch, P; Meyer-Lindenberg, A; Mier, D; Rausch, F; Schirmbeck, F; Zink, M | 1 |
| Barak, Y; Baruch, Y; Pridan, S; Swartz, M | 1 |
| Andersen, CU; Dabrowski, K; Hansen, KB; Høimark, L; Sædder, E | 2 |
| Gillies, D; Kalakouti, E; Kyprianou, K; McLoughlin, BC; Pushpa-Rajah, JA; Rathbone, J; Variend, H | 1 |
| Bianchini, O; Porcelli, S; Serretti, A | 1 |
| Cipriani, A; Davis, JM; Furukawa, TA; Goldberg, Y; Leucht, S; Levine, SZ; Samara, M; Tanaka, S | 1 |
| Amorin-Díaz, M; Aparicio-Castro, E; López-Rodríguez, E; Molina, JD; Muñoz Algar, MJ; Toledo-Romero, F | 1 |
| Chen, CY; Chen, TY; Chuang, WC; Kuo, SC; Yeh, YW | 1 |
| Adali, I; Asri, F; Benali, A; Manoudi, F; Nabih, FO | 1 |
| Dimitrakopoulou, V; Efthimiou, O; Leucht, S; Salanti, G | 1 |
| Abler, B; Graf, H; Grön, G; Metzger, CD; Walter, M; Wiegers, M | 2 |
| Berling, I; Isbister, GK | 1 |
| Chee, IS; Kang, SG; Lee, HJ; Lee, J; Lee, K; Na, KS | 1 |
| Allerup, P; Bak, N; Frandsen, E; Glenthøj, BY; Jensen, LT; Nielsen, MØ; Pinborg, LH; Rasmussen, H; Rostrup, E; Svarer, C; Wulff, S | 1 |
| Haker, H; Kahnt, T; Robbins, TW; Tobler, PN; Weber, SC | 1 |
| Hołuj, M; Nikiforuk, A; Popik, P | 1 |
| Arango, C; Fleischhacker, WW; Glenthøj, B; Heres, S; Kahn, RS; Kapur, S; Leboyer, M; Leucht, S; Leweke, FM; Lewis, S; McGuire, P; Meyer-Lindenberg, A; Rujescu, D; Sommer, IE; Winter-van Rossum, I | 1 |
| Chen, CK; Chen, TY; Chu, CS; Hong, CC; Yeh, TC | 1 |
| López-Jornet, P; Silvestre, FJ; Silvestre-Rangil, J | 1 |
| Cordes, J; Grohmann, R; Konstantinidis, A; Laoutidis, ZG; Luckhaus, C; Mobascher, J | 1 |
| Barceló, D; Gros, M; Kookana, RS; Llorca, M; Rodriguez-Mozaz, S; Williams, M | 1 |
| Joyce, DW; Mateos Fernandez, MJ; Sarkar, SN; Shergill, SS; Tracy, DK | 1 |
| Abler, B; Graf, H; Metzger, CD; Walter, M; Wiegers, M | 1 |
| Dulawa, SC; Ho, EV; Klenotich, SJ; McMurray, MS; Server, CH | 1 |
| Gao, N; Huang, JZ; Li, KQ; Liang, Y; Si, TM; Su, YA; Tang, MQ; Yang, FD; Yu, X; Zhao, ZG | 1 |
| Düring, S; Glenthøj, BY; Oranje, B | 1 |
| Ananthan, S; Głowacka, U; Kosmowska, B; Ossowska, K; Wardas, J | 1 |
| Chang, CM; Chen, PJ; Lee, CP | 1 |
| Hsieh, CY; Kao Yang, YH; Lai, EC; Lin, SJ; Setoguchi, S; Wong, MB; Yang, YK | 1 |
| Howes, O; Jauhar, S; McCutcheon, R; Rogdaki, M | 1 |
| Ebdrup, BH; Glenthøj, B; Nielsen, MØ; Raghava, JM; Rostrup, E | 1 |
| Chen, CY; Ho, PS; Huang, SY; Kuo, SC; Liang, CS; Lu, RB; Yeh, YW; Yen, CH | 1 |
| Ebdrup, BH; Glenthøj, B; Nielsen, MØ; Rostrup, E; Wulff, S | 1 |
| Dafreville, C; Mété, D; Paitel, V; Wind, P | 1 |
| Hema, T; Maran, S; Subhashini, G | 1 |
| Garg, A; Sinha, P | 1 |
| Antczak, A; Górski, P; Karbownik, MS; Kowalczyk, E; Pietras, T; Szemraj, J; Wieteska, Ł | 1 |
| Cao, C; Chen, Z; Deng, H; Dong, F; Gao, M; Hong, L; Li, X; Li, Y; Liang, Y; Liu, T; Lu, S; Su, L; Tang, J; Tang, M; Wang, C; Wang, X; Xie, S; Xin, L; Xu, X; Yang, F; Yu, J; Yu, X; Zhang, C; Zhang, Y; Zhu, C | 1 |
| Joyce, DA; OʼHalloran, SJ; Wong, A | 1 |
| Fordham, N; Koh, M; Pickard, L | 1 |
| Chen, CS; Huang, MF; Su, CH | 1 |
| Buonaguro, EF; de Bartolomeis, A; Iasevoli, F; Latte, G; Marmo, F; Tomasetti, C | 1 |
| Ferber, G; Fernandes, S; Täubel, J | 1 |
| Furtado, VA; Li, BG; Sampford, JR; Sampson, S; Xia, J; Zhao, S | 1 |
| Beck-Schimmer, B; Kajdi, ME; Müller, D; Quednow, BB; Tobler, PN; Weber, SC | 1 |
| Bertrand, J; Brownings, S; D'Antonio, F; Greaves, S; Howard, R; McLachlan, E; Nair, A; Reeves, S; Smith, A; Taylor, D | 1 |
| Bollmann, AF; Lucke, T; Prasse, C; Schulz, W; Seitz, W; Ternes, T | 1 |
| Akpek, M; Avcil, M; Kantekin, B; Kapçı, M; Yavaşoğlu, I | 1 |
| Bas, A; Bas, TO; Duran, A; Emul, M; Gultekin, G; Incir, S | 1 |
| Bergese, SD; Candiotti, KA; Chassard, D; Diemunsch, P; Eberhart, L; Fox, G; Gan, TJ; Kovac, AL; Kranke, P; Leiman, DG; Melson, TI; Minkowitz, HS; Motsch, J | 1 |
| Skibinski, R; Trawinski, J | 1 |
| Kahnt, T; Tobler, PN | 1 |
| Beyer, C; Fisher, DS; Flanagan, RJ; Seedat, S; van Schalkwyk, G | 1 |
| Chee, IS; Kang, SG; Lee, J; Lee, K | 1 |
| Barber, S; Cipriani, A; Corsi, M; Olotu, U | 1 |
| Bertrand, J; Brownings, S; D'Antonio, F; Dunn, J; Greaves, S; Howard, R; Kessler, R; Marsden, P; McLachlan, E; Nair, A; Reeves, S; Smith, A; Taylor, D | 1 |
| Chen, DY; Zhang, WP | 1 |
| Bonarek, P; Chmielińska, A; Dziedzicka-Wasylewska, M; Polit, A; Skrobecki, P; Stepien, P; Wisniewska-Becker, A | 1 |
| Bak, N; Düring, SW; Ebdrup, BH; Fagerlund, B; Glenthøj, BY; Hansen, LK; Jensen, MH; Nielsen, MØ; Oranje, B | 1 |
| Fahmy, RH; Gamal, W; Mohamed, MI | 2 |
| Christensen, TB; Daugaard, G; Fox, GM; Herrstedt, J; Holmskov, K; Molassiotis, A; Summers, Y; Taylor, PD | 1 |
| Bertrand, J; Brownings, S; D'Antonio, F; Dunn, JT; Greaves, S; Howard, R; Kessler, R; Marsden, P; McLachlan, E; Nair, A; Reeves, S; Smith, A; Taylor, D; Uchida, H | 1 |
| Amos, T; Bagalkote, H; Barnes, TR; Davies, L; Fitzgerald, Z; Fridrich, P; Haddad, PM; Husni, M; Iqbal, K; Keown, P; Kumar, R; Leeson, VC; Marston, L; Osborn, D; Paton, C; Singh, V; Whittaker, W; Zafar, R | 1 |
| Chang, HS; Chee, IS; Kang, SG; Lee, J; Lee, K; Na, KS | 1 |
| Barrimi, M; El Ghazouani, F; Oneib, B; Zaimi, O | 1 |
| Abd El-Rahman, MK; Habib, BA; Nageeb El-Helaly, S | 1 |
| Gao, LJ; Guo, HG; Liang, ZT; Yang, Y; Zhong, XX; Zhu, JC | 1 |
| Ahmed Farid, OA; Shukr, MH | 1 |
| Jasińska-Stroschein, M; Jóźwiak-Bębenista, M; Kowalczyk, E | 1 |
| Aguirre, C; Erezuma, I; Garcia, M; Hernandez, R; Lertxundi, U; Medrano, J | 1 |
| Li, L; Ning, YP; Shang, DW; Wen, YG | 1 |
| Claro, A; Corte-Real, F; Franco, J; Monteiro, C; Mustra, C; Proença, P | 1 |
| Ni, Y; Pan, A; Wang, G; Zheng, L; Zhou, B | 1 |
| Gao, Z; Jin, W; Ren, Z; Sun, F; Yu, F | 1 |
| Berg, M; Lincoln, T; Rief, W | 1 |
| Osman, E; Yıldız, M | 1 |
| Chiron, S; Gomez, O; Manasfi, R; Perez, S; Tadić, D | 1 |
| Hu, QY; Huang, Y; Jin, Y; Li, ZZ; Liu, MJ; Liu, ZJ; Lv, QY; Shi, DH; Tan, HY; Wu, FC; Yang, JY; Yi, ZH; Zhao, L; Zhu, MH; Zhu, N | 1 |
| Berg, M; Lincoln, T; Rief, W; Riehle, M | 1 |
| Wang, H; Wang, Y; Yang, S; Zheng, GF | 1 |
80 review(s) available for dan 2163 and sulpiride
| Article | Year |
|---|---|
Chemical update on the potential for serotonin 5-HT
Topics: Alzheimer Disease; Animals; Humans; Nootropic Agents; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 2021 |
Clinical trials of benzamides in psychiatry.
Topics: Amisulpride; Animals; Benzamides; Humans; Mental Disorders; Metoclopramide; Sulpiride; Tiapamil Hydrochloride | 1982 |
[The place of amisulpride in the atypical neuroleptic class].
Topics: Amisulpride; Animals; Depression; Humans; Limbic System; Neurologic Examination; Rats; Receptors, Dopamine; Schizophrenia; Schizophrenic Psychology; Sulpiride | 1996 |
Amisulpride compared with standard neuroleptics in acute exacerbations of schizophrenia: three efficacy studies.
Topics: Adult; Amisulpride; Antipsychotic Agents; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Flupenthixol; Haloperidol; Humans; Male; Middle Aged; Multicenter Studies as Topic; Neurologic Examination; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Sulpiride; Treatment Outcome | 1997 |
Clinical update on amisulpride in deficit schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Depression; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Sulpiride; Treatment Outcome | 1997 |
Amisulpride: from animal pharmacology to therapeutic action.
Topics: Amisulpride; Animals; Antipsychotic Agents; Behavior, Animal; Brain; Humans; Limbic System; Mice; Rats; Receptors, Dopamine D2; Receptors, Dopamine D3; Schizophrenia; Sulpiride | 1997 |
Safety of amisulpride (Solian): a review of 11 clinical studies.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Basal Ganglia Diseases; Blood Cell Count; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Electrocardiography; Female; Hemodynamics; Humans; Liver Function Tests; Male; Middle Aged; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Sulpiride | 1999 |
[New antipsychotic agents].
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Pirenzepine; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Sulpiride; Thiazoles | 1999 |
Amisulpride: a review of its efficacy in schizophrenia.
Topics: Acute Disease; Amisulpride; Antipsychotic Agents; Brief Psychiatric Rating Scale; Chronic Disease; Clinical Trials as Topic; Flupenthixol; Haloperidol; Humans; Risperidone; Schizophrenia; Sulpiride; Treatment Outcome | 2000 |
Safety profile of amisulpride in short- and long-term use.
Topics: Amisulpride; Antipsychotic Agents; Chronic Disease; Clinical Trials as Topic; Drug Administration Schedule; Female; Haloperidol; Humans; Male; Risperidone; Schizophrenia; Sulpiride; Treatment Outcome | 2000 |
[New i.e. atypical neuroleptic agents for negative symptoms of schizophrenia: results and methodological problems of evaluation].
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dibenzothiepins; Double-Blind Method; Dyskinesia, Drug-Induced; Humans; Imidazoles; Indoles; Neurotransmitter Agents; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride; Thiazoles | 2000 |
Atypical antipsychotics and weight gain--a systematic review.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dibenzothiepins; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Risperidone; Sulpiride; Thiazoles; Weight Gain | 2000 |
Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Drug Costs; Humans; Imidazoles; Indoles; Olanzapine; Pirenzepine; Quetiapine Fumarate; Regression Analysis; Risperidone; Schizophrenia; Sulpiride | 2000 |
Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dibenzothiepins; Dopamine Antagonists; Drug Monitoring; Haloperidol; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Receptors, Dopamine D2; Receptors, Dopamine D4; Risperidone; Schizophrenia; Schizophrenic Psychology; Serotonin Antagonists; Sulpiride; Thiazoles; Treatment Outcome | 2001 |
[Atypical neuroleptics: new approaches to drug therapy of schizophrenic disorders].
Topics: Aged; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Controlled Clinical Trials as Topic; Dibenzothiazepines; Dibenzothiepins; Haloperidol; Humans; Imidazoles; Indoles; Multicenter Studies as Topic; Olanzapine; Piperazines; Pirenzepine; Placebos; Quetiapine Fumarate; Risperidone; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sulpiride; Thiazoles | 2000 |
Which role for amisulpride in rehabilitation of schizophrenic patients with acute exacerbation?
Topics: Acute Disease; Amisulpride; Antipsychotic Agents; Dose-Response Relationship, Drug; Humans; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Sulpiride; Treatment Outcome | 2000 |
Consensus on the Practical Use of Amisulpride, an Atypical Antipsychotic, in the Treatment of Schizophrenia.
Topics: Adult; Aged; Amisulpride; Antipsychotic Agents; Double-Blind Method; Feasibility Studies; France; Humans; Middle Aged; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Sulpiride; Treatment Outcome | 2001 |
Amisulpride: a review of its use in the management of schizophrenia.
Topics: Acute Disease; Administration, Oral; Adsorption; Amisulpride; Antipsychotic Agents; Chronic Disease; Dose-Response Relationship, Drug; Drug Costs; Humans; Neurosecretory Systems; Psychometrics; Quality of Life; Randomized Controlled Trials as Topic; Receptors, Dopamine; Schizophrenia; Sulpiride; Tissue Distribution; Treatment Outcome | 2001 |
Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Models, Neurological; Olanzapine; Pirenzepine; Quetiapine Fumarate; Receptors, Dopamine D2; Risperidone; Schizophrenia; Sulpiride | 2001 |
Social functioning and quality of life in the schizophrenic patient: advantages of amisulpride.
Topics: Amisulpride; Antipsychotic Agents; Humans; Quality of Life; Schizophrenia; Schizophrenic Psychology; Social Behavior; Sulpiride | 2002 |
Amisulpride, an unusual "atypical" antipsychotic: a meta-analysis of randomized controlled trials.
Topics: Amisulpride; Antipsychotic Agents; Humans; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Sulpiride; Treatment Outcome | 2002 |
Spotlight on amisulpride in schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Humans; Schizophrenia; Sulpiride | 2002 |
The substituted benzamides and their clinical potential on dysthymia and on the negative symptoms of schizophrenia.
Topics: Amisulpride; Antidepressive Agents; Benzamides; Dysthymic Disorder; Humans; Receptors, Dopamine D1; Schizophrenia; Structure-Activity Relationship; Sulpiride | 2002 |
Tardive dyskinesias and antipsychotics: a review.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dyskinesia, Drug-Induced; Humans; Olanzapine; Pirenzepine; Prevalence; Psychotic Disorders; Risperidone; Sulpiride | 2002 |
Amisulpride for schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Humans; Randomized Controlled Trials as Topic; Schizophrenia; Sulpiride | 2002 |
Focus on amisulpride.
Topics: Amisulpride; Antipsychotic Agents; Controlled Clinical Trials as Topic; Dysthymic Disorder; Humans; Schizophrenia; Schizophrenic Psychology; Sulpiride; Treatment Outcome | 2002 |
A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers.
Topics: Amisulpride; Antipsychotic Agents; Clinical Trials as Topic; Dopamine; Electroencephalography; Humans; Memory; Psychomotor Performance; Psychotic Disorders; Sulpiride | 2002 |
Clinical implications of dopamine research in schizophrenia.
Topics: Amisulpride; Animals; Antipsychotic Agents; Basal Ganglia Diseases; Humans; Receptors, Dopamine; Research; Schizophrenia; Sulpiride | 2002 |
Amisulpride: progress and outcomes.
Topics: Amisulpride; Antipsychotic Agents; Basal Ganglia Diseases; Humans; Quality of Life; Receptors, Dopamine; Schizophrenia; Sulpiride; Treatment Outcome | 2002 |
Switching to amisulpride.
Topics: Amisulpride; Antipsychotic Agents; Humans; Patient Care Planning; Practice Guidelines as Topic; Practice Patterns, Physicians'; Schizophrenia; Sulpiride | 2002 |
[Schizoaffective disorder: clinical symptoms and present-day approach to treatment].
Topics: Adolescent; Amisulpride; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Child; Diagnosis, Differential; Dibenzothiazepines; Dogs; Female; Humans; Imidazoles; Indoles; Lithium Carbonate; Male; Mianserin; Middle Aged; Mirtazapine; Olanzapine; Piperazines; Pirenzepine; Placebos; Prognosis; Psychotic Disorders; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Sulpiride; Thiazoles; Time Factors | 2002 |
Dopaminergic deficit and the role of amisulpride in the treatment of mood disorders.
Topics: Amisulpride; Animals; Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder, Major; Dopamine; Dysthymic Disorder; Humans; Sulpiride | 2002 |
Dopaminergic deficit and the role of amisulpride in the treatment of schizophrenia.
Topics: Amisulpride; Animals; Antipsychotic Agents; Clinical Trials as Topic; Dopamine; Dose-Response Relationship, Drug; Humans; Rats; Schizophrenia; Schizophrenic Psychology; Sulpiride | 2002 |
Pharmacological approaches to the management of schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Pirenzepine; Quetiapine Fumarate; Risperidone; Schizophrenia; Sulpiride | 2003 |
Amisulpride: limbic specificity and the mechanism of antipsychotic atypicality.
Topics: Amisulpride; Animals; Antipsychotic Agents; Catalepsy; Dissociative Disorders; Dopamine Antagonists; Dose-Response Relationship, Drug; Humans; Limbic System; Receptors, Dopamine; Receptors, Presynaptic; Sulpiride | 2003 |
Combination of clozapine and amisulpride in treatment-resistant schizophrenia--case reports and review of the literature.
Topics: Adult; Amisulpride; Antipsychotic Agents; Body Weight; Clozapine; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Psychiatric Status Rating Scales; Retrospective Studies; Schizophrenia; Schizophrenic Psychology; Sulpiride | 2004 |
Amisulpride a selective dopamine antagonist and atypical antipsychotic: results of a meta-analysis of randomized controlled trials.
Topics: Amisulpride; Antipsychotic Agents; Brief Psychiatric Rating Scale; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Humans; Limbic System; Mesencephalon; Randomized Controlled Trials as Topic; Receptors, Dopamine D3; Schizophrenia; Schizophrenic Psychology; Sulpiride; Treatment Outcome | 2004 |
How do we choose between atypical antipsychotics? The advantages of amisulpride.
Topics: Adverse Drug Reaction Reporting Systems; Amisulpride; Antipsychotic Agents; Clinical Trials as Topic; Dopamine Antagonists; Humans; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Sulpiride; Treatment Outcome; Weight Gain | 2004 |
Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Benzodiazepines; Child; Dibenzothiazepines; Double-Blind Method; Dyskinesia, Drug-Induced; Haloperidol; Humans; Middle Aged; Neurologic Examination; Olanzapine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risk; Sulpiride; Thiazoles | 2004 |
[Current pharmacotherapy of schizophrenia].
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Serotonin Antagonists; Sulpiride; Thiazoles | 2004 |
[The features of atypical neuroleptic amisulpride action].
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amisulpride; Antipsychotic Agents; Clinical Trials as Topic; Drug Interactions; Drug Therapy, Combination; Electrocardiography; Female; Haloperidol; Humans; Male; Middle Aged; Multicenter Studies as Topic; Risperidone; Schizophrenia; Sulpiride | 2004 |
Consensus on the use of substituted benzamides in psychiatric patients.
Topics: Amisulpride; Antipsychotic Agents; Benzamides; Depressive Disorder; Humans; Mental Disorders; Schizophrenia; Sulpiride | 2004 |
[Psychotropics and weight gain].
Topics: Adolescent; Adult; Amisulpride; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Mass Index; Child; Clozapine; Dibenzothiazepines; Double-Blind Method; Female; Fructose; Haloperidol; Humans; Imidazoles; Indoles; Male; Obesity; Olanzapine; Piperazines; Placebos; Psychotropic Drugs; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Socioeconomic Factors; Sulpiride; Thiazoles; Time Factors; Topiramate; Valproic Acid; Weight Gain | 2004 |
Amisulpride: a review of its use in the management of schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Interactions; Drug Tolerance; Economics, Pharmaceutical; Humans; Quality of Life; Schizophrenia; Schizophrenic Psychology; Sulpiride; Treatment Outcome | 2004 |
Schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Clozapine; Cognitive Behavioral Therapy; Dibenzothiepins; Haloperidol; Humans; Olanzapine; Patient Compliance; Perazine; Pimozide; Risperidone; Schizophrenia; Sulpiride | 2003 |
Schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Clozapine; Haloperidol; Humans; Olanzapine; Patient Compliance; Perazine; Pimozide; Risperidone; Schizophrenia; Sulpiride | 2004 |
Early-onset hypothesis of antipsychotic drug action: a hypothesis tested, confirmed and extended.
Topics: Amisulpride; Antipsychotic Agents; Brief Psychiatric Rating Scale; Databases as Topic; Female; Humans; Male; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Sensitivity and Specificity; Statistics as Topic; Sulpiride; Time Factors; Treatment Outcome | 2005 |
A typical mood stabilizers: a "typical role for atypical antipsychotics.
Topics: Affect; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Clozapine; Dibenzothiazepines; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Secondary Prevention; Sulpiride; Thiazoles | 2005 |
[From cradle to grave? Expectations from atypical antipsychotics].
Topics: Amisulpride; Antipsychotic Agents; Clozapine; Humans; Sulpiride | 2005 |
Schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Chlorpromazine; Clozapine; Cognitive Behavioral Therapy; Dibenzothiepins; Family Therapy; Haloperidol; Humans; Patient Compliance; Risperidone; Schizophrenia; Secondary Prevention; Sulpiride; Thioridazine | 2005 |
Haloperidol alone or in combination for acute mania.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Dibenzothiazepines; Drug Therapy, Combination; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Sulpiride; Valproic Acid | 2006 |
[The benzamides tiapride, sulpiride, and amisulpride in treatment for Tourette's syndrome].
Topics: Amisulpride; Anti-Dyskinesia Agents; Benzamides; Dopamine Antagonists; Germany; Humans; Practice Guidelines as Topic; Practice Patterns, Physicians'; Sulpiride; Tiapamil Hydrochloride; Tourette Syndrome; Treatment Outcome | 2007 |
[The use of atypical antipsychotics in the long-term care of schizophrenia].
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Benzodiazepines; Clozapine; Cognition Disorders; Drug Tolerance; Dyskinesia, Drug-Induced; Haloperidol; Humans; Olanzapine; Piperazines; Quinolones; Risperidone; Schizophrenia; Sulpiride; Time Factors | 2006 |
Practical issues with amisulpride in the management of patients with schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Drug Resistance; Drug Therapy, Combination; Humans; Schizophrenia; Schizophrenic Psychology; Sulpiride | 2008 |
Akathisia and second-generation antipsychotic drugs.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Isoxazoles; Olanzapine; Piperazines; Piperidines; Prevalence; Psychomotor Agitation; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risk Factors; Risperidone; Sulpiride; Thiazoles | 2009 |
Amisulpride - dose, plasma concentration, occupancy and response: implications for therapeutic drug monitoring.
Topics: Amisulpride; Antipsychotic Agents; Basal Ganglia Diseases; Clinical Trials as Topic; Drug Monitoring; Humans; Psychotic Disorders; Receptors, Dopamine; Schizophrenia; Sulpiride; Treatment Outcome | 2009 |
Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Clozapine; Dibenzothiazepines; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride; Thiazoles | 2009 |
Ziprasidone versus other atypical antipsychotics for schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride; Thiazoles | 2009 |
Amisulpride versus other atypical antipsychotics for schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Humans; Olanzapine; Piperazines; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride; Thiazoles | 2010 |
Antipsychotic medication, functional outcome and quality of life in schizophrenia: focus on amisulpride.
Topics: Activities of Daily Living; Amisulpride; Antipsychotic Agents; Clinical Trials as Topic; Humans; Quality of Life; Schizophrenia; Sulpiride; Treatment Outcome | 2010 |
Olanzapine versus other atypical antipsychotics for schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Sulpiride; Thiazoles | 2010 |
Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood Glucose; Cholesterol; Clinical Trials as Topic; Clozapine; Dibenzothiazepines; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Sulpiride; Thiazoles; Weight Gain | 2010 |
Second-generation antipsychotics in major depressive disorder: update and clinical perspective.
Topics: Adult; Amisulpride; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Depressive Disorder, Major; Dibenzothiazepines; Drug Therapy, Combination; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Sulpiride | 2011 |
Second-generation antipsychotics for major depressive disorder and dysthymia.
Topics: Amisulpride; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Depressive Disorder, Major; Dibenzothiazepines; Dysthymic Disorder; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Sulpiride | 2010 |
Risperidone versus other atypical antipsychotics for schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride; Thiazoles | 2011 |
Temporal lobe epilepsy masquerading as psychosis--a case report and literature review.
Topics: Adult; Amisulpride; Anticonvulsants; Antipsychotic Agents; Diagnosis, Differential; Epilepsy, Temporal Lobe; Female; Humans; Lamotrigine; Psychotic Disorders; Sulpiride; Treatment Outcome; Triazines | 2012 |
Delayed- and early-onset hypotheses of antipsychotic drug action in the negative symptoms of schizophrenia.
Topics: Amisulpride; Anhedonia; Antipsychotic Agents; Drug Resistance; Humans; Randomized Controlled Trials as Topic; Reproducibility of Results; Schizophrenia; Schizophrenic Psychology; Sulpiride; Time Factors | 2012 |
Drug-induced hypo- and hyperprolactinemia: mechanisms, clinical and therapeutic consequences.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Blood-Brain Barrier; Humans; Hyperprolactinemia; Isoxazoles; Paliperidone Palmitate; Piperazines; Prolactin; Pyrimidines; Quinolones; Receptors, Dopamine D2; Risperidone; Stress, Psychological; Sulpiride; Xenobiotics | 2013 |
Atypical antipsychotics in the treatment of delirium.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Delirium; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Sulpiride; Thiazoles | 2013 |
Is amisulpride safe when prescribed to breast and prostate cancer patients?
Topics: Amisulpride; Antidepressive Agents; Breast Neoplasms; Depression; Female; Humans; Hyperprolactinemia; Male; Prostatic Neoplasms; Risk Assessment; Sulpiride | 2013 |
Current status of atypical antipsychotics for the treatment of fibromyalgia.
Topics: Amisulpride; Antipsychotic Agents; Anxiety; Benzodiazepines; Comorbidity; Depression; Dibenzothiazepines; Fibromyalgia; Humans; Olanzapine; Patient Selection; Piperazines; Quetiapine Fumarate; Sulpiride; Thiazoles; Treatment Outcome | 2014 |
[Sparse evidence of antipsychotic drugs for the treatment of delirium].
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Delirium; Evidence-Based Medicine; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Sulpiride; Thiazoles | 2014 |
Cannabis and schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Cannabinoids; Humans; Marijuana Abuse; Medical Marijuana; Olanzapine; Psychotherapy; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride | 2014 |
[Sparse evidence of antipsychotic drugs for the treatment of delirium].
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Delirium; Evidence-Based Medicine; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Sulpiride; Thiazoles | 2014 |
Initial severity of schizophrenia and efficacy of antipsychotics: participant-level meta-analysis of 6 placebo-controlled studies.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Drug Monitoring; Female; Humans; Male; Olanzapine; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Sulpiride; Treatment Outcome | 2015 |
The optimization of treatment and management of schizophrenia in Europe (OPTiMiSE) trial: rationale for its methodology and a review of the effectiveness of switching antipsychotics.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Disease Management; Europe; Humans; Multicenter Studies as Topic; Olanzapine; Outcome Assessment, Health Care; Psychotic Disorders; Randomized Controlled Trials as Topic; Schizophrenia; Sulpiride | 2015 |
Burning mouth syndrome: a review and update.
Topics: Adult; Age Distribution; Aged; Algorithms; Amisulpride; Antidepressive Agents; Burning Mouth Syndrome; Clonazepam; Deficiency Diseases; Dentures; Duloxetine Hydrochloride; Female; Humans; Male; Menopause; Middle Aged; Mood Disorders; Nerve Fibers, Unmyelinated; Orthodontic Appliances; Sex Distribution; Sulpiride; Tongue Habits | 2015 |
Fluphenazine (oral) versus atypical antipsychotics for schizophrenia.
Topics: Administration, Oral; Amisulpride; Antipsychotic Agents; Benzodiazepines; Fluphenazine; Humans; Olanzapine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride; Treatment Outcome | 2016 |
Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Clozapine; Dibenzothiazepines; Drug Resistance; Drug Therapy, Combination; Female; Haloperidol; Humans; Male; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride; Thiazoles; Weight Gain | 2017 |
A systematic review and combined meta-analysis of concentration of oral amisulpride.
Topics: Aged; Amisulpride; Antipsychotic Agents; Drug Monitoring; Female; Humans; Schizophrenia; Sulpiride | 2020 |
145 trial(s) available for dan 2163 and sulpiride
| Article | Year |
|---|---|
Amisulpride versus bromocriptine in infantile autism: a controlled crossover comparative study of two drugs with opposite effects on dopaminergic function.
Topics: Adolescent; Amisulpride; Antipsychotic Agents; Autistic Disorder; Brain; Bromocriptine; Child; Child, Preschool; Dopamine Antagonists; Double-Blind Method; Female; Humans; Male; Psychiatric Status Rating Scales; Receptors, Dopamine; Sulpiride | 1992 |
Treatment of positive and negative symptoms: pharmacologic approaches.
Topics: Adult; Amisulpride; Antipsychotic Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Sulpiride | 1990 |
Amisulpride versus haloperidol in treatment of schizophrenic patients--results of a double-blind study.
Topics: Adult; Amisulpride; Antipsychotic Agents; Basal Ganglia Diseases; Double-Blind Method; Female; Haloperidol; Hemodynamics; Humans; Male; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Sulpiride | 1990 |
Akathisia, motility, and locomotion in healthy volunteers.
Topics: Adult; Affect; Akathisia, Drug-Induced; Amisulpride; Apomorphine; Dopamine; Double-Blind Method; Gait; Humans; Male; Motor Activity; Psychotropic Drugs; Sulpiride | 1990 |
[Benzamides, a therapeutic response adapted to 2 sides, paranoid and hebephrenic, of schizophrenia].
Topics: Amisulpride; Antipsychotic Agents; Benzamides; Clinical Trials as Topic; Double-Blind Method; Humans; Psychotropic Drugs; Schizophrenia; Schizophrenia, Disorganized; Schizophrenia, Paranoid; Sulpiride | 1985 |
Amisulpride--an open clinical study of a new benzamide in schizophrenic patients.
Topics: Adult; Amisulpride; Antipsychotic Agents; Basal Ganglia Diseases; Clinical Trials as Topic; Electroencephalography; Female; Humans; Male; Schizophrenia; Sulpiride | 1984 |
[Comparative study of the effects of sultopride and haloperidol in agitation states. 94 cases at the psychiatric infirmary of the Paris police headquarters].
Topics: Amisulpride; Haloperidol; Humans; Psychomotor Agitation; Sulpiride | 1983 |
[Longterm psychosis and sultopride].
Topics: Adult; Amisulpride; Chronic Disease; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Psychotic Disorders; Psychotropic Drugs; Sulpiride | 1983 |
[Early infantile psychoses and sultopride].
Topics: Adult; Amisulpride; Clinical Trials as Topic; Humans; Male; Psychotic Disorders; Psychotropic Drugs; Sulpiride | 1982 |
Improvement of some schizophrenic deficit symptoms with low doses of amisulpride.
Topics: Adult; Amisulpride; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Placebos; Psychiatric Status Rating Scales; Psychotropic Drugs; Schizophrenia; Schizophrenic Psychology; Sulpiride; Treatment Outcome | 1995 |
Neuroendocrine profile of SDZ HDC-912 and OPC-4392, two new atypical antipsychotic drugs, in schizophrenic patients.
Topics: Adult; Amisulpride; Antipsychotic Agents; Apomorphine; Dopamine Agonists; Ergolines; Female; Growth Hormone; Humans; Male; Neurosecretory Systems; Piperazines; Prolactin; Quinolones; Schizophrenia; Sulpiride | 1993 |
Treatment of negative symptoms in schizophrenia with amisulpride.
Topics: Adult; Amisulpride; Antipsychotic Agents; Depression; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Receptors, Dopamine; Schizophrenia; Schizophrenic Psychology; Sulpiride | 1995 |
Clinical, EEG mapping and psychometric studies in negative schizophrenia: comparative trials with amisulpride and fluphenazine.
Topics: Adult; Amisulpride; Antipsychotic Agents; Arousal; Attention; Brain Mapping; Cerebral Cortex; Dose-Response Relationship, Drug; Double-Blind Method; Electroencephalography; Evoked Potentials; Female; Fluphenazine; Humans; Male; Neuropsychological Tests; Psychiatric Status Rating Scales; Psychometrics; Schizophrenia; Schizophrenic Psychology; Signal Processing, Computer-Assisted; Sulpiride | 1994 |
[Comparison of the effect of amisulpride and viloxazine in the treatment of dysthymia].
Topics: Adolescent; Adult; Age Distribution; Amisulpride; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychotropic Drugs; Sex Distribution; Socioeconomic Factors; Sulpiride; Viloxazine | 1994 |
Stereospecific determination of amisulpride, a new benzamide derivative, in human plasma and urine by automated solid-phase extraction and liquid chromatography on a chiral column. application to pharmacokinetics.
Topics: Amisulpride; Antipsychotic Agents; Autoanalysis; Chromatography, High Pressure Liquid; Humans; Indicators and Reagents; Reference Standards; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Stereoisomerism; Sulpiride | 1996 |
Determination of amisulpride, a new benzamide derivative, in human plasma and urine by liquid-liquid extraction or solid-phase extraction in combination with high-performance liquid chromatography and fluorescence detection. application to pharmacokinetic
Topics: Amisulpride; Antipsychotic Agents; Chromatography, High Pressure Liquid; Humans; Indicators and Reagents; Reference Standards; Solutions; Spectrometry, Fluorescence; Sulpiride | 1996 |
Single oral doses of amisulpride do not enhance the effects of alcohol on the performance and memory of healthy subjects.
Topics: Adult; Amisulpride; Analysis of Variance; Antipsychotic Agents; Cognition; Cross-Over Studies; Double-Blind Method; Drug Interactions; Ethanol; Female; Humans; Male; Memory; Psychomotor Performance; Sulpiride | 1996 |
In vivo characteristics of dopamine D2 receptor occupancy by amisulpride in schizophrenia.
Topics: Adult; Amisulpride; Brain; Female; Humans; Male; Receptors, Dopamine D2; Schizophrenia; Sulpiride; Tomography, Emission-Computed | 1996 |
Amisulpride versus placebo in the medium-term treatment of the negative symptoms of schizophrenia.
Topics: Adult; Akathisia, Drug-Induced; Amisulpride; Antiparkinson Agents; Antipsychotic Agents; Double-Blind Method; Female; Humans; Male; Schizophrenia; Sulpiride; Treatment Outcome; Treatment Refusal | 1997 |
Amisulpride versus imipramine and placebo in dysthymia and major depression. Amisulpride Study Group.
Topics: Adult; Aged; Amisulpride; Antidepressive Agents; Antidepressive Agents, Tricyclic; Depression; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Sulpiride | 1997 |
Effects of haloperidol and amisulpride on motor and cognitive skill learning in healthy volunteers.
Topics: Adult; Amisulpride; Analysis of Variance; Antipsychotic Agents; Cognition; Female; Haloperidol; Humans; Learning; Male; Memory; Psychomotor Performance; Sulpiride | 1997 |
Improvement of acute exacerbations of schizophrenia with amisulpride: a comparison with haloperidol. PROD-ASLP Study Group.
Topics: Adult; Akathisia, Drug-Induced; Amisulpride; Antipsychotic Agents; Brief Psychiatric Rating Scale; Double-Blind Method; Female; Haloperidol; Humans; Male; Movement Disorders; Schizophrenia; Sulpiride | 1997 |
Amisulpride versus fluoxetine in patients with dysthymia or major depression in partial remission: a double-blind, comparative study.
Topics: Adolescent; Adult; Aged; Amisulpride; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Double-Blind Method; Dysthymic Disorder; Female; Fluoxetine; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Remission Induction; Severity of Illness Index; Sulpiride | 1998 |
One-year, low-dose neuroleptic study of in-patients with chronic schizophrenia characterised by persistent negative symptoms. Amisulpride v. haloperidol.
Topics: Adult; Aged; Amisulpride; Antipsychotic Agents; Chronic Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Schizophrenia; Schizophrenic Psychology; Sulpiride | 1997 |
Amisulpride versus flupentixol in schizophrenia with predominantly positive symptomatology -- a double-blind controlled study comparing a selective D2-like antagonist to a mixed D1-/D2-like antagonist. The Amisulpride Study Group.
Topics: Adult; Amisulpride; Antipsychotic Agents; Dopamine Antagonists; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Flupenthixol; Humans; Male; Middle Aged; Neurologic Examination; Psychiatric Status Rating Scales; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride; Treatment Outcome | 1998 |
Amisulpride, and atypical antipsychotic, in the treatment of acute episodes of schizophrenia: a dose-ranging study vs. haloperidol. The Amisulpride Study Group.
Topics: Acute Disease; Adult; Amisulpride; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Haloperidol; Humans; Male; Middle Aged; Neurologic Examination; Psychiatric Status Rating Scales; Schizophrenia; Sulpiride; Treatment Outcome | 1998 |
Safety and pharmacokinetics of a single oral dose of amisulpride in healthy elderly volunteers.
Topics: Administration, Oral; Adult; Aged; Aging; Amisulpride; Antipsychotic Agents; Drug Administration Schedule; Female; Humans; Male; Sulpiride | 1998 |
Amisulpride versus amineptine and placebo for the treatment of dysthymia.
Topics: Amisulpride; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Dibenzocycloheptenes; Double-Blind Method; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Sulpiride | 1999 |
Neuroendocrine response to antipsychotics: effects of drug type and gender.
Topics: Adult; Amisulpride; Antipsychotic Agents; Double-Blind Method; Female; Flupenthixol; Human Growth Hormone; Humans; Male; Neurosecretory Systems; Prolactin; Schizophrenia; Schizophrenic Psychology; Sex Factors; Sulpiride; Thyrotropin | 1999 |
Improvement of schizophrenic patients with primary negative symptoms treated with amisulpride. Amisulpride Study Group.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Single-Blind Method; Sulpiride; Treatment Outcome | 1999 |
Psychomotor, Cognitive, extrapyramidal, and affective functions of healthy volunteers during treatment with an atypical (amisulpride) and a classic (haloperidol) antipsychotic.
Topics: Adult; Affective Disorders, Psychotic; Amisulpride; Antipsychotic Agents; Basal Ganglia Diseases; Cognition; Cross-Over Studies; Double-Blind Method; Female; Haloperidol; Humans; Male; Psychomotor Performance; Sulpiride | 1999 |
Amisulpride in medium-term treatment of dysthymia: a six-month, double-blind safety study versus amitriptyline. AMILONG investigators.
Topics: Adult; Aged; Amisulpride; Amitriptyline; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Double-Blind Method; Dysthymic Disorder; Female; Humans; Italy; Male; Middle Aged; Psychiatric Status Rating Scales; Single-Blind Method; Sulpiride | 1999 |
Effects of 50mg amisulpride on EEG, psychomotor and cognitive functions in healthy sleep-deprived subjects.
Topics: Adult; Amisulpride; Analysis of Variance; Antipsychotic Agents; Cognition; Dose-Response Relationship, Drug; Double-Blind Method; Electroencephalography; Headache; Humans; Male; Nausea; Psychomotor Performance; Reaction Time; Sleep; Sleep Deprivation; Sulpiride; Treatment Outcome | 1999 |
Amisulpride vs. risperidone in the treatment of acute exacerbations of schizophrenia. Amisulpride study group.
Topics: Acute Disease; Adult; Amisulpride; Antipsychotic Agents; Body Weight; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Remission Induction; Risperidone; Schizophrenia; Sulpiride; Treatment Outcome | 1999 |
Long-term safety and efficacy of amisulpride in subchronic or chronic schizophrenia. Amisulpride Study Group.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Chronic Disease; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Sulpiride | 2000 |
The acute effects of amisulpride (50 mg and 200 mg) and haloperidol (2 mg) on cognitive function in healthy elderly volunteers.
Topics: Aged; Aged, 80 and over; Amisulpride; Antipsychotic Agents; Arousal; Cognition; Cross-Over Studies; Double-Blind Method; Female; Flicker Fusion; Haloperidol; Humans; Male; Mental Recall; Reaction Time; Sulpiride | 2000 |
Amisulpride has a superior benefit/risk profile to haloperidol in schizophrenia: results of a multicentre, double-blind study (the Amisulpride Study Group).
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Brief Psychiatric Rating Scale; Double-Blind Method; Female; Haloperidol; Health Status; Humans; Male; Middle Aged; Quality of Life; Schizophrenia; Sulpiride; Surveys and Questionnaires; Treatment Outcome | 2000 |
Effects of newer atypical antipsychotics on autonomic neurocardiac function: a comparison between amisulpride, olanzapine, sertindole, and clozapine.
Topics: Adult; Amisulpride; Antipsychotic Agents; Autonomic Nervous System; Benzodiazepines; Clozapine; Electrocardiography; Female; Heart; Heart Rate; Humans; Imidazoles; Indoles; Male; Middle Aged; Olanzapine; Pirenzepine; Prospective Studies; Sulpiride | 2001 |
A single blind comparison of amisulpride, fluoxetine and clomipramine in the treatment of restricting anorectics.
Topics: Adult; Amenorrhea; Amisulpride; Anorexia Nervosa; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Body Image; Clomipramine; Diet Therapy; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Single-Blind Method; Sulpiride; Treatment Outcome; Weight Gain | 2001 |
Faster response on amisulpride 50 mg versus sertraline 50-100 mg in patients with dysthymia or double depression: a randomized, double-blind, parallel group study.
Topics: Adolescent; Adult; Aged; Amisulpride; Antidepressive Agents; Antipsychotic Agents; Depressive Disorder; Double-Blind Method; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Sertraline; Sulpiride | 2001 |
Efficacy and safety of amisulpride 50 mg versus paroxetine 20 mg in major depression: a randomized, double-blind, parallel group study.
Topics: Adolescent; Adult; Aged; Amisulpride; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Outpatients; Paroxetine; Psychiatric Status Rating Scales; Sulpiride | 2002 |
Amisulpride: efficacy in the management of chronic patients with predominant negative symptoms of schizophrenia.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Basal Ganglia Diseases; Chronic Disease; Double-Blind Method; Female; Haloperidol; Humans; Male; Middle Aged; Pilot Projects; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Sulpiride | 2001 |
Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single-blind study.
Topics: Amisulpride; Antipsychotic Agents; Burning Mouth Syndrome; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Single-Blind Method; Sulpiride; Treatment Outcome | 2002 |
A comparison of paroxetine and amisulpride in the treatment of dysthymic disorder.
Topics: Administration, Oral; Adult; Amisulpride; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Drug Therapy, Combination; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Sulpiride; Treatment Outcome | 2002 |
Differential effects of high-dose amisulpride versus flupentixol on latent dimensions of depressive and negative symptomatology in acute schizophrenia: an evaluation using confirmatory factor analysis.
Topics: Adolescent; Adult; Affect; Aged; Amisulpride; Antipsychotic Agents; Double-Blind Method; Factor Analysis, Statistical; Female; Flupenthixol; Humans; Male; Middle Aged; Schizophrenia; Schizophrenic Psychology; Sulpiride | 2002 |
Long-term effects of the substituted benzamide derivative amisulpride on baseline and stimulated prolactin levels.
Topics: Adult; Amisulpride; Antipsychotic Agents; Drug Administration Schedule; Female; Flupenthixol; Humans; Male; Middle Aged; Prolactin; Schizophrenia; Sulpiride; Thyrotropin-Releasing Hormone; Time Factors | 2002 |
Amisulpride does not prevent relapse in primary alcohol dependence: results of a pilot randomized, placebo-controlled trial.
Topics: Adult; Alcoholism; Amisulpride; Analysis of Variance; Chi-Square Distribution; Double-Blind Method; Female; Humans; Male; Middle Aged; Pilot Projects; Secondary Prevention; Statistics, Nonparametric; Sulpiride; Temperance | 2002 |
A comparison of paroxetine versus paroxetine plus amisulpride in the treatment of dysthymic disorder: efficacy and psychosocial outcomes.
Topics: Adult; Amisulpride; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Drug Therapy, Combination; Dysthymic Disorder; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paroxetine; Personality Inventory; Social Adjustment; Social Behavior; Sulpiride; Treatment Outcome | 2002 |
A double-blind, randomised comparative trial of amisulpride versus olanzapine in the treatment of schizophrenia: short-term results at two months.
Topics: Adolescent; Adult; Aged; Amisulpride; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Body Weight; Double-Blind Method; Female; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Schizophrenia; Schizophrenic Psychology; Selective Serotonin Reuptake Inhibitors; Sulpiride; Time Factors | 2002 |
Dose-related effects of amisulpride on five dimensions of psychopathology in patients with acute exacerbation of schizophrenia.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Sulpiride; Treatment Outcome | 2002 |
Amisulpride vs. risperidone in chronic schizophrenia: results of a 6-month double-blind study.
Topics: Adolescent; Adult; Aged; Amisulpride; Analysis of Variance; Chi-Square Distribution; Chronic Disease; Confidence Intervals; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Single-Blind Method; Sulpiride | 2002 |
Amisulpride versus risperidone in the treatment of schizophrenic patients: a double-blind pilot study in Taiwan.
Topics: Amisulpride; Antipsychotic Agents; Double-Blind Method; Female; Humans; Male; Pilot Projects; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Statistics, Nonparametric; Sulpiride; Taiwan; Treatment Outcome | 2003 |
Lack of effect of amisulpride on the pharmacokinetics and safety of lithium.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Area Under Curve; Double-Blind Method; Drug Interactions; Humans; Lithium; Male; Sulpiride | 2003 |
Amisulpiride augmentation in treatment resistant obsessive-compulsive disorder: an open trial.
Topics: Adult; Aged; Amisulpride; Antidepressive Agents; Antipsychotic Agents; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sulpiride; Treatment Outcome | 2003 |
Amisulpride is an "atypical" antipsychotic associated with low weight gain.
Topics: Amisulpride; Antipsychotic Agents; Databases as Topic; Dose-Response Relationship, Drug; Humans; Male; Prospective Studies; Psychotic Disorders; Regression Analysis; Sulpiride; Time Factors; Treatment Outcome; Weight Gain | 2004 |
Plasma amisulpride levels in schizophrenia or schizoaffective disorder.
Topics: Adolescent; Adult; Age Factors; Amisulpride; Antipsychotic Agents; Biomimetics; Chromatography, High Pressure Liquid; Drug Therapy, Combination; Female; Fluorometry; Humans; Male; Middle Aged; Psychotic Disorders; Schizophrenia; Sex Factors; Smoking; Sulpiride | 2004 |
A double-blind, randomized comparative trial of amisulpride versus olanzapine for 6 months in the treatment of schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Benzodiazepines; Brief Psychiatric Rating Scale; Double-Blind Method; Female; Humans; Male; Middle Aged; Olanzapine; Quality of Life; Schizophrenia; Sulpiride; Treatment Outcome | 2004 |
Clozapine with amisulpride for refractory schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Brief Psychiatric Rating Scale; Clozapine; Drug Therapy, Combination; Electrocardiography; Female; Heart Rate; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Sulpiride; Treatment Outcome | 2004 |
Amisulpride augmentation of clozapine: an open non-randomized study in patients with schizophrenia partially responsive to clozapine.
Topics: Amisulpride; Antipsychotic Agents; Brief Psychiatric Rating Scale; Clozapine; Diagnostic and Statistical Manual of Mental Disorders; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Schizophrenia; Sulpiride | 2004 |
Usefulness of bromocriptine in the treatment of amisulpride-induced hyperprolactinemia: a case report.
Topics: Adult; Amisulpride; Antipsychotic Agents; Bromocriptine; Estradiol; Female; Follicle Stimulating Hormone; Hormone Antagonists; Humans; Hyperprolactinemia; Luteinizing Hormone; Middle Aged; Prolactin; Psychotic Disorders; Sulpiride | 2004 |
Cognitive improvement in schizophrenic patients does not require a serotonergic mechanism: randomized controlled trial of olanzapine vs amisulpride.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Attention; Benzodiazepines; Cognition; Dose-Response Relationship, Drug; Female; Humans; Male; Memory; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Olanzapine; Psychiatric Status Rating Scales; Psychomotor Performance; Schizophrenia; Schizophrenic Psychology; Selective Serotonin Reuptake Inhibitors; Serotonin; Sulpiride; Verbal Learning | 2005 |
Hyperprolactinemia after low dose of amisulpride.
Topics: Adult; Amisulpride; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Depression; Drug Therapy, Combination; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Prolactin; Sulpiride | 2004 |
Non-uniform blockade of intrastriatal D2/D3 receptors by risperidone and amisulpride.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzamides; Binding, Competitive; Brain Mapping; Case-Control Studies; Corpus Striatum; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Female; Humans; Iodine Isotopes; Male; Pyrrolidines; Receptors, Dopamine D3; Risperidone; Schizophrenia; Sulpiride; Tomography, Emission-Computed, Single-Photon | 2005 |
Cost analysis of treating schizophrenia with amisulpride: naturalistic mirror image study.
Topics: Adult; Amisulpride; Antipsychotic Agents; Cost of Illness; Cost-Benefit Analysis; Costs and Cost Analysis; Drug Costs; Female; Health Resources; Humans; Inpatients; Male; Psychiatric Status Rating Scales; Quality of Life; Schizophrenia; Schizophrenic Psychology; Sulpiride | 2005 |
The effects of amisulpride on five dimensions of psychopathology in patients with schizophrenia: a prospective open-label study.
Topics: Adult; Amisulpride; Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Models, Psychological; Prospective Studies; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Sulpiride; Treatment Outcome | 2005 |
An open-label study of amisulpride in the treatment of mania.
Topics: Adult; Amisulpride; Antipsychotic Agents; Bipolar Disorder; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Prospective Studies; Psychiatric Status Rating Scales; Research Design; Sulpiride; Treatment Outcome | 2005 |
Effects of dopaminergic and serotonergic manipulation on emotional processing: a pharmacological fMRI study.
Topics: Adult; Amisulpride; Amygdala; Brain; Dopamine Agents; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Emotions; Fluvoxamine; Hemodynamics; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Selective Serotonin Reuptake Inhibitors; Serotonin Agents; Single-Blind Method; Sulpiride | 2005 |
Sensorimotor gating and habituation of the startle response in schizophrenic patients randomly treated with amisulpride or olanzapine.
Topics: Acoustic Stimulation; Adult; Amisulpride; Antipsychotic Agents; Attention; Benzodiazepines; Dopamine D2 Receptor Antagonists; Follow-Up Studies; Habituation, Psychophysiologic; Humans; Longitudinal Studies; Middle Aged; Olanzapine; Receptors, Dopamine D3; Reference Values; Reflex, Startle; Schizophrenia; Schizophrenic Psychology; Serotonin 5-HT2 Receptor Antagonists; Sulpiride | 2006 |
Amisulpride has no effect on plasma clozapine concentrations.
Topics: Adult; Amisulpride; Antipsychotic Agents; Clozapine; Drug Combinations; Drug Interactions; Female; Half-Life; Humans; Male; Middle Aged; Psychotic Disorders; Spectrophotometry, Ultraviolet; Sulpiride | 2005 |
Amisulpride versus quetiapine for the treatment of delirium: a randomized, open prospective study.
Topics: Amisulpride; Antipsychotic Agents; Delirium; Dibenzothiazepines; Female; Humans; Male; Middle Aged; Prospective Studies; Psychiatric Status Rating Scales; Quetiapine Fumarate; Sleep; Sulpiride | 2005 |
A double-blind, randomised, controlled clinical trial of acetyl-L-carnitine vs. amisulpride in the treatment of dysthymia.
Topics: Acetylcarnitine; Adolescent; Adult; Amisulpride; Antipsychotic Agents; Demography; Double-Blind Method; Drug Evaluation; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Sulpiride; Time Factors; Treatment Outcome; Vitamin B Complex | 2006 |
Amisulpride treatment of clozapine-induced hypersalivation in schizophrenia patients: a randomized, double-blind, placebo-controlled cross-over study.
Topics: Amisulpride; Antipsychotic Agents; Clozapine; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Placebos; Schizophrenia; Sialorrhea; Sulpiride | 2006 |
Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Amisulpride; Antipsychotic Agents; Behavioral Symptoms; Double-Blind Method; Female; Hospitalization; Humans; Ketones; Male; Middle Aged; Movement Disorders; Piperazines; Psychiatric Status Rating Scales; Schizophrenia; Sulpiride; Thiazoles; Time Factors; Treatment Outcome; Weight Gain; Weight Loss | 2006 |
Switching to amisulpride monotherapy for treatment-resistant schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Drug Resistance; Follow-Up Studies; Humans; Male; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Sulpiride; Treatment Outcome | 2006 |
Gender aspects in the clinical treatment of schizophrenic inpatients with amisulpride: a therapeutic drug monitoring study.
Topics: Adult; Amisulpride; Antipsychotic Agents; Drug Administration Schedule; Drug Monitoring; Drug Tolerance; Female; Hospitalization; Humans; Male; Schizophrenia; Sex Factors; Sulpiride | 2006 |
Comparison of pramipexole and amisulpride on alertness, autonomic and endocrine functions in healthy volunteers.
Topics: Adult; Amisulpride; Antiparkinson Agents; Arousal; Autonomic Nervous System; Benzothiazoles; Blood Pressure; Body Temperature; Cross-Over Studies; Dopamine Agonists; Dopamine Antagonists; Double-Blind Method; Endocrine System; Heart Rate; Human Growth Hormone; Humans; Male; Pramipexole; Prolactin; Psychiatric Status Rating Scales; Pupil; Reference Values; Reflex, Pupillary; Salivation; Sulpiride; Thyrotropin | 2006 |
Amisulpride in the treatment of behavioural disturbances among patients with moderate to severe Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Aggression; Alzheimer Disease; Amisulpride; Antipsychotic Agents; Anxiety Disorders; Arousal; Cognition; Female; Humans; Irritable Mood; Male; Mental Disorders; Motor Activity; Neuropsychological Tests; Psychomotor Agitation; Schizophrenia, Paranoid; Sulpiride; Treatment Outcome | 2006 |
Early changes of plasma lipids during treatment with atypical antipsychotics.
Topics: Adolescent; Adult; Aged; Amisulpride; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Body Weight; Cholesterol; Clozapine; Humans; Lipids; Middle Aged; Olanzapine; Piperazines; Prospective Studies; Schizophrenia; Sulpiride; Thiazoles; Time Factors; Triglycerides | 2006 |
The treatment of negative symptoms and deficit states of chronic schizophrenia: olanzapine compared to amisulpride and placebo in a 6-month double-blind controlled clinical trial.
Topics: Adult; Affect; Amisulpride; Antipsychotic Agents; Attention; Basal Ganglia Diseases; Benzodiazepines; Brief Psychiatric Rating Scale; Chronic Disease; Depression; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Olanzapine; Psychotic Disorders; Recurrence; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Sulpiride; Surveys and Questionnaires | 2006 |
Efficacy of amisulpride in treating primary negative symptoms in first-episode psychosis: a pilot study.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Female; Humans; Male; Neuropsychological Tests; Pilot Projects; Psychiatric Status Rating Scales; Psychotic Disorders; Sulpiride | 2006 |
A double-blind randomised comparative trial of amisulpride versus olanzapine for 2 months in the treatment of subjects with schizophrenia and comorbid depression.
Topics: Adult; Amisulpride; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Comorbidity; Depressive Disorder; Double-Blind Method; Female; France; Humans; Italy; Male; Olanzapine; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Sulpiride; Time Factors; Treatment Outcome; Triglycerides; Tunisia; Weight Gain | 2006 |
Delta power in sleep in relation to neuropsychological performance in healthy subjects and schizophrenia patients.
Topics: Adult; Amisulpride; Antipsychotic Agents; Case-Control Studies; Delta Rhythm; Female; Fourier Analysis; Humans; Male; Neuropsychological Tests; Schizophrenia; Sleep; Sulpiride | 2006 |
Remission of severely impaired subjective wellbeing in 727 patients with schizophrenia treated with amisulpride.
Topics: Adult; Amisulpride; Antipsychotic Agents; Female; Humans; International Classification of Diseases; Male; Prospective Studies; Quality of Life; Remission Induction; Schizophrenia; Severity of Illness Index; Sulpiride; Surveys and Questionnaires | 2007 |
Amisulpride versus risperidone treatment for behavioral and psychological symptoms in patients with dementia of the Alzheimer type: a randomized, open, prospective study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amisulpride; Antipsychotic Agents; Behavioral Symptoms; Female; Humans; Male; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Severity of Illness Index; Sulpiride; Time Factors | 2006 |
A preliminary fMRI study of the effects on cortical activation of the treatment of refractory auditory hallucinations with rTMS.
Topics: Adult; Amisulpride; Antipsychotic Agents; Clozapine; Combined Modality Therapy; Female; Functional Laterality; Hallucinations; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Parietal Lobe; Reaction Time; Schizophrenia; Sulpiride; Temporal Lobe; Transcranial Magnetic Stimulation; Treatment Outcome | 2007 |
Metabolic control in patients with schizophrenia treated with amisulpride or olanzapine.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Body Mass Index; Body Weight; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Humans; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Risk Factors; Schizophrenia; Sulpiride | 2007 |
Treatment with amisulpride and olanzapine improve neuropsychological function in schizophrenia.
Topics: Acute Disease; Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Olanzapine; Prognosis; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Sulpiride | 2007 |
Amisulpride versus risperidone in the treatment of depression in patients with schizophrenia: a randomized, open-label, controlled trial.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Depressive Disorder; Electrocardiography; Endpoint Determination; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Sulpiride | 2007 |
Increase in plasma concentration of amisulpride after addition of concomitant lithium.
Topics: Adult; Amisulpride; Antimanic Agents; Antipsychotic Agents; Borderline Personality Disorder; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Lithium Compounds; Longitudinal Studies; Male; Middle Aged; Schizophrenia; Sulpiride | 2007 |
The role of dopamine in attentional and memory biases for emotional information.
Topics: Adolescent; Adult; Amisulpride; Attention; Dopamine; Dopamine Antagonists; Emotions; Humans; Male; Memory; Perception; Placebos; Psychotic Disorders; Reaction Time; Recognition, Psychology; Single-Blind Method; Sulpiride; Task Performance and Analysis; Visual Perception | 2007 |
Two-year study of relapse prevention by a new education program in schizophrenic patients treated with the same antipsychotic drug.
Topics: Adult; Amisulpride; Antipsychotic Agents; Clinical Trials, Phase IV as Topic; Control Groups; Female; Humans; Male; Patient Education as Topic; Prognosis; Psychiatric Status Rating Scales; Psychotherapy; Schizophrenia; Schizophrenic Psychology; Secondary Prevention; Sulpiride; Treatment Outcome | 2008 |
Acute effects of treatment for prodromal symptoms for people putatively in a late initial prodromal state of psychosis.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Combined Modality Therapy; Drug Administration Schedule; Early Diagnosis; Female; Humans; Male; Needs Assessment; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizotypal Personality Disorder; Sulpiride; Treatment Outcome | 2007 |
Differences in the effect of second-generation antipsychotics on prolactinaemia: six weeks open-label trial in female in-patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amisulpride; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Dibenzothiepins; Female; Humans; Hyperprolactinemia; Middle Aged; Olanzapine; Prolactin; Prospective Studies; Quetiapine Fumarate; Risperidone; Schizophrenia; Statistics, Nonparametric; Sulpiride | 2007 |
Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Brief Psychiatric Rating Scale; Clozapine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Synergism; Evaluation Studies as Topic; Female; Humans; Male; Middle Aged; Pilot Projects; Schizophrenia; Sulpiride | 2008 |
Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Haloperidol; Humans; Linear Models; Male; Olanzapine; Patient Compliance; Piperazines; Proportional Hazards Models; Quetiapine Fumarate; Schizophrenia; Sulpiride; Thiazoles; Treatment Outcome | 2008 |
Combination therapy with amisulpride and antidepressants: clinical observations in case series of elderly patients with psychotic depression.
Topics: Aged; Aged, 80 and over; Amisulpride; Antidepressive Agents; Antipsychotic Agents; Depression; Drug Therapy, Combination; Female; Humans; Male; Psychotic Disorders; Sulpiride | 2008 |
Amisulpride doses and plasma levels in different age groups of patients with schizophrenia or schizoaffective disorder.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amisulpride; Antipsychotic Agents; Comorbidity; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Male; Middle Aged; Psychotic Disorders; Schizophrenia; Sulpiride; Young Adult | 2009 |
Striatal D2/D3 receptor occupancy, clinical response and side effects with amisulpride: an iodine-123-iodobenzamide SPET study.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzamides; Corpus Striatum; Dose-Response Relationship, Drug; Female; Humans; Iodine Radioisotopes; Male; Psychotic Disorders; Pyrrolidines; Receptors, Dopamine D2; Schizophrenia; Severity of Illness Index; Statistics, Nonparametric; Sulpiride; Tomography, Emission-Computed, Single-Photon | 2008 |
Effects of amisulpride on emotional memory using a dual-process model in healthy male volunteers.
Topics: Adolescent; Adult; Amisulpride; Dopamine Antagonists; Emotions; Humans; Male; Mental Recall; Reaction Time; Recognition, Psychology; ROC Curve; Signal Detection, Psychological; Sulpiride | 2010 |
A pilot study of the safety and efficacy of amisulpride and risperidone in elderly psychotic patients.
Topics: Age Factors; Aged; Amisulpride; Antipsychotic Agents; Diagnostic and Statistical Manual of Mental Disorders; Drug Therapy, Combination; Dyspnea; Female; Humans; Intestinal Obstruction; Male; Pilot Projects; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride; Treatment Outcome | 2009 |
Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Brain; Clozapine; Cognition Disorders; Female; Follow-Up Studies; Haloperidol; Humans; Male; Neuropsychological Tests; Olanzapine; Perphenazine; Piperazines; Prospective Studies; Psychotic Disorders; Risperidone; Severity of Illness Index; Sulpiride; Thiazoles | 2009 |
Changes in neurocognitive function in patients with schizophrenia after starting or switching to amisulpride in comparison with the normal controls.
Topics: Adult; Amisulpride; Antipsychotic Agents; Cognition Disorders; Female; Follow-Up Studies; Humans; Male; Neuropsychological Tests; Schizophrenia; Schizophrenic Psychology; Sulpiride; Time Factors; Trail Making Test; Treatment Outcome; Wechsler Scales; Young Adult | 2009 |
Comparative bioavailability study of amisulpride tablets in healthy Indian volunteers.
Topics: Adult; Amisulpride; Antipsychotic Agents; Area Under Curve; Biological Availability; Chromatography, High Pressure Liquid; Cross-Over Studies; Half-Life; Humans; India; Indicators and Reagents; Male; Spectrophotometry, Ultraviolet; Sulpiride; Tablets; Young Adult | 2009 |
Study on the efficacy and tolerability of amisulpride in medical/surgical inpatients with delirium admitted to a general hospital.
Topics: Aged; Aged, 80 and over; Amisulpride; Antipsychotic Agents; Delirium; Dose-Response Relationship, Drug; Female; Hospitalization; Humans; Male; Mental Status Schedule; Middle Aged; Pilot Projects; Prospective Studies; Psychiatric Status Rating Scales; Sulpiride; Treatment Outcome | 2009 |
Early- and delayed antipsychotic response and prediction of outcome in 528 severely impaired patients with schizophrenia treated with amisulpride.
Topics: Adult; Amisulpride; Antipsychotic Agents; Cohort Studies; Female; Humans; Linear Models; Male; Prognosis; Prospective Studies; Psychiatric Status Rating Scales; Remission Induction; Reproducibility of Results; Schizophrenia; Sulpiride; Time Factors; Treatment Outcome | 2009 |
Amisulpride versus olanzapine in the treatment of schizophrenia in Indian patients: randomized controlled trial.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Brief Psychiatric Rating Scale; Drug Administration Schedule; Female; Follow-Up Studies; Humans; India; Male; Olanzapine; Schizophrenia; Schizophrenic Psychology; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Sleep Initiation and Maintenance Disorders; Sulpiride; Treatment Outcome; Tremor; Weight Gain | 2010 |
Drug attitude as predictor for effectiveness in first-episode schizophrenia: Results of an open randomized trial (EUFEST).
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Haloperidol; Humans; Male; Medication Adherence; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Quetiapine Fumarate; ROC Curve; Schizophrenia; Schizophrenic Psychology; Sulpiride; Surveys and Questionnaires; Thiazoles; Treatment Outcome | 2010 |
Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment.
Topics: Adult; Amisulpride; Celecoxib; Cyclooxygenase 2 Inhibitors; Dopamine Antagonists; Dose-Response Relationship, Drug; Double-Blind Method; Drug Synergism; Female; Humans; Male; Psychiatric Status Rating Scales; Pyrazoles; Schizophrenia; Sulfonamides; Sulpiride; Time Factors; Treatment Outcome; Young Adult | 2010 |
Amisulpride versus moclobemide in treatment of clozapine-induced hypersalivation.
Topics: Adult; Aged; Amisulpride; Antipsychotic Agents; Clozapine; Cross-Over Studies; Female; Humans; Male; Middle Aged; Moclobemide; Psychotic Disorders; Schizophrenia; Severity of Illness Index; Sialorrhea; Sulpiride | 2011 |
Amisulpride vs. fluoxetine treatment of chronic fatigue syndrome: a pilot study.
Topics: Amisulpride; Dopamine Antagonists; Fatigue Syndrome, Chronic; Female; Fluoxetine; Humans; Male; Pilot Projects; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Sulpiride; Treatment Outcome | 2011 |
Efficacy of antipsychotic drugs against hostility in the European First-Episode Schizophrenia Trial (EUFEST).
Topics: Adult; Aggression; Amisulpride; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Haloperidol; Hostility; Humans; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Schizophrenia; Schizophrenic Psychology; Sulpiride; Thiazoles; Treatment Outcome | 2011 |
Response perseveration in stimulant dependence is associated with striatal dysfunction and can be ameliorated by a D(2/3) receptor agonist.
Topics: Adult; Amisulpride; Amphetamine-Related Disorders; Benzothiazoles; Brain Mapping; Cocaine-Related Disorders; Compulsive Behavior; Corpus Striatum; Dopamine Agonists; Dopamine Antagonists; Female; Humans; Magnetic Resonance Imaging; Male; Obsessive-Compulsive Disorder; Pramipexole; Reversal Learning; Sulpiride | 2011 |
A validation of cognitive biomarkers for the early identification of cognitive enhancing agents in schizotypy: a three-center double-blind placebo-controlled study.
Topics: Adult; Amisulpride; Analysis of Variance; Biomarkers; Cognition Disorders; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Memory, Short-Term; Neuropsychological Tests; Nootropic Agents; Personality Inventory; Reproducibility of Results; Risperidone; Schizotypal Personality Disorder; Sulpiride; Surveys and Questionnaires; United Kingdom; Verbal Behavior; Young Adult | 2012 |
The acute and long-term effectiveness of amisulpride in patients with schizophrenia: results of a 12-month open-label prospective follow-up study.
Topics: Adult; Amisulpride; Antipsychotic Agents; Female; Follow-Up Studies; Humans; Male; Prospective Studies; Schizophrenia; Schizophrenic Psychology; Sulpiride; Time Factors; Treatment Outcome; Young Adult | 2011 |
No negative symptoms in healthy volunteers after single doses of amisulpride, aripiprazole, and haloperidol: a double-blind placebo-controlled trial.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Cognitive Dysfunction; Dizziness; Double-Blind Method; Female; Haloperidol; Humans; Hypnotics and Sedatives; Male; Neurotoxicity Syndromes; Piperazines; Psychiatric Status Rating Scales; Quinolones; Risperidone; Severity of Illness Index; Sulpiride; Time Factors; Young Adult | 2012 |
Hyperprolactinemia induced by low-dosage amisulpride in Korean psychiatric patients.
Topics: Adult; Amisulpride; Asian People; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Humans; Hyperprolactinemia; Male; Mental Disorders; Republic of Korea; Sulpiride | 2012 |
Relationship between prolactin levels and subjective endocrine-related adverse effects in patients with schizophrenia receiving long-term treatment with amisulpride.
Topics: Adult; Amisulpride; Antipsychotic Agents; Drug Tolerance; Female; Humans; Hyperprolactinemia; Male; Prevalence; Psychiatric Status Rating Scales; Republic of Korea; Schizophrenia; Self Report; Sex Characteristics; Sulpiride; Time Factors | 2012 |
Insulin secretion and sensitivity after single-dose amisulpride, olanzapine or placebo in young male subjects: double blind, cross-over glucose clamp study.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; C-Peptide; Cross-Over Studies; Double-Blind Method; Glucose Clamp Technique; Humans; Insulin; Insulin Resistance; Insulin Secretion; Male; Olanzapine; Proinsulin; Sulpiride | 2012 |
Persistent negative symptoms in first episode patients with schizophrenia: results from the European First Episode Schizophrenia Trial.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Dibenzothiazepines; Female; Haloperidol; Humans; Male; Neuropsychological Tests; Olanzapine; Piperazines; Psychomotor Disorders; Psychotic Disorders; Quetiapine Fumarate; Schizophrenia; Schizophrenic Psychology; Sulpiride; Thiazoles; Treatment Outcome; Young Adult | 2013 |
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia.
Topics: Acute Disease; Adult; Amides; Amisulpride; Antipsychotic Agents; Arachidonic Acids; Cannabidiol; Double-Blind Method; Drug Therapy, Combination; Endocannabinoids; Ethanolamines; Female; Humans; Male; Oleic Acids; Palmitic Acids; Polyunsaturated Alkamides; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Signal Transduction; Sulpiride; Young Adult | 2012 |
A 6-week, randomized, multicentre, open-label study comparing efficacy and tolerability of amisulpride at a starting dose of 400 mg/day versus 800 mg/day in patients with acute exacerbations of schizophrenia.
Topics: Adult; Aged; Amisulpride; Analysis of Variance; Antipsychotic Agents; Chi-Square Distribution; Disease Progression; Dyskinesia, Drug-Induced; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Psychiatric Status Rating Scales; Quality of Life; Republic of Korea; Schizophrenia; Schizophrenic Psychology; Sulpiride; Time Factors; Treatment Outcome; Weight Gain; Young Adult | 2012 |
Cognitive effects of a single dose of atypical antipsychotics in healthy volunteers compared with placebo or haloperidol.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Cognition; Double-Blind Method; Female; Haloperidol; Humans; Hypnotics and Sedatives; Male; Piperazines; Psychomotor Performance; Quinolones; Risperidone; Sulpiride; Treatment Outcome; Young Adult | 2012 |
Identifying clinically meaningful symptom response cut-off values on the SANS in predominant negative symptoms.
Topics: Amisulpride; Antipsychotic Agents; Double-Blind Method; Female; Humans; Intention; Male; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Sulpiride; Treatment Outcome | 2013 |
Effects of risperidone, amisulpride and nicotine on eye movement control and their modulation by schizotypy.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Double-Blind Method; Female; Humans; Male; Nicotine; Psychometrics; Pursuit, Smooth; Risperidone; Saccades; Schizotypal Personality Disorder; Sulpiride; Surveys and Questionnaires; Young Adult | 2013 |
Effects of amisulpride on human resting cerebral perfusion.
Topics: Adult; Amisulpride; Cerebral Cortex; Cross-Over Studies; Dopamine Antagonists; Double-Blind Method; Humans; Male; Rest; Sulpiride; Young Adult | 2013 |
Antipsychotic combination using low-dose antipsychotics is as efficacious and safe as, but cheaper, than optimal-dose monotherapy in the treatment of schizophrenia: a randomized, double-blind study.
Topics: Acute Disease; Adult; Amisulpride; Antipsychotic Agents; Cost Savings; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Costs; Drug Therapy, Combination; Female; Hospitals, Psychiatric; Humans; Intention to Treat Analysis; Male; Middle Aged; Patient Dropouts; Psychiatric Status Rating Scales; Quality of Life; Schizophrenia; Sulpiride; Taiwan | 2013 |
I.V. APD421 (amisulpride) prevents postoperative nausea and vomiting: a randomized, double-blind, placebo-controlled, multicentre trial.
Topics: Adult; Aged; Aged, 80 and over; Amisulpride; Anesthesia, Inhalation; Antiemetics; Dopamine Antagonists; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Injections, Intravenous; Male; Middle Aged; Postoperative Nausea and Vomiting; Postoperative Period; Preanesthetic Medication; Sulpiride; Treatment Outcome; Young Adult | 2013 |
Effectiveness of antipsychotic drugs against hostility in patients with schizophrenia in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study.
Topics: Adult; Aggression; Amisulpride; Antipsychotic Agents; Benzodiazepines; Female; Haloperidol; Hostility; Humans; Male; Middle Aged; Olanzapine; Perphenazine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride; Thiazoles | 2014 |
Prandial effect on the systemic exposure of amisulpride.
Topics: Adult; Amisulpride; Antipsychotic Agents; Fasting; Humans; Male; Postprandial Period; Sulpiride; Young Adult | 2014 |
Treatment response heterogeneity in the predominant negative symptoms of schizophrenia: analysis of amisulpride vs placebo in three clinical trials.
Topics: Adult; Amisulpride; Antipsychotic Agents; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Schizophrenia; Sulpiride; Treatment Outcome | 2014 |
Erotic stimulus processing under amisulpride and reboxetine: a placebo-controlled fMRI study in healthy subjects.
Topics: Adrenergic Uptake Inhibitors; Adult; Amisulpride; Brain; Brain Mapping; Cross-Over Studies; Dopamine Antagonists; Double-Blind Method; Erotica; Humans; Magnetic Resonance Imaging; Male; Morpholines; Motion Perception; Photic Stimulation; Reboxetine; Sexual Behavior; Sulpiride; Surveys and Questionnaires; Video Recording; Young Adult | 2014 |
Dopamine D2-receptor blockade enhances decoding of prefrontal signals in humans.
Topics: Adolescent; Adult; Amisulpride; Association Learning; Dopamine Antagonists; Humans; Magnetic Resonance Imaging; Male; Prefrontal Cortex; Receptors, Dopamine D2; Reward; Signal Transduction; Sulpiride; Young Adult | 2015 |
Local and Global Resting State Activity in the Noradrenergic and Dopaminergic Pathway Modulated by Reboxetine and Amisulpride in Healthy Subjects.
Topics: Adrenergic Neurons; Adrenergic Uptake Inhibitors; Adult; Amisulpride; Animals; Brain; Cross-Over Studies; Dopamine Antagonists; Dopaminergic Neurons; Double-Blind Method; Healthy Volunteers; Humans; Magnetic Resonance Imaging; Male; Morpholines; Neural Pathways; Reboxetine; Sulpiride; Young Adult | 2015 |
Acute Effects of Haloperidol, Amisulpride, and Quetiapine on Bone Turnover Markers in Patients With Schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Biomarkers; Bone Remodeling; Bone Resorption; Female; Haloperidol; Humans; Male; Osteogenesis; Prospective Studies; Quetiapine Fumarate; Schizophrenia; Sulpiride; Young Adult | 2015 |
The effectiveness and safety of amisulpride in Chinese patients with schizophrenia: An 8-week, prospective, open-label, multicenter, single-arm study.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Female; Humans; Male; Middle Aged; Prospective Studies; Schizophrenia; Sulpiride; Treatment Outcome; Young Adult | 2016 |
Dopamine D2/3- and μ-opioid receptor antagonists reduce cue-induced responding and reward impulsivity in humans.
Topics: Amisulpride; Cues; Delay Discounting; Dopamine Antagonists; Double-Blind Method; Female; Healthy Volunteers; Humans; Impulsive Behavior; Male; Naltrexone; Narcotic Antagonists; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Opioid, mu; Reward; Sulpiride; Young Adult | 2016 |
Intravenous Amisulpride for the Prevention of Postoperative Nausea and Vomiting: Two Concurrent, Randomized, Double-blind, Placebo-controlled Trials.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amisulpride; Dopamine Antagonists; Double-Blind Method; Female; Humans; Injections, Intravenous; Male; Middle Aged; Postoperative Nausea and Vomiting; Sulpiride; Treatment Outcome; Young Adult | 2017 |
rs7968606 polymorphism of ANKS1B is associated with improvement in the PANSS general score of schizophrenia caused by amisulpride.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Carrier Proteins; Double-Blind Method; Female; Genetic Association Studies; Humans; Intracellular Signaling Peptides and Proteins; Male; Middle Aged; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Schizophrenia; Sulpiride; Treatment Outcome; Young Adult | 2017 |
Therapeutic window of dopamine D2/3 receptor occupancy to treat psychosis in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amisulpride; Antipsychotic Agents; Benzamides; Dopamine Agents; Female; Humans; Male; Positron-Emission Tomography; Psychotic Disorders; Pyrrolidines; Receptors, Dopamine D2; Receptors, Dopamine D3; Socioeconomic Factors; Sulpiride; Treatment Outcome | 2017 |
Two subgroups of antipsychotic-naive, first-episode schizophrenia patients identified with a Gaussian mixture model on cognition and electrophysiology.
Topics: Adult; Algorithms; Amisulpride; Antipsychotic Agents; Cognition Disorders; Electroencephalography; Evoked Potentials; Female; Follow-Up Studies; Humans; Machine Learning; Male; Mental Processes; Neuropsychological Tests; Normal Distribution; Psychiatric Status Rating Scales; Psychometrics; Reference Values; Schizophrenia; Schizophrenic Psychology; Sulpiride | 2017 |
Noradrenergic modulation of neural erotic stimulus perception.
Topics: Adrenergic Uptake Inhibitors; Adult; Amisulpride; Anticipation, Psychological; Attention; Brain; Brain Mapping; Cross-Over Studies; Dopamine Antagonists; Double-Blind Method; Emotions; Erotica; Humans; Magnetic Resonance Imaging; Male; Morpholines; Neuropsychological Tests; Norepinephrine; Reboxetine; Sexual Behavior; Sulpiride; Visual Perception; Young Adult | 2017 |
Amisulpride in the prevention of nausea and vomiting induced by cisplatin-based chemotherapy: a dose-escalation study.
Topics: Adult; Aged; Amisulpride; Antiemetics; Cisplatin; Dopamine Antagonists; Female; Humans; Male; Middle Aged; Nausea; Ondansetron; Remission Induction; Serotonin 5-HT3 Receptor Antagonists; Sulpiride; Vomiting | 2018 |
Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness.
Topics: Adult; Amisulpride; Antipsychotic Agents; Clozapine; Cost-Benefit Analysis; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Psychiatric Status Rating Scales; Quality-Adjusted Life Years; Schizophrenia; Sulpiride; Technology Assessment, Biomedical; Treatment Outcome | 2017 |
Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial.
Topics: Amisulpride; Antipsychotic Agents; Clozapine; Cognition; Humans; Schizophrenia; Schizophrenia, Treatment-Resistant; Sulpiride | 2022 |
Does partial blockade of dopamine D2 receptors with Amisulpride cause anhedonia? An experimental study in healthy volunteers.
Topics: Amisulpride; Anhedonia; Antipsychotic Agents; Healthy Volunteers; Humans; Receptors, Dopamine D2; Receptors, Dopamine D3; Sulpiride | 2023 |
394 other study(ies) available for dan 2163 and sulpiride
| Article | Year |
|---|---|
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
[Introductory report for the discussion on Barnetil].
Topics: Amisulpride; Antipsychotic Agents; Humans; Mental Disorders; Psychotropic Drugs; Sulpiride | 1979 |
[Attempt at a synthesis of the neurophysiological data concerning sulpiride and sultopride].
Topics: Amisulpride; Animals; Cats; Central Nervous System; Evoked Potentials; Hippocampus; Hypothalamus; Motor Activity; Psychotropic Drugs; Sleep Stages; Sulpiride | 1979 |
[Sultopride and the therapeutic relationship].
Topics: Aggression; Amisulpride; Hospitals, Psychiatric; Humans; Impulsive Behavior; Mental Disorders; Physician-Patient Relations; Psychiatry; Psychomotor Agitation; Psychotropic Drugs; Sulpiride | 1979 |
[Sultopride in a day hospital].
Topics: Amisulpride; Bipolar Disorder; Day Care, Medical; Hospitals, Psychiatric; Humans; Male; Mental Disorders; Middle Aged; Psychotic Disorders; Psychotropic Drugs; Sulpiride | 1979 |
Effect of substituted benzamides on prolactin secretion in the rat.
Topics: Amisulpride; Animals; Antipsychotic Agents; Benzamides; Dose-Response Relationship, Drug; Injections, Intravenous; Male; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereoisomerism; Stimulation, Chemical; Sulpiride; Tiapamil Hydrochloride | 1992 |
[Arrhythmogenic effects of sultopride chlorhydrate: clinical and cellular electrophysiological correlation].
Topics: Action Potentials; Amisulpride; Animals; Antipsychotic Agents; Electrocardiography; Female; Humans; Magnesium Sulfate; Middle Aged; Purkinje Fibers; Research Design; Sulpiride; Torsades de Pointes | 1992 |
[Torsades de pointes during sultopride poisoning].
Topics: Adult; Amisulpride; Antipsychotic Agents; Humans; Male; Potassium Chloride; Sulpiride; Torsades de Pointes | 1992 |
Comparison of HPLC and RIA methods applied to the quantification of amisulpride in human plasma.
Topics: Amisulpride; Chromatography, High Pressure Liquid; Humans; Iodine Radioisotopes; Psychotropic Drugs; Radioimmunoassay; Sulpiride | 1991 |
Determination of sultopride and tiapride in serum by gas chromatography using a surface ionisation detector.
Topics: Amisulpride; Chromatography, Gas; Humans; Ions; Male; Psychotropic Drugs; Radioimmunoassay; Sulpiride; Tiapamil Hydrochloride | 1991 |
[Treatment of Gilles de la Tourette's disease with amisulpride].
Topics: Adolescent; Amisulpride; Antipsychotic Agents; Child; Child, Preschool; Female; Humans; Male; Sulpiride; Tourette Syndrome | 1990 |
Structure of the neuroleptic drug 4-amino-N-1-[(1-ethyl-2-pyrrolidinyl)methyl]-5-(ethylsulfonyl)-2- methoxybenzamide (amisulpride).
Topics: Amisulpride; Antipsychotic Agents; Molecular Conformation; Sulpiride; X-Ray Diffraction | 1990 |
Potentiation of apomorphine-induced stereotyped behaviour by acute treatment with dopamine depleting agents: a potential role for an increased stimulation of D1 dopamine receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenylyl Cyclases; alpha-Methyltyrosine; Amisulpride; Animals; Apomorphine; Corpus Striatum; Cyclic AMP; Dopamine Antagonists; Drug Synergism; In Vitro Techniques; Male; Methyltyrosines; Metoclopramide; Mice; Phenethylamines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reserpine; Stereotyped Behavior; Sulpiride | 1989 |
Definition of the in-vivo binding of [3H]spiperone in rat brain using substituted benzamide drugs.
Topics: Amisulpride; Animals; Apomorphine; Benzamides; Binding, Competitive; Brain Chemistry; Female; Haloperidol; Rats; Rats, Inbred Strains; Spiperone; Stereotyped Behavior; Sulpiride | 1989 |
Performance deficit induced by low doses of dopamine agonists in rats. Toward a model for approaching the neurobiology of negative schizophrenic symptomatology?
Topics: Amisulpride; Animals; Antipsychotic Agents; Apomorphine; Disease Models, Animal; Male; Phenothiazines; Pimozide; Piperidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reinforcement Schedule; Reinforcement, Psychology; Schizophrenia; Schizophrenic Psychology; Sulpiride | 1986 |
[Comparative study of the pharmacological properties of sultopride sulpiride and other antipsychotic drugs: influence of sultopride, sulpiride and other antipsychotic drugs on spontaneous locomotor activity and changes in locomotor activity induced by apo
Topics: Amisulpride; Animals; Antipsychotic Agents; Apomorphine; Chlorpromazine; Clonidine; Drug Interactions; Haloperidol; Imipramine; Male; Mice; Motor Activity; Pimozide; Sulpiride; Yohimbine | 1986 |
[Efficacy of low doses of atypical neuroleptics (benzamides) in defect states].
Topics: Amisulpride; Antipsychotic Agents; Brief Psychiatric Rating Scale; Humans; Schizophrenia; Sulpiride | 1986 |
[The role of a mediator object in the initial analytic therapy of psychotics].
Topics: Amisulpride; Antipsychotic Agents; Combined Modality Therapy; Humans; Psychoanalytic Therapy; Psychotic Disorders; Sulpiride | 1986 |
Determination of a new benzamide, amisulpride, in human plasma by reversed-phase ion-pair high-performance liquid chromatography.
Topics: Amisulpride; Antipsychotic Agents; Chromatography, High Pressure Liquid; Humans; Indicators and Reagents; Kinetics; Spectrophotometry, Ultraviolet; Sulpiride | 1987 |
Pisa syndrome. Report of a case.
Topics: Adult; Amisulpride; Antipsychotic Agents; Dyskinesia, Drug-Induced; Haloperidol; Humans; Male; Schizophrenia; Sulpiride; Syndrome | 1988 |
D-2 selective receptor antagonists suppress sucrose sham feeding in the rat.
Topics: Amisulpride; Animals; Feeding Behavior; Food Deprivation; Haloperidol; Male; Pimozide; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Reward; Stereoisomerism; Sucrose; Sulpiride; Taste; Water Deprivation | 1986 |
[Interactions of 5 benzamides with ethanol on various psychopharmacology tests].
Topics: Amisulpride; Animals; Behavior, Animal; Benzamides; Drug Interactions; Ethanol; Male; Metoclopramide; Mice; Psychopharmacology; Rats; Rats, Inbred Strains; Sulpiride; Tiapamil Hydrochloride | 1985 |
[Sultopride therapy of behavior disorders in a child with severe mental retardation].
Topics: Adolescent; Aggression; Amisulpride; Humans; Intellectual Disability; Male; Psychotropic Drugs; Social Behavior Disorders; Sulpiride | 1985 |
Treatment of an aggressive, compulsive adolescent with sultopride.
Topics: Adolescent; Aggression; Amisulpride; Child Behavior Disorders; Compulsive Behavior; Humans; Male; Psychotropic Drugs; Sulpiride | 1985 |
[Determination of sulpiride and sultopride by high-performance liquid chromatography for pharmacokinetic studies].
Topics: Amisulpride; Chromatography, High Pressure Liquid; Erythrocytes; Humans; Kinetics; Plasma; Spectrophotometry, Ultraviolet; Sulpiride; Time Factors | 1985 |
Biotransformation of sultopride in man and several animal species.
Topics: Amisulpride; Animals; Bile; Biotransformation; Brain; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Dogs; Female; Humans; Male; Methylation; Oxidation-Reduction; Psychotropic Drugs; Rabbits; Rats; Scintillation Counting; Sulpiride | 1985 |
Absorption, distribution and excretion of sultopride in man and several animal species.
Topics: Absorption; Adult; Amisulpride; Animals; Dogs; Female; Humans; Kidney; Male; Milk; Pregnancy; Protein Binding; Rabbits; Rats; Sulpiride; Tissue Distribution | 1985 |
The binding of [3H]N-(chloroethyl)-norapomorphine to rat striatal membranes.
Topics: Amisulpride; Animals; Aporphines; Binding, Competitive; Butaclamol; Corpus Striatum; Dopamine Antagonists; Female; Flupenthixol; Hydrogen-Ion Concentration; In Vitro Techniques; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone; Stereoisomerism; Sulpiride; Tritium | 1984 |
Characteristics of [3H]sultopride binding to rat brain.
Topics: Amisulpride; Animals; Antipsychotic Agents; Brain; Cations; Corpus Striatum; In Vitro Techniques; Kinetics; Male; Neurotransmitter Agents; Rats; Rats, Inbred Strains; Spiperone; Sulpiride | 1982 |
Behavioral pharmacology of the benzamides as compared to standard neuroleptics.
Topics: Amisulpride; Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Benzamides; Catalepsy; Humans; Male; Metoclopramide; Mice; Oxotremorine; Rats; Rats, Inbred Strains; Stereotyped Behavior; Sulpiride | 1982 |
[Use of sultopride in a case of neuroleptic-induced late dyskinesia].
Topics: Amisulpride; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Sulpiride | 1982 |
[Active treatment of behavior problems of the mentally retarded. Sultopride].
Topics: Adult; Amisulpride; Antipsychotic Agents; Female; Humans; Intellectual Disability; Male; Social Behavior Disorders; Sulpiride | 1983 |
A comparison of the effect of substituted benzamides in radioreceptor binding assays with their effects on brain dopaminergic systems in vivo.
Topics: Amisulpride; Animals; Benzamides; Brain; Butaclamol; Cattle; Corpus Striatum; Dihydroergotoxine; Dopamine; In Vitro Techniques; Olfactory Bulb; Radioligand Assay; Spiperone; Sulpiride; Tiapamil Hydrochloride | 1982 |
[Sultopride and agitation].
Topics: Adult; Amisulpride; Female; Humans; Middle Aged; Psychomotor Agitation; Psychotropic Drugs; Sulpiride | 1982 |
[Sultopride treatment of a chronic psychotic child with predominantly maniacal manifestations].
Topics: Affective Disorders, Psychotic; Amisulpride; Bipolar Disorder; Child; Female; Humans; Psychotropic Drugs; Sulpiride | 1982 |
[Open trial of sultopride in psychiatric emergencies].
Topics: Amisulpride; Emergencies; Humans; Mental Disorders; Psychomotor Agitation; Sulpiride | 1983 |
[Sultopride in the treatment of agitation].
Topics: Adult; Amisulpride; Humans; Male; Middle Aged; Psychomotor Agitation; Sulpiride | 1983 |
[The use of a sedative neuroleptic agent, sultopride, in posttraumatic Korsakoff syndrome in a young adult].
Topics: Adult; Amisulpride; Craniocerebral Trauma; Drug Therapy, Combination; Female; Humans; Meprobamate; Neurocognitive Disorders; Psychotropic Drugs; Sulpiride | 1983 |
[Ambulatory treatment of agitation in encephalopathies].
Topics: Adult; Ambulatory Care; Amisulpride; Brain Diseases; Humans; Male; Psychomotor Agitation; Sulpiride | 1983 |
Regional distribution of sultopride and sulpiride in rat brain measured by radioimmunoassay.
Topics: Amisulpride; Animals; Brain; Cross Reactions; Half-Life; Male; Radioimmunoassay; Rats; Rats, Inbred Strains; Sulpiride | 1983 |
Effect of sultopride on prolactin secretion in rats.
Topics: Amisulpride; Animals; Dopamine; Dose-Response Relationship, Drug; Female; Follicle Stimulating Hormone; Luteinizing Hormone; Male; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred Strains; Sex Factors; Stereoisomerism; Sulpiride; Time Factors | 1984 |
Effects of chronic sultopride treatment on endocrine systems in psychotic women.
Topics: Adult; Amisulpride; Chronic Disease; Estradiol; Female; Follicle Stimulating Hormone; Growth Hormone; Hormones; Humans; Hydrocortisone; Luteinizing Hormone; Prolactin; Psychotic Disorders; Psychotropic Drugs; Sulpiride; Thyrotropin | 1984 |
In vitro transfer of six benzamides in the human placenta.
Topics: Amisulpride; Benzamides; Chemical Phenomena; Chemistry, Physical; Diffusion; Female; Humans; In Vitro Techniques; Mathematics; Placenta; Pregnancy; Sulpiride; Tiapamil Hydrochloride | 1984 |
Determination of sultopride in serum and saliva by high-performance liquid chromatography.
Topics: Amisulpride; Chromatography, High Pressure Liquid; Humans; Saliva; Sulpiride | 1983 |
The effects of substituted benzamides on frog rectus abdominis.
Topics: Amisulpride; Animals; Benzamides; Cholinesterase Inhibitors; In Vitro Techniques; Metoclopramide; Muscles; Procainamide; Rana esculenta; Sulpiride; Tiapamil Hydrochloride | 1980 |
[Sultopride used at low doses in the older child and adolescent].
Topics: Adolescent; Amisulpride; Child; Female; Humans; Male; Mental Disorders; Sulpiride | 1980 |
Development of radioimmunoassay for sultopride and sulpiride.
Topics: Amisulpride; Animals; Biotransformation; Cross Reactions; Humans; Immune Sera; Male; Psychotropic Drugs; Rabbits; Radioimmunoassay; Sulpiride | 1981 |
The dopaminergic system modulates the endogenous opioid system in guinea-pig isolated ileal longitudinal muscle.
Topics: Amisulpride; Animals; Antipsychotic Agents; Dopamine; Dose-Response Relationship, Drug; Electric Stimulation; Guinea Pigs; Haloperidol; Ileum; Male; Models, Neurological; Muscle Contraction; Opioid Peptides; Sulpiride | 1995 |
Differences in effects of sultopride and sulpiride on dopamine turnover in rat brain.
Topics: Amisulpride; Animals; Antipsychotic Agents; Apomorphine; Brain; Corpus Striatum; Dopamine; Gyrus Cinguli; Limbic System; Male; Rats; Rats, Sprague-Dawley; Substantia Nigra; Sulpiride | 1995 |
Amisulpride poisoning: a report on two cases.
Topics: Adult; Amisulpride; Antipsychotic Agents; Chromatography, High Pressure Liquid; Female; Humans; Male; Sulpiride | 1995 |
Disposition of enantiomers of sultopride in a human, rats and rabbits.
Topics: Amisulpride; Animals; Antipsychotic Agents; Chromatography, High Pressure Liquid; Humans; Injections, Intravenous; Male; Rabbits; Rats; Rats, Wistar; Stereoisomerism; Sulpiride | 1993 |
Effects of benzamide derivatives on dopamine release from striatal slices of rats.
Topics: Amisulpride; Animals; Benzamides; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Male; Pyrrolidines; Rats; Rats, Wistar; Sulpiride | 1993 |
Inhibitory effects of procainamide and probenecid on renal excretion of sultopride enantiomers in rats.
Topics: Amisulpride; Animals; Drug Interactions; Injections, Intravenous; Kidney; Male; Probenecid; Procainamide; Psychotropic Drugs; Rats; Rats, Wistar; Stereoisomerism; Sulpiride | 1993 |
Evidence for a functional role of the dopamine D3 receptors in the cerebellum.
Topics: Amisulpride; Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Cerebellum; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Female; Haloperidol; Locomotion; Naphthalenes; Nucleus Accumbens; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Sulpiride | 1996 |
Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
Topics: Amisulpride; Animals; Antipsychotic Agents; Apomorphine; Body Temperature; Dextroamphetamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Grooming; Limbic System; Male; Mice; Motor Activity; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D3; Receptors, Presynaptic; Sulpiride | 1997 |
Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity.
Topics: Acetylcholine; Amisulpride; Animals; Antipsychotic Agents; Cattle; CHO Cells; Cricetinae; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Humans; Limbic System; Male; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Presynaptic; Sulpiride; Swine | 1997 |
Selective determination of sultopride in human plasma using high-performance liquid chromatography with ultraviolet detection and particle beam mass spectrometry.
Topics: Adult; Aged; Amisulpride; Antipsychotic Agents; Chromatography, High Pressure Liquid; Humans; Male; Mass Spectrometry; Middle Aged; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Sulpiride | 1997 |
Effects of amisulpride, an atypical antipsychotic which blocks preferentially presynaptic dopamine autoreceptors, on integrated functional cerebral activity in the rat.
Topics: Amisulpride; Animals; Antipsychotic Agents; Auditory Pathways; Corpus Striatum; Deoxyglucose; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Extrapyramidal Tracts; Glucose; Male; Nerve Net; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Sulpiride; Tomography, Emission-Computed; Visual Pathways | 1997 |
Binding of antipsychotic drugs to cortical 5-HT2A receptors: a PET study of chlorpromazine, clozapine, and amisulpride in schizophrenic patients.
Topics: Adolescent; Adult; Amisulpride; Animals; Antipsychotic Agents; Cerebral Cortex; Chlorpromazine; Clozapine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorine Radioisotopes; Humans; Male; Pyrimidinones; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Schizophrenia; Sulpiride; Tomography, Emission-Computed | 1998 |
Presynaptic receptors: more hetero than auto.
Topics: Amisulpride; Antipsychotic Agents; Humans; Receptors, Presynaptic; Serotonin Receptor Agonists; Sulpiride; Sumatriptan | 1998 |
Amisulpride in schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Humans; Schizophrenia; Sulpiride | 1998 |
Effects of acute and repeated administration of amisulpride, a dopamine D2/D3 receptor antagonist, on the electrical activity of midbrain dopaminergic neurons.
Topics: Amisulpride; Animals; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Male; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D3; Substantia Nigra; Sulpiride; Ventral Tegmental Area | 1998 |
[Amisulpride--a neuroleptic agent for all phases of schizophrenia].
Topics: Amisulpride; Antipsychotic Agents; Chronic Disease; Humans; Hyperkinesis; Hypertension; Risk Factors; Schizophrenia; Sulpiride; Tremor | 1999 |
Pharmacological profile of MS-377, a novel antipsychotic agent with selective affinity for sigma receptors.
Topics: Amisulpride; Animals; Antipsychotic Agents; Apomorphine; Catalepsy; Dopamine Agonists; Free Radical Scavengers; Guinea Pigs; Haloperidol; Head Movements; Male; Mice; Phenazocine; Phencyclidine; Piperazines; Pyrrolidines; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Serotonin; Receptors, sigma; Risperidone; Serotonin; Serotonin Antagonists; Stereotyped Behavior; Sulpiride; Tartrates | 1999 |
Antidepressant-like activity of amisulpride in two animal models of depression.
Topics: Amisulpride; Animals; Antidepressive Agents; Antipsychotic Agents; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Imipramine; Male; Motivation; Motor Activity; Rats; Rats, Wistar; Sulpiride; Treatment Outcome | 2000 |
Amisulpride: its role in the therapeutic management of the schizophrenic patient. Introduction.
Topics: Amisulpride; Antipsychotic Agents; Cognition Disorders; Humans; Schizophrenia; Sulpiride | 2000 |
Amisulpride: its role in the therapeutic management of the schizophrenia patient. Conclusions.
Topics: Amisulpride; Antipsychotic Agents; Humans; Schizophrenia; Sulpiride | 2000 |
[Atypical antipsychotics].
Topics: Acute Disease; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Cost-Benefit Analysis; Dibenzothiazepines; Dibenzothiepins; Dyskinesia, Drug-Induced; Germany; Humans; Neurotransmitter Agents; Olanzapine; Patient Compliance; Pirenzepine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride | 2000 |
[Acute tongue and pharyngeal spasms during changeover from clozapine to amisulpride. A case example].
Topics: Acute Disease; Adult; Amisulpride; Antipsychotic Agents; Clozapine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Pharyngeal Diseases; Psychotic Disorders; Receptors, Dopamine; Spasm; Sulpiride; Tongue Diseases | 2000 |
From pharmacological profiles to clinical outcomes.
Topics: Amisulpride; Antipsychotic Agents; Frontal Lobe; Humans; Limbic System; Receptors, Dopamine; Schizophrenia; Sulpiride | 2000 |
Is amisulpride an 'atypical' atypical antipsychotic agent?
Topics: Amisulpride; Antipsychotic Agents; Basal Ganglia Diseases; Humans; Limbic System; Receptors, Dopamine; Schizophrenia; Sulpiride | 2000 |
Acute phase of schizophrenia: impact of atypical antipsychotics.
Topics: Acute Disease; Amisulpride; Antipsychotic Agents; Haloperidol; Humans; Prognosis; Recurrence; Risperidone; Schizophrenia; Severity of Illness Index; Sulpiride | 2000 |
In vivo extrastriatal and striatal D2 dopamine receptor blockade by amisulpride in schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Corpus Striatum; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Female; Humans; Male; Middle Aged; Pyrrolidines; Receptors, Dopamine D2; Salicylamides; Schizophrenia; Statistics, Nonparametric; Sulpiride; Temporal Lobe; Thalamus; Tomography, Emission-Computed | 2001 |
The changes of biological markers and treatment efficacy in schizophrenia.
Topics: Acute Disease; Adult; Amisulpride; Antipsychotic Agents; Biomarkers; Brain; Cognition; Dexamethasone; Follow-Up Studies; Haloperidol; Humans; Hydrocortisone; Inpatients; Memory; Perphenazine; Psychological Tests; Psychomotor Performance; Reaction Time; Schizophrenia; Schizophrenic Psychology; Sulpiride; Time Factors; Tomography, X-Ray Computed | 2001 |
Establishment of enzyme immunoassay for measuring serum sultopride levels.
Topics: Adult; Aged; Amisulpride; Antipsychotic Agents; Chromatography, High Pressure Liquid; Female; Humans; Immunoenzyme Techniques; Male; Middle Aged; Sulpiride | 2001 |
[Initial experiences with amisulpride, an in Germany novel, atypical neuroleptic drug in treatment of adolescents with psychiatric disorders].
Topics: Adolescent; Amisulpride; Antipsychotic Agents; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Approval; Female; Humans; Male; Psychotic Disorders; Recurrence; Schizophrenia, Childhood; Sulpiride; Treatment Outcome | 2001 |
Physostigmine as treatment for severe CNS anticholinergic toxicity.
Topics: Amisulpride; Antipsychotic Agents; Cholinesterase Inhibitors; Drug Overdose; Humans; Male; Muscarinic Antagonists; Physostigmine; Poisoning; Procyclidine; Sulpiride | 2001 |
[Incompatibility of olanzapine and amisulpride in multisystemic myotonic myopathy].
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Creatine Kinase; Drug Interactions; Genetic Predisposition to Disease; Humans; Male; Malignant Hyperthermia; Muscle, Skeletal; Myotonic Disorders; Olanzapine; Pirenzepine; Remission Induction; Risperidone; Schizophrenia; Sulpiride; Treatment Outcome | 2001 |
(-)S amisulpride binds with high affinity to cloned dopamine D(3) and D(2) receptors.
Topics: Amisulpride; Animals; Benzamides; Binding, Competitive; Cell Line; DNA, Recombinant; Dopamine Antagonists; Dose-Response Relationship, Drug; Humans; Radioligand Assay; Rats; Receptors, Dopamine D2; Receptors, Dopamine D3; Spiperone; Stereoisomerism; Sulpiride; Tritium | 2001 |
Asymptomatic bradycardia associated with amisulpride.
Topics: Adult; Amisulpride; Antipsychotic Agents; Bradycardia; Heart Rate; Humans; Male; Schizophrenia, Paranoid; Sulpiride | 2001 |
Atypical antipsychotic medications and the treatment of schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Double-Blind Method; Humans; Meta-Analysis as Topic; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Sulpiride; Treatment Outcome | 2002 |
Sub-chronic treatment with classical but not atypical antipsychotics produces morphological changes in rat nigro-striatal dopaminergic neurons directly related to "early onset" vacuous chewing.
Topics: Amisulpride; Animals; Antipsychotic Agents; Clozapine; Dopamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyskinesia, Drug-Induced; Haloperidol; Male; Mastication; Neostriatum; Nerve Degeneration; Neural Pathways; Neurons; Rats; Rats, Sprague-Dawley; Risperidone; Substance Withdrawal Syndrome; Substantia Nigra; Sulpiride | 2002 |
[QT prolongation and torsade de pointes--tachycardia in therapy with maprotiline].
Topics: Amisulpride; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Brain Damage, Chronic; Heart Arrest; Humans; Long QT Syndrome; Male; Maprotiline; Middle Aged; Schizophrenia; Sulpiride; Tachycardia; Torsades de Pointes | 2002 |
Switching to amisulpride due to hepatic complications.
Topics: Adult; Amisulpride; Antipsychotic Agents; Chemical and Drug Induced Liver Injury; Flupenthixol; Haloperidol; Humans; Male; Perazine; Schizophrenia; Sulpiride | 2002 |
[Atypical neuroleptics--a heterogenous group. Valuable option in acute psychoses].
Topics: Amisulpride; Antipsychotic Agents; Germany; Humans; Meta-Analysis as Topic; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Sulpiride | 2002 |
Carmoxirole is able to reduce amisulpride-induced hyperprolactinemia without affecting its central effect.
Topics: Amisulpride; Animals; Antipsychotic Agents; Binding, Competitive; Bromocriptine; Dopamine Agonists; Hyperprolactinemia; In Vitro Techniques; Indoles; Male; Pituitary Gland; Prolactin; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Sulpiride; Synaptosomes; Yawning | 2002 |
Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient.
Topics: Amisulpride; Antipsychotic Agents; Clozapine; Female; Humans; Middle Aged; Neuroleptic Malignant Syndrome; Risperidone; Schizophrenia; Sulpiride | 2002 |
Amisulpride improves depressive symptoms in acute exacerbations of schizophrenia: comparison with haloperidol and risperidone.
Topics: Adult; Amisulpride; Antipsychotic Agents; Brief Psychiatric Rating Scale; Depression; Double-Blind Method; Female; Haloperidol; Humans; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride; Treatment Outcome | 2002 |
Effect of the amisulpride isomers on rat prolactinemia.
Topics: Amisulpride; Animals; Dose-Response Relationship, Drug; Hyperprolactinemia; Male; Pituitary Gland; Prolactin; Rats; Rats, Sprague-Dawley; Stereoisomerism; Sulpiride | 2002 |
Effects of sigma(1) receptor ligand MS-377 on D(2) antagonists-induced behaviors.
Topics: Amisulpride; Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Catalepsy; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Interactions; Female; Haloperidol; Male; Mice; Nootropic Agents; Phenazocine; Piperazines; Pyridines; Pyrrolidines; Rats; Receptors, sigma; Serotonin Antagonists; Sigma-1 Receptor; Sulpiride; Tartrates | 2002 |
SPECT imaging, clinical features, and cognition before and after low doses of amisulpride in schizophrenic patients with the deficit syndrome.
Topics: Adult; Amisulpride; Antipsychotic Agents; Cerebral Cortex; Dominance, Cerebral; Dose-Response Relationship, Drug; Female; Humans; Male; Neuropsychological Tests; Psychiatric Status Rating Scales; Regional Blood Flow; Schizophrenia, Disorganized; Sulpiride; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2002 |
Effect of the amisulpride isomers on rat catalepsy.
Topics: Amisulpride; Analysis of Variance; Animals; Brain; Catalepsy; Dose-Response Relationship, Drug; Male; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Stereoisomerism; Structure-Activity Relationship; Sulpiride | 2002 |
Switching antipsychotic medications: general recommendations and switching to amisulpride.
Topics: Adult; Amisulpride; Antipsychotic Agents; Female; Humans; Male; Retrospective Studies; Schizophrenia; Sulpiride; Surveys and Questionnaires; Treatment Outcome | 2002 |
Catatonia and transcranial magnetic stimulation.
Topics: Adolescent; Amisulpride; Antipsychotic Agents; Catatonia; Female; Humans; Prefrontal Cortex; Schizophrenia; Sulpiride; Transcranial Magnetic Stimulation; Treatment Outcome | 2002 |
Effects of amisulpride on consummatory negative contrast.
Topics: Amisulpride; Animals; Antipsychotic Agents; Conditioning, Operant; Consummatory Behavior; Contrast Sensitivity; Dose-Response Relationship, Drug; Male; Rats; Rats, Long-Evans; Sulpiride | 2002 |
Discriminative stimulus properties in rats of the novel antipsychotic quetiapine.
Topics: Amisulpride; Analysis of Variance; Animals; Antipsychotic Agents; Chlorpromazine; Clozapine; Dibenzothiazepines; Discrimination Learning; Discrimination, Psychological; Dose-Response Relationship, Drug; Female; Generalization, Psychological; Haloperidol; Loxapine; Quetiapine Fumarate; Quinoxalines; Rats; Rats, Wistar; Risperidone; Sulpiride | 2002 |
Automated determination of amisulpride by liquid chromatography with column switching and spectrophotometric detection.
Topics: Amisulpride; Chromatography, High Pressure Liquid; Humans; Reference Standards; Spectrophotometry; Sulpiride | 2003 |
Acute psychosis after administration of bupropion hydrochloride (Zyban).
Topics: Adult; Amisulpride; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Bupropion; Hallucinations; Humans; Male; Psychoses, Substance-Induced; Smoking Cessation; Sulpiride | 2002 |
[Frontal dysfunctions in Huntington's disease -- neuropsychology and therapy].
Topics: Adult; Amisulpride; Antipsychotic Agents; Attention; Brain; Dose-Response Relationship, Drug; Female; Frontal Lobe; Humans; Huntington Disease; Magnetic Resonance Imaging; Neuropsychological Tests; Social Behavior; Sulpiride; Treatment Outcome | 2003 |
Respective roles of dopamine D2 and D3 receptors in food-seeking behaviour in rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amisulpride; Analysis of Variance; Animals; Apomorphine; Benzazepines; Benzopyrans; Conditioning, Operant; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Synergism; Feeding Behavior; Haloperidol; Male; Naphthalenes; Pyrroles; Pyrrolidines; Quinolines; Raclopride; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Reinforcement, Psychology; Sulpiride; Tetrahydronaphthalenes | 2003 |
Foreword. The clinical aspects of deficit in dopaminergic ways.
Topics: Amisulpride; Antidepressive Agents; Autoreceptors; Dopamine; Dopamine D2 Receptor Antagonists; Humans; Mental Disorders; Receptors, Dopamine D2; Receptors, Dopamine D3; Sulpiride | 2002 |
Rapid high-performance liquid chromatographic measurement of amisulpride in human plasma: application to manage acute intoxication.
Topics: Amisulpride; Antipsychotic Agents; Chromatography, High Pressure Liquid; Humans; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Sulpiride | 2003 |
How does the benzamide antipsychotic amisulpride get into the brain?--An in vitro approach comparing amisulpride with clozapine.
Topics: Amisulpride; Animals; Antipsychotic Agents; Benzamides; Brain; Caco-2 Cells; Clozapine; Dose-Response Relationship, Drug; Humans; Sulpiride; Swine | 2003 |
Amisulpride-induced mania in a patient with schizophrenia.
Topics: Adolescent; Amisulpride; Antipsychotic Agents; Bipolar Disorder; Female; Humans; Schizophrenia; Sulpiride | 2003 |
Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? an in vivo quantitative [123I]epidepride SPET study of amisulpride-treated patients.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzamides; Corpus Striatum; Dopamine D2 Receptor Antagonists; Female; Humans; Iodine Radioisotopes; Limbic System; Male; Middle Aged; Pyrrolidines; Receptors, Dopamine D2; Receptors, Dopamine D3; Schizophrenia; Sulpiride; Temporal Lobe; Thalamus; Tomography, Emission-Computed, Single-Photon | 2003 |
Visual and auditory hallucinations with excessive intake of paroxetine.
Topics: Adult; Amisulpride; Antipsychotic Agents; Auditory Perception; Brain; Female; Hallucinations; Humans; Japan; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sulpiride; Visual Perception | 2003 |
[Plasma prolactin level and incidence of adverse endocrinologic effects during therapy with atypical neuroleptics].
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Depressive Disorder, Major; Dibenzothiazepines; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Olanzapine; Pirenzepine; Product Surveillance, Postmarketing; Prolactin; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Sulpiride | 2003 |
Response of catatonic schizophrenia to amisulpride: a case report.
Topics: Adult; Amisulpride; Antipsychotic Agents; Chronic Disease; Humans; Male; Schizophrenia, Catatonic; Sulpiride; Treatment Outcome | 2003 |
The antinociceptive effect of amisulpride in mice is mediated through opioid mechanisms.
Topics: Amisulpride; Analgesics; Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred ICR; Naloxone; Narcotic Antagonists; Pain Measurement; Receptors, Opioid; Sulpiride | 2003 |
Combination of amisulpride and olanzapine in treatment-resistant schizophrenic psychoses.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Olanzapine; Psychotic Disorders; Retrospective Studies; Schizophrenia; Sulpiride | 2004 |
Dosage finding and outcome in the treatment of schizophrenic inpatients with amisulpride. Results of a drug utilization observation study.
Topics: Adult; Amisulpride; Chi-Square Distribution; Drug Utilization Review; Female; Hospitalization; Humans; Linear Models; Male; Middle Aged; Multivariate Analysis; Regression Analysis; Schizophrenia; Sulpiride; Treatment Outcome | 2004 |
Prolactinemia is uncoupled from central D2/D3 dopamine receptor occupancy in amisulpride treated patients.
Topics: Adult; Amisulpride; Antipsychotic Agents; Brain; Contrast Media; Dopamine D2 Receptor Antagonists; Drug Tolerance; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Psychotic Disorders; Receptors, Dopamine D2; Receptors, Dopamine D3; Schizophrenia; Sulpiride; Tomography, Emission-Computed, Single-Photon | 2004 |
Successful treatment of Tourette's disorder with amisulpride.
Topics: Adult; Amisulpride; Antipsychotic Agents; Female; Humans; Sulpiride; Tourette Syndrome | 2004 |
Serotonin reuptake inhibitor provoked recurrence of alcohol hallucinosis--remission with additive amisulpride medication. A case report.
Topics: Alcohol Withdrawal Delirium; Amisulpride; Antipsychotic Agents; Drug Therapy, Combination; Humans; Male; Middle Aged; Recurrence; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sertraline; Sulpiride | 2004 |
A possible effect of amisulpride on a prolactinoma growth in a woman with borderline personality disorder.
Topics: Adult; Amisulpride; Borderline Personality Disorder; Female; Humans; Pituitary Neoplasms; Prolactin; Prolactinoma; Sulpiride | 2004 |
Improvement of amisulpride-induced extrapyramidal symptoms with quetiapine.
Topics: Aged; Amisulpride; Antipsychotic Agents; Basal Ganglia Diseases; Dibenzothiazepines; Humans; Male; Middle Aged; Psychotic Disorders; Quetiapine Fumarate; Sulpiride | 2004 |
Effects of amisulpride, risperidone and chlorpromazine on auditory and visual latent inhibition, prepulse inhibition, executive function and eye movements in healthy volunteers.
Topics: Acoustic Stimulation; Administration, Oral; Adult; Akathisia, Drug-Induced; Amisulpride; Blood Pressure; Chlorpromazine; Controlled Clinical Trials as Topic; Demography; Double-Blind Method; Eye Movements; Humans; Male; Neuropsychological Tests; Photic Stimulation; Problem Solving; Reaction Time; Reflex, Startle; Risperidone; Space Perception; Sulpiride; Verbal Behavior | 2004 |
Identification of P-glycoprotein substrates and inhibitors among psychoactive compounds--implications for pharmacokinetics of selected substrates.
Topics: Amisulpride; Animals; Antipsychotic Agents; ATP Binding Cassette Transporter, Subfamily B; Brain; Caco-2 Cells; Cyclosporine; Drug Interactions; Fluphenazine; Humans; Immunosuppressive Agents; Male; Rats; Substrate Specificity; Sulpiride; Tissue Distribution | 2004 |
Transient hyperproinsulinemia during treatment with clozapine and amisulpride.
Topics: Adult; Amisulpride; Antipsychotic Agents; Blood Glucose; Drug Interactions; Drug Therapy, Combination; Humans; Insulin; Loxapine; Male; Proinsulin; Schizophrenia, Paranoid; Sulpiride | 2004 |
A successful antipsychotic combination trial. Quo Vadis?
Topics: Amisulpride; Antipsychotic Agents; Clozapine; Drug Synergism; Drug Therapy, Combination; Humans; Psychotic Disorders; Sulpiride | 2004 |
Amisulpride-associated pedal edema.
Topics: Amisulpride; Antipsychotic Agents; Diuretics; Edema; Foot Diseases; Furosemide; Humans; Male; Middle Aged; Schizophrenia; Sulpiride | 2004 |
EEG abnormalities under treatment with atypical antipsychotics: effects of olanzapine and amisulpride as compared to haloperidol.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Chi-Square Distribution; Dose-Response Relationship, Drug; Electroencephalography; Female; Follow-Up Studies; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Schizophrenia; Sulpiride | 2004 |
[Rehospitalization rates of newly diagnosed schizophrenic patients on atypical neuroleptic medication].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amisulpride; Antipsychotic Agents; Benzodiazepines; Female; Follow-Up Studies; Germany; Humans; Long-Term Care; Male; Middle Aged; Olanzapine; Patient Readmission; Retrospective Studies; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride; Treatment Outcome; Treatment Refusal | 2004 |
Rhabdomyolysis and coma associated with amisulpride: a probable atypical presentation of neuroleptic malignant syndrome.
Topics: Adult; Amisulpride; Antipsychotic Agents; Coma; Creatine Kinase; Female; Humans; Leukocytosis; Neuroleptic Malignant Syndrome; Rhabdomyolysis; Schizophrenia; Sulpiride | 2004 |
Effectiveness of amisulpride augmentation of clozapine in a non-responder to either drug alone: a case report.
Topics: Adult; Amisulpride; Antipsychotic Agents; Clozapine; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Humans; Schizophrenia; Sulpiride | 2005 |
High striatal occupancy of D2-like dopamine receptors by amisulpride in the brain of patients with schizophrenia.
Topics: Adult; Algorithms; Amisulpride; Antipsychotic Agents; Area Under Curve; Caudate Nucleus; Cerebral Cortex; Female; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Neostriatum; Positron-Emission Tomography; Putamen; Radiopharmaceuticals; Receptors, Dopamine D2; Salicylamides; Schizophrenia; Sulpiride | 2004 |
Reduction of side effects by combining clozapine with amisulpride: case report and short review of clozapine-induced hypersalivation-a case report.
Topics: Adult; Amisulpride; Antipsychotic Agents; Clozapine; Drug Therapy, Combination; Humans; Male; Schizophrenia, Paranoid; Sialorrhea; Sulpiride | 2005 |
Augmentation of clozapine with amisulpride: a promising therapeutic approach to refractory schizophrenic symptoms.
Topics: Adult; Amisulpride; Antipsychotic Agents; Clozapine; Drug Synergism; Drug Therapy, Combination; Humans; Schizophrenia; Schizophrenic Psychology; Sulpiride | 2005 |
Combined use of amisulpride and clozapine for patients with treatment-resistant schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Clozapine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Patient Satisfaction; Schizophrenia; Schizophrenic Psychology; Sulpiride; Treatment Outcome | 2004 |
Aripiprazole in a patient vulnerable to side effects.
Topics: Adult; Amenorrhea; Amisulpride; Antipsychotic Agents; Aripiprazole; Female; Galactorrhea; Humans; Piperazines; Quinolones; Sulpiride; Tourette Syndrome; Treatment Outcome | 2005 |
Pheochromocytoma unmasked by amisulpride and tiapride.
Topics: Adult; Amisulpride; Antipsychotic Agents; Calcium Channel Blockers; Headache; Humans; Hypertension; Male; Nicardipine; Pheochromocytoma; Sulpiride; Tiapamil Hydrochloride; Verapamil; Vomiting | 2005 |
[Costs related to change to amisulpride in patients suffering from schizophrenia].
Topics: Adult; Aged; Amisulpride; Antipsychotic Agents; Cost of Illness; Cost Savings; Cost-Benefit Analysis; Drug Costs; Female; Humans; Hungary; Male; Middle Aged; Schizophrenia; Sulpiride | 2004 |
[Functional magnetic resonance tomography of central motor areas in schizophrenic patients].
Topics: Amisulpride; Antipsychotic Agents; Biomechanical Phenomena; Dyskinesia, Drug-Induced; Gait Apraxia; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Motor Activity; Motor Cortex; Schizophrenia; Sensitivity and Specificity; Sulpiride | 2005 |
Pharmacological modulations in human cognitive processes: an fMRI study.
Topics: Amisulpride; Antipsychotic Agents; Brain; Cognition; Decision Making; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Humans; Magnetic Resonance Imaging; Male; Sulpiride | 2005 |
Dopamine D3 modulation of locomotor activity and sleep in the nucleus accumbens and in lobules 9 and 10 of the cerebellum in the rat.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amisulpride; Amphetamine; Animals; Cerebellum; Dopamine Agonists; Dopamine Antagonists; Dopamine Uptake Inhibitors; Female; Haloperidol; Microinjections; Motor Activity; Naphthalenes; Nucleus Accumbens; Pyrrolidines; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Sleep; Sulpiride; Tetrahydronaphthalenes | 2005 |
D2 receptor occupancy during high- and low-dose therapy with the atypical antipsychotic amisulpride: a 123I-iodobenzamide SPECT study.
Topics: Adult; Amisulpride; Antipsychotic Agents; Brain; Dose-Response Relationship, Drug; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Radiopharmaceuticals; Receptors, Dopamine D2; Schizophrenia; Sulpiride; Tomography, Emission-Computed, Single-Photon | 2005 |
Two cases of amisulpride overdose: a cause for prolonged QT syndrome.
Topics: Adult; Amisulpride; Antipsychotic Agents; Calcium Gluconate; Female; Humans; Hypocalcemia; Infusions, Intravenous; Long QT Syndrome; Male; Sulpiride | 2005 |
Amisulpride may help alcoholics in the early postdetoxification phase.
Topics: Adult; Alcohol Withdrawal Delirium; Amisulpride; Antipsychotic Agents; Female; Humans; Male; Middle Aged; Pilot Projects; Sulpiride; Treatment Outcome | 2005 |
Effects of novel antipsychotics, amisulpiride and aripiprazole, on maternal behavior in rats.
Topics: Amisulpride; Animals; Antipsychotic Agents; Aripiprazole; Brain; Dose-Response Relationship, Drug; Female; Maternal Behavior; Piperazines; Quinolones; Rats; Rats, Sprague-Dawley; Sulpiride | 2005 |
Amisulpride and cardiomyopathy.
Topics: Adult; Amisulpride; Antipsychotic Agents; Cardiomyopathies; Humans; Hypertrophy, Left Ventricular; Male; Schizophrenia; Sulpiride | 2005 |
Facilitation of enkephalins-induced delta-opioid behavioral responses by chronic amisulpride treatment.
Topics: Amisulpride; Animals; Behavior, Animal; Disulfides; Dopamine Antagonists; Enkephalins; Male; Mice; Motor Activity; Naloxone; Narcotic Antagonists; Pain Measurement; Phenylalanine; Reaction Time; Receptors, Opioid, delta; Sulpiride; Swimming | 2005 |
Normalization of hyperprolactinaemia after withdrawal of a low dose of amisulpride.
Topics: Adult; Amisulpride; Antipsychotic Agents; Depressive Disorder; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Prolactin; Sulpiride | 2005 |
Atypical anti-psychotics in the real world--a naturalistic comparative outcome study.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Olanzapine; Patient Compliance; Probability; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Quality of Life; Quetiapine Fumarate; Risk Assessment; Risperidone; Severity of Illness Index; Statistics, Nonparametric; Sulpiride; Treatment Outcome | 2005 |
Clinical implications of Brief Psychiatric Rating Scale scores.
Topics: Acute Disease; Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Female; Humans; Male; Olanzapine; Psychiatric Status Rating Scales; Schizophrenia; Severity of Illness Index; Sulpiride; Treatment Outcome | 2005 |
[Amisulpride in Huntington's disease].
Topics: Aged; Amisulpride; Antipsychotic Agents; Delusions; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Huntington Disease; Male; Middle Aged; Neurologic Examination; Neuropsychological Tests; Parkinson Disease, Secondary; Psychotic Disorders; Sulpiride; Treatment Outcome | 2005 |
Amisulpride related tic-like symptoms in an adolescent schizophrenic.
Topics: Adolescent; Amisulpride; Antipsychotic Agents; Female; Humans; Schizophrenia; Sulpiride; Tic Disorders | 2006 |
Cyclosporine A (CsA) affects the pharmacodynamics and pharmacokinetics of the atypical antipsychotic amisulpride probably via inhibition of P-glycoprotein (P-gp).
Topics: Amisulpride; Animals; Antipsychotic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Blood-Brain Barrier; Brain; Caco-2 Cells; Cyclosporine; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Humans; Liver; Male; Metabolic Clearance Rate; Microsomes; Motor Activity; Radioligand Assay; Rats; Sulpiride; Time Factors | 2006 |
The antipsychotic sultopride is overdosed--a PET study of drug-induced receptor occupancy in comparison with sulpiride.
Topics: Adult; Amisulpride; Antipsychotic Agents; Brain; Dose-Response Relationship, Drug; Humans; Male; Positron-Emission Tomography; Radioligand Assay; Receptors, Dopamine D2; Sulpiride | 2006 |
Therapeutic drug monitoring for optimizing amisulpride therapy in patients with schizophrenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amisulpride; Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Monitoring; Dyskinesia, Drug-Induced; Female; Germany; Humans; Male; Middle Aged; Neurologic Examination; Psychiatric Status Rating Scales; Retrospective Studies; ROC Curve; Schizophrenia; Statistics as Topic; Sulpiride | 2007 |
Selective and sensitive determination of amisulpride in human plasma by liquid chromatography-tandem mass spectrometry with positive electrospray ionisation and multiple reaction monitoring.
Topics: Amisulpride; Chromatography, Liquid; Drug Stability; Humans; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Sulpiride | 2006 |
[Treatment resistant schizophrenia, residual subtype: symptom improvement after additional treatment with amisulpride].
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Commitment of Mentally Ill; Drug Resistance; Drug Therapy, Combination; Follow-Up Studies; Haloperidol; Homicide; Humans; Insanity Defense; Male; Olanzapine; Prisoners; Schizophrenia, Paranoid; Sulpiride; Treatment Outcome | 2006 |
Improvement of patient compliance after switching from conventional neuroleptics to the atypical neuroleptic amisulpride.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Female; Humans; Male; Middle Aged; Outpatients; Patient Compliance; Psychiatric Status Rating Scales; Quality of Life; Schizophrenia; Schizophrenic Psychology; Sulpiride; Surveys and Questionnaires | 2006 |
Acute weight gain induced by amisulpride monotherapy in a first-episode schizophrenic patient.
Topics: Adult; Amisulpride; Antipsychotic Agents; Female; Humans; Schizophrenia; Sulpiride; Time Factors; Weight Gain | 2006 |
Improvement of tardive dyskinesia following amisulpride treatment.
Topics: Amisulpride; Antipsychotic Agents; Dyskinesias; Female; Humans; Middle Aged; Schizophrenia, Paranoid; Sulpiride | 2006 |
Amisulpride deliberate self-poisoning causing severe cardiac toxicity including QT prolongation and torsades de pointes.
Topics: Adult; Amisulpride; Antipsychotic Agents; Arrhythmias, Cardiac; Drug Overdose; Electrocardiography; Emergency Medicine; Fatal Outcome; Female; Humans; Male; Suicide; Sulpiride; Torsades de Pointes; Treatment Outcome | 2006 |
Pergolide as adjuvant therapy to amisulpride in the treatment of negative and depressive symptoms in schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Comorbidity; Depressive Disorder; Dopamine Agonists; Drug Therapy, Combination; Frontal Lobe; Hallucinations; Humans; Male; Neural Pathways; Pergolide; Psychiatric Status Rating Scales; Receptors, Dopamine D1; Receptors, Dopamine D2; Schizophrenia, Paranoid; Sulpiride; Treatment Outcome | 2006 |
Blockade of cue-induced brain activation of abstinent alcoholics by a single administration of amisulpride as measured with fMRI.
Topics: Adult; Alcoholism; Amisulpride; Brain; Cues; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Sulpiride; Temperance | 2006 |
Is the superior efficacy of new generation antipsychotics an artifact of LOCF?
Topics: Amisulpride; Artifacts; Benzodiazepines; Bias; Flupenthixol; Haloperidol; Humans; Olanzapine; Patient Dropouts; Psychiatric Status Rating Scales; Psychotropic Drugs; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Sulpiride; Treatment Outcome | 2007 |
Amisulpride-induced hyperprolactinemia is reversible following discontinuation.
Topics: Adult; Aged; Amisulpride; Antipsychotic Agents; Dose-Response Relationship, Drug; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Prolactin; Psychiatric Status Rating Scales; Psychotic Disorders; Sex Characteristics; Sulpiride | 2007 |
Amisulpride-induced hyperprolactinaemia is not reversed by addition of aripiprazole.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Dopamine Agonists; Dopamine Antagonists; Drug Therapy, Combination; Female; Humans; Hyperprolactinemia; Middle Aged; Piperazines; Quinolones; Schizophrenia; Sulpiride; Treatment Failure | 2007 |
Amisulpride-induced tardive dyskinesia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Dyskinesia, Drug-Induced; Extrapyramidal Tracts; Humans; Male; Sulpiride | 2006 |
Alterations of glucose metabolism during treatment with clozapine or amisulpride: results from a prospective 16-week study.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Body Mass Index; Clozapine; Female; Glucose; Glucose Metabolism Disorders; Homeostasis; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Prospective Studies; Risk Factors; Schizophrenia; Sulpiride | 2007 |
[Endocrine side effects among psychiatric patients treated with antipsychotics].
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Breast; Dibenzothiazepines; Endocrine System; Female; Galactorrhea; Gynecomastia; Humans; Male; Olanzapine; Piperazines; Prolactin; Quetiapine Fumarate; Quinolones; Schizophrenia; Sulpiride | 2006 |
Remission and relapse in the outpatient care of schizophrenia: three-year results from the Schizophrenia Outpatient Health Outcomes study.
Topics: Adult; Ambulatory Care; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Cohort Studies; Dibenzothiazepines; Europe; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Olanzapine; Prospective Studies; Quetiapine Fumarate; Recurrence; Risk Factors; Risperidone; Schizophrenia; Sulpiride; Time Factors; Treatment Outcome | 2006 |
Development of tardive dyskinesia in a patient taking amisulpride.
Topics: Adult; Akathisia, Drug-Induced; Amisulpride; Antipsychotic Agents; Female; Humans; Prolactin; Schizophrenia, Paranoid; Sulpiride | 2007 |
Transient hyperglycemia and decreased glucose tolerance during antipsychotic monotherapy with amisulpride.
Topics: Adult; Amisulpride; Antipsychotic Agents; Glucose Intolerance; Humans; Hyperglycemia; Male; Schizophrenia, Paranoid; Sulpiride | 2007 |
Atypical antipsychotics and pituitary neoplasms in the WHO database.
Topics: Adenoma; Adult; Adverse Drug Reaction Reporting Systems; Amisulpride; Antipsychotic Agents; Causality; Female; Humans; Male; Pituitary Neoplasms; Risk; Risperidone; Schizophrenia; Sulpiride; World Health Organization | 2007 |
Amisulpride augmentation after the failure of citalopram for depression: a case report.
Topics: Adult; Amisulpride; Citalopram; Depression; Dopamine Antagonists; Drug Therapy, Combination; Female; Humans; Selective Serotonin Reuptake Inhibitors; Sulpiride; Treatment Failure | 2007 |
Outcomes in schizophrenia outpatients treated with amisulpride or olanzapine.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Olanzapine; Outpatients; Psychiatric Status Rating Scales; Quality of Life; Schizophrenia; Schizophrenic Psychology; Social Behavior; Sulpiride; Treatment Outcome; Weight Gain | 2007 |
Blockade of morphine-induced behavioral sensitization by a combination of amisulpride and RB101, comparison with classical opioid maintenance treatments.
Topics: Amisulpride; Animals; Behavior, Animal; Buprenorphine; Disulfides; Male; Methadone; Mice; Morphine; Motor Activity; Opioid-Related Disorders; Phenylalanine; Sulpiride | 2007 |
Amisulpride in the short-term treatment of depressive and physical symptoms in cancer patients during chemotherapies.
Topics: Adult; Aged; Aged, 80 and over; Amisulpride; Antipsychotic Agents; Cohort Studies; Depression; Female; Humans; Interviews as Topic; Italy; Male; Middle Aged; Neoplasms; Outcome Assessment, Health Care; Single-Blind Method; Sulpiride | 2007 |
Amenorrhea after sertraline introduction in an amisulpride-treated patient with undiagnosed polycystic ovary disease.
Topics: Adult; Amenorrhea; Amisulpride; Antipsychotic Agents; Depression; Drug Interactions; Female; Humans; Hyperprolactinemia; Polycystic Ovary Syndrome; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Sertraline; Sulpiride | 2007 |
Do differences in atypical antipsychotics matter in routine practice? Medication switch from olanzapine and risperidone to amisulpride.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Drug Utilization; Dyskinesia, Drug-Induced; Female; Germany; Humans; Male; Middle Aged; Olanzapine; Risperidone; Schizophrenia; Schizophrenic Psychology; Structure-Activity Relationship; Sulpiride; Weight Gain | 2007 |
Comparative validation of amisulpride determination in pharmaceuticals by several chromatographic, electrophoretic and spectrophotometric methods.
Topics: Amisulpride; Calibration; Chromatography, High Pressure Liquid; Densitometry; Drug Stability; Electrophoresis, Capillary; Spectrophotometry, Ultraviolet; Sulpiride; Tablets | 2007 |
Atypical antipsychotic therapy for treatment of schizophrenia in Hong Kong Chinese patients--a cost analysis.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; China; Cost of Illness; Cost-Benefit Analysis; Databases, Factual; Delayed-Action Preparations; Dibenzothiazepines; Female; Health Care Costs; Hong Kong; Hospitalization; Humans; Male; Medical Records; Middle Aged; Olanzapine; Quetiapine Fumarate; Regression Analysis; Retrospective Studies; Risperidone; Schizophrenia; Substance-Related Disorders; Sulpiride | 2007 |
[Gilles-de-la-Tourette Syndrome as a Tardive Dyskinesia].
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Long-Term Care; Male; Middle Aged; Olanzapine; Promethazine; Sulpiride; Tourette Syndrome; Verbal Behavior | 2007 |
Enantioselective analysis of amisulpride in pharmaceutical formulations by means of capillary electrophoresis.
Topics: Amisulpride; Antipsychotic Agents; beta-Cyclodextrins; Buffers; Citrates; Dosage Forms; Electrophoresis, Capillary; Hydrogen-Ion Concentration; Methanol; Reproducibility of Results; Silicon Dioxide; Stereoisomerism; Sulfates; Sulpiride; Technology, Pharmaceutical; Temperature | 2008 |
Prevalence of hyperprolactinaemia in a naturalistic cohort of schizophrenia and bipolar outpatients during treatment with typical and atypical antipsychotics.
Topics: Adult; Amisulpride; Antipsychotic Agents; Bipolar Disorder; Cohort Studies; Cross-Sectional Studies; England; Female; Humans; Hyperprolactinemia; Male; Mass Screening; Middle Aged; Prevalence; Prolactin; Risperidone; Schizophrenia; Severity of Illness Index; Sex Factors; Sulpiride | 2007 |
The use of atypical antipsychotics in French psychiatric hospitals.
Topics: Adult; Age Factors; Amisulpride; Antimanic Agents; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clozapine; Cross-Sectional Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; France; Hospitals, Psychiatric; Humans; Male; Mental Disorders; Middle Aged; Olanzapine; Practice Patterns, Physicians'; Psychotic Disorders; Risperidone; Sex Factors; Sulpiride | 2007 |
Atypical antipsychotic drugs in the treatment of delusional parasitosis.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Benzodiazepines; Female; Follow-Up Studies; Humans; Injections; Male; Middle Aged; Myocardial Infarction; Olanzapine; Parasitic Diseases; Paresthesia; Patient Compliance; Risperidone; Schizophrenia, Paranoid; Somatoform Disorders; Sulpiride; Treatment Outcome | 2007 |
Clozapine and amisulpride in refractory schizophrenia and alcohol dependence.
Topics: Alcoholism; Amisulpride; Antipsychotic Agents; Behavior, Addictive; Blood Glucose; Clozapine; Comorbidity; Diabetes Mellitus; Diagnosis, Dual (Psychiatry); Drug Therapy, Combination; Humans; Male; Middle Aged; Schizophrenia; Sulpiride | 2007 |
[Malignant neuroleptic syndrome associated with amisulpride].
Topics: Affective Disorders, Psychotic; Amisulpride; Anticonvulsants; Antipsychotic Agents; Creatine Kinase; Diagnosis, Differential; Electromyography; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Middle Aged; Muscle, Skeletal; Neuroleptic Malignant Syndrome; Schizophrenia, Paranoid; Sulpiride; Valproic Acid | 2008 |
Amisulpride-induced neuroleptic malignant syndrome.
Topics: Aged; Amisulpride; Antipsychotic Agents; Bipolar Disorder; Creatine Kinase; Humans; Male; Neuroleptic Malignant Syndrome; Psychiatric Status Rating Scales; Sulpiride | 2007 |
Is aripiprazole the only choice of treatment of the patients who developed anti-psychotic agents-induced leucopenia and neutropenia? A case report.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Blood Cell Count; Dibenzothiazepines; Female; Humans; Leukopenia; Neutropenia; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Sulpiride | 2008 |
Clozapine-induced myocarditis after long-term treatment: case presentation and clinical perspectives.
Topics: Amisulpride; Antipsychotic Agents; Clozapine; Dibenzothiazepines; Humans; Male; Middle Aged; Myocarditis; Quetiapine Fumarate; Schizophrenia; Sulpiride | 2008 |
Comparing the use and discontinuation of antipsychotics in clinical practice: an observational study.
Topics: Adult; Aged; Amisulpride; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clozapine; Dibenzothiazepines; Drug Administration Schedule; Female; Humans; Male; Medical Records; Middle Aged; Olanzapine; Patient Admission; Polypharmacy; Practice Patterns, Physicians'; Quetiapine Fumarate; Research Design; Retrospective Studies; Risperidone; Schizophrenia; Scotland; Sulpiride | 2008 |
Amisulpride improves obsessive-compulsive symptoms in schizophrenia patients taking atypical antipsychotics: an open-label switch study.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Comorbidity; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quinolones; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride; Treatment Outcome | 2008 |
Amisulpride-induced dystonia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Dystonia; Female; Humans; Schizophrenia; Sulpiride | 2008 |
Fatality due to amisulpride toxicity: a case report.
Topics: Adult; Amisulpride; Antipsychotic Agents; Forensic Toxicology; Humans; Male; Schizophrenia; Sulpiride | 2008 |
Subnanomolar dopamine D3 receptor antagonism coupled to moderate D2 affinity results in favourable antipsychotic-like activity in rodent models: II. behavioural characterisation of RG-15.
Topics: Amisulpride; Animals; Antipsychotic Agents; Avoidance Learning; Benzodiazepines; Biological Availability; Catalepsy; Clozapine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Male; Motor Activity; Olanzapine; Pyridines; Rats; Rats, Wistar; Receptors, Dopamine D3; Sulfonamides; Sulpiride; Tissue Distribution | 2008 |
Subnanomolar dopamine D3 receptor antagonism coupled to moderate D2 affinity results in favourable antipsychotic-like activity in rodent models: I. neurochemical characterisation of RG-15.
Topics: Amisulpride; Animals; CHO Cells; Cricetinae; Cricetulus; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Haloperidol; Humans; Inhibitory Concentration 50; Male; Mice; Nitriles; Prolactin; Pyridines; Rats; Rats, Wistar; Receptors, Dopamine D3; Sulfonamides; Sulpiride; Tetrahydroisoquinolines | 2008 |
Catatonia, neuroleptics and brain damage--a case report.
Topics: Amisulpride; Antipsychotic Agents; Atrophy; Catatonia; Epilepsy, Temporal Lobe; Female; Frontal Lobe; Humans; Middle Aged; Neuroleptic Malignant Syndrome; Parietal Lobe; Psychotic Disorders; Sulpiride | 2009 |
Hyperprolactinemia and possibly related development of prolactinoma during amisulpride treatment; three cases.
Topics: Adult; Amisulpride; Antipsychotic Agents; Brain; Female; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Sulpiride | 2009 |
Repeated acute dystonia following administration of amisulpride and ziprasidone in a patient with iron deficiency.
Topics: Adolescent; Amisulpride; Anemia, Iron-Deficiency; Antipsychotic Agents; Dibenzothiazepines; Dystonia; Female; Hemoglobins; Humans; Piperazines; Quetiapine Fumarate; Schizophrenia; Sulpiride; Thiazoles | 2008 |
Amisulpride-induced both oculogyric crisis and trismus.
Topics: Amisulpride; Antipsychotic Agents; Dystonia; Humans; Male; Ocular Motility Disorders; Schizophrenia; Sulpiride; Trismus; Young Adult | 2008 |
Urinary incontinence associated with amisulpride.
Topics: Adolescent; Amisulpride; Antipsychotic Agents; Female; Humans; Schizophrenia, Paranoid; Sulpiride; Urinary Incontinence | 2009 |
Liquid chromatography tandem mass spectrometry method for the quantification of amisulpride with LLOQ of 100 pg/mL using 100 microL of plasma.
Topics: Amisulpride; Chromatography, Liquid; Dopamine Antagonists; Humans; Molecular Structure; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Sulpiride; Tandem Mass Spectrometry | 2008 |
Heart rate variability in schizophrenic patients switched from typical antipsychotic agents to amisulpride and olanzapine. 3-month follow-up.
Topics: Amisulpride; Antipsychotic Agents; Autonomic Nervous System; Benzodiazepines; Female; Heart Rate; Humans; Male; Middle Aged; Olanzapine; Schizophrenia; Statistics, Nonparametric; Sulpiride | 2008 |
Amisulpride the 'atypical' atypical antipsychotic--comparison to haloperidol, risperidone and clozapine.
Topics: Amisulpride; Amphetamine; Animals; Antipsychotic Agents; Basal Ganglia; Behavior, Animal; Blood-Brain Barrier; Brain; Clozapine; Conditioning, Psychological; Haloperidol; Male; Models, Animal; Motor Activity; Phencyclidine; Prefrontal Cortex; Prolactin; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Serotonin; Risperidone; Sulpiride | 2008 |
A flow-cytometric method to investigate glutamate-receptor-sensitivity in whole blood platelets - results from healthy controls and patients with schizophrenia.
Topics: Adult; Amisulpride; Analysis of Variance; Blood Platelets; Calcium; Dizocilpine Maleate; Dopamine Antagonists; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Female; Flow Cytometry; Humans; Intracellular Membranes; Male; Middle Aged; Pilot Projects; Receptors, Glutamate; Reference Values; Reproducibility of Results; Schizophrenia; Sensitivity and Specificity; Sulpiride; Young Adult | 2009 |
Antipsychotics possessing antidepressive efficacy increase Golf protein in rat striatum.
Topics: Amisulpride; Animals; Antipsychotic Agents; Benzodiazepines; Blotting, Western; Clozapine; Corpus Striatum; Depressive Disorder; Dose-Response Relationship, Drug; GTP-Binding Protein alpha Subunits; Haloperidol; Injections, Intraperitoneal; Male; Olanzapine; Rats; Rats, Wistar; Risperidone; Sulpiride; Time Factors | 2008 |
Tardive dystonia associated with low-dose of amisulpride: a case report.
Topics: Adult; Amisulpride; Antipsychotic Agents; Clozapine; Dyskinesia, Drug-Induced; Dystonia; Humans; Male; Schizophrenia, Paranoid; Sulpiride | 2008 |
Weight gain in a patient with schizophrenia switched from quetiapine to amisulpride.
Topics: Adult; Amisulpride; Antipsychotic Agents; Appetite; Dibenzothiazepines; Dose-Response Relationship, Drug; Eating; Female; Humans; Hyperprolactinemia; Hypertriglyceridemia; Quetiapine Fumarate; Recurrence; Schizophrenia, Paranoid; Sulpiride | 2008 |
Aripiprazole resolves amisulpride and ziprasidone-induced hyperprolactinemia.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Female; Humans; Hyperprolactinemia; Long-Term Care; Piperazines; Quinolones; Schizophrenia, Paranoid; Sulpiride; Thiazoles; Young Adult | 2008 |
Torsade de pointes associated with low-dose amisulpride: a case report.
Topics: Amisulpride; Antipsychotic Agents; Female; Humans; Middle Aged; Sulpiride; Torsades de Pointes | 2010 |
Amisulpride and galactorrhoea: delayed or withdrawal?
Topics: Adult; Amisulpride; Antipsychotic Agents; Female; Galactorrhea; Humans; Receptors, Dopamine D2; Receptors, Dopamine D3; Substance Withdrawal Syndrome; Sulpiride | 2009 |
Amisulpride for the treatment of very-late-onset schizophrenia-like psychosis.
Topics: Age of Onset; Aged; Aged, 80 and over; Amisulpride; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Sulpiride; Treatment Outcome | 2009 |
Hyperpigmentation with amisulpride.
Topics: Adult; Amisulpride; Antipsychotic Agents; Chronic Disease; Drug Therapy, Combination; Female; Fluvoxamine; Humans; Hyperpigmentation; Obsessive-Compulsive Disorder; Photosensitivity Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline; Sulpiride | 2009 |
[Costs of treatment in patients with schizophrenia switched to amisulpride--one-year follow-up].
Topics: Adult; Aged; Amisulpride; Antipsychotic Agents; Cost of Illness; Drug Costs; Efficiency; Employment; Female; Follow-Up Studies; Health Care Costs; Health Resources; Humans; Hungary; Income; Male; Middle Aged; Retrospective Studies; Schizophrenia; Severity of Illness Index; Sulpiride; Treatment Outcome; Volunteers | 2008 |
Successful treatment with amisulpride for the progression of olfactory reference syndrome to schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Humans; Male; Middle Aged; Olfactory Perception; Perceptual Disorders; Schizophrenia; Sulpiride | 2009 |
Inhibitory effects of polyphenol compounds on lipid peroxidation caused by antipsychotics (haloperidol and amisulpride) in human plasma in vitro.
Topics: Adult; Amisulpride; Antioxidants; Antipsychotic Agents; Female; Haloperidol; Humans; In Vitro Techniques; Lipid Peroxidation; Male; Quercetin; Resveratrol; Stilbenes; Sulpiride; Thiobarbituric Acid Reactive Substances | 2010 |
Aripiprazole in combination with other antipsychotic drugs may worsen psychosis.
Topics: Amisulpride; Anti-Dyskinesia Agents; Antipsychotic Agents; Aripiprazole; Biperiden; Dopamine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Male; Piperazines; Psychotic Disorders; Quinolones; Schizophrenia, Paranoid; Schizophrenic Psychology; Sulpiride; Young Adult | 2009 |
Is second-generation antipsychotic-induced hyperprolactinemia due to biologically active prolactin or to biologically inactive macroprolactin? Results from a prospective study.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Diagnosis, Differential; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Prolactin; Prospective Studies; Risk Factors; Risperidone; Schizophrenia; Sulpiride; Young Adult | 2009 |
Amisulpride treatment of adolescent patients with schizophrenia or schizo-affective disorders.
Topics: Adolescent; Amisulpride; Antiparkinson Agents; Antipsychotic Agents; Biperiden; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Female; Galactorrhea; Humans; Psychotic Disorders; Schizophrenia; Sulpiride; Treatment Outcome | 2009 |
Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo.
Topics: Amisulpride; Analysis of Variance; Animals; Antipsychotic Agents; Behavior, Animal; Binding, Competitive; Dose-Response Relationship, Drug; Hindlimb Suspension; Humans; Lysergic Acid Diethylamide; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Protein Binding; Receptors, Serotonin; Sulpiride; Swimming; Tritium | 2009 |
Amisulpride-induced tardive dyskinesia and possible association of dyskinesia with hypothyroidism.
Topics: Amisulpride; Dopamine Antagonists; Dyskinesia, Drug-Induced; Humans; Hypothyroidism; Male; Sulpiride; Young Adult | 2009 |
[Prolonged QT interval in two cases of amisulpride overdose].
Topics: Amisulpride; Antipsychotic Agents; Drug Overdose; Female; Follow-Up Studies; Humans; Long QT Syndrome; Male; Middle Aged; Schizophrenia; Suicide, Attempted; Sulpiride; Time Factors | 2010 |
Low-dose amisulpride induced Pisa syndrome in an alcohol-dependent patient with liver cirrhosis.
Topics: Alcoholism; Amisulpride; Dystonia; Humans; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Sulpiride; Syndrome | 2009 |
Targeting cognition in schizophrenia research: from etiology to treatment.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Cognition; Cognition Disorders; Dibenzothiazepines; Drug Administration Schedule; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Reaction Time; Schizophrenia; Sulpiride; Thiazoles | 2009 |
Amisulpride treatment for clozapine-induced sialorrhea.
Topics: Adult; Amisulpride; Antipsychotic Agents; Clozapine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Humans; Male; Receptors, Dopamine D3; Schizophrenia, Paranoid; Sialorrhea; Sulpiride | 2009 |
Causal model of insight and psychopathology based on the PANSS factors: 1-year cross-sectional and longitudinal revalidation.
Topics: Adult; Amisulpride; Antipsychotic Agents; Cognition; Female; Humans; Male; Models, Psychological; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Sulpiride; Time Factors | 2009 |
Tardive dyskinesia in a patient treated with quetiapine.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Dibenzothiazepines; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Sulpiride; Thiazoles | 2009 |
Amisulpride-induced mania with interictal psychosis.
Topics: Adolescent; Amisulpride; Antipsychotic Agents; Bipolar Disorder; Humans; Male; Psychotic Disorders; Sulpiride | 2009 |
A tryptamine-derived catecholaminergic enhancer, (-)-1-(benzofuran-2-yl)-2-propylaminopentane [(-)-BPAP], attenuates reinstatement of methamphetamine-seeking behavior in rats.
Topics: Adrenergic Agents; Amisulpride; Amphetamine-Related Disorders; Animals; Benzazepines; Benzofurans; Central Nervous System Stimulants; Conditioning, Classical; Cues; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Extinction, Psychological; Male; Methamphetamine; Rats; Rats, Wistar; Self Administration; Sulpiride | 2010 |
Improved body weight and metabolic outcomes in overweight or obese psychiatric patients switched to amisulpride from other atypical antipsychotics.
Topics: Adult; Amisulpride; Antipsychotic Agents; Body Weight; Energy Metabolism; Female; Follow-Up Studies; Hospitalization; Humans; Male; Mental Disorders; Middle Aged; Obesity; Overweight; Prospective Studies; Sulpiride; Treatment Outcome | 2009 |
Amisulpride-induced tardive dystonia: a case report.
Topics: Adult; Amisulpride; Antipsychotic Agents; Dyskinesia, Drug-Induced; Dystonia; Electroencephalography; Humans; Magnetic Resonance Imaging; Male; Schizophrenia, Paranoid; Sulpiride | 2010 |
Acute rhabdomyolysis during treatment with amisulpride and metformin.
Topics: Acute Disease; Adult; Amisulpride; Antipsychotic Agents; Biomarkers; Creatine Kinase, MM Form; Humans; Hypoglycemic Agents; Male; Metformin; Rhabdomyolysis; Sulpiride | 2010 |
The effects of psychopathology on subjective experience of side effects of antipsychotics in patients with schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Anxiety; Benzodiazepines; Cognition Disorders; Depressive Disorder; Female; Humans; Linear Models; Male; Models, Psychological; Olanzapine; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Sulpiride | 2010 |
Dual motor response to l-dopa and nociceptin/orphanin FQ receptor antagonists in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) treated mice: Paradoxical inhibition is relieved by D(2)/D(3) receptor blockade.
Topics: Amisulpride; Animals; Antiparkinson Agents; Benzimidazoles; Benzothiazoles; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Interactions; Drug Synergism; Levodopa; Male; Mice; Mice, Inbred C57BL; Motor Activity; Neural Inhibition; Nociceptin; Opioid Peptides; Parkinsonian Disorders; Piperidines; Pramipexole; Pyridines; Reaction Time; Receptors, Dopamine D3; Sulpiride | 2010 |
Familial differential treatment response in schizophrenia--lessons from a case of three affected siblings.
Topics: Adult; Amisulpride; Antipsychotic Agents; Dibenzothiazepines; Diseases in Twins; Female; Humans; Lorazepam; Male; Quetiapine Fumarate; Schizophrenia; Siblings; Sulpiride; Twins, Dizygotic | 2010 |
Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Brain-Derived Neurotrophic Factor; Case-Control Studies; Female; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Risperidone; Schizophrenia; Sulpiride; Treatment Failure | 2010 |
Amisulpride-induced tardive dyskinesia in childhood onset schizophrenia.
Topics: Adolescent; Amisulpride; Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Male; Schizophrenia; Sulpiride | 2010 |
Development and validation of spectrophotometric methods for estimating amisulpride in pharmaceutical preparations.
Topics: Amisulpride; Drug Compounding; Indicators and Reagents; Nitrous Acid; Pharmaceutical Preparations; Spectrophotometry; Sulpiride | 2010 |
Hyperprolactinaemia and acute psychosis: prolactinoma or medication-induced phenomenon?
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Female; Follow-Up Studies; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Middle Aged; Olanzapine; Pituitary Gland; Pituitary Neoplasms; Prolactinoma; Psychotic Disorders; Remission, Spontaneous; Sulpiride; Thyrotropin-Releasing Hormone | 2010 |
Neuroleptic malignant syndrome.
Topics: Adult; Amisulpride; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Lithium Carbonate; Neuroleptic Malignant Syndrome; Recurrence; Risk Factors; Sulpiride | 2010 |
Tardive dystonia induced by switch of atypical antipsychotics.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Olanzapine; Schizophrenia; Sulpiride | 2010 |
Amisulpride monotherapy in a patient with clozapine-resistant schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Humans; Male; Receptors, Dopamine D3; Schizophrenia; Sulpiride; Treatment Outcome | 2010 |
Influence of compulsivity of drug abuse on dopaminergic modulation of attentional bias in stimulant dependence.
Topics: Adult; Amisulpride; Amphetamine-Related Disorders; Attention; Benzothiazoles; Bias; Cerebellar Cortex; Cocaine-Related Disorders; Compulsive Behavior; Dopamine; Dopamine Agonists; Dopamine Antagonists; England; Female; Functional Laterality; Humans; Individuality; Magnetic Resonance Imaging; Male; Pramipexole; Prefrontal Cortex; Receptors, Dopamine; Stroop Test; Substance-Related Disorders; Sulpiride; Surveys and Questionnaires | 2010 |
Amisulpride overdose is frequently associated with QT prolongation and torsades de pointes.
Topics: Adult; Amisulpride; Antipsychotic Agents; Bradycardia; Cohort Studies; Drug Overdose; Electrocardiography; Female; Heart Rate; Humans; Hypotension; Long QT Syndrome; Male; Poison Control Centers; Prospective Studies; Sulpiride; Torsades de Pointes; Young Adult | 2010 |
Gender, psychosis and psychotropic drugs: differences and similarities.
Topics: Acute Disease; Adult; Affect; Amisulpride; Antipsychotic Agents; Benzodiazepines; Brain; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Hospitalization; Humans; Internal-External Control; Male; Olanzapine; Psychiatric Status Rating Scales; Psychotic Disorders; Sex Factors; Sulpiride; Thinking | 2010 |
Amisulpride for clozapine induced sialorrhea.
Topics: Adult; Amisulpride; Antipsychotic Agents; Clozapine; Female; Humans; Sialorrhea; Sulpiride | 2009 |
Amisulpride overdose: suggested management of prolonged QTc.
Topics: Adult; Amisulpride; Antipsychotic Agents; Calcium; Drug Overdose; Humans; Hypocalcemia; Infusions, Intravenous; Long QT Syndrome; Male; Schizophrenia; Sulpiride | 2010 |
Successful treatment with amisulpride for poststroke psychosis.
Topics: Amisulpride; Antipsychotic Agents; Female; Humans; Middle Aged; Psychotic Disorders; Stroke; Sulpiride; Treatment Outcome | 2010 |
Possible rabbit syndrome with amisulpride.
Topics: Aged; Amisulpride; Dyskinesia, Drug-Induced; Humans; Male; Sulpiride | 2010 |
Amisulpride may worsen dyskinesia and trigger new-onset dyskinetic movements.
Topics: Aged; Amisulpride; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Humans; Schizophrenia; Sulpiride | 2010 |
Pisa syndrome during amisulpride treatment.
Topics: Adult; Amisulpride; Antipsychotic Agents; Dystonia; Humans; Male; Schizophrenia; Sulpiride | 2010 |
Estimation of rac-amisulpride transfer into milk and of infant dose via milk during its use in a lactating woman with bipolar disorder and schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Bipolar Disorder; Breast Feeding; Child Development; Chromatography, High Pressure Liquid; Directive Counseling; Drug Monitoring; Female; Humans; Infant; Lactation; Maternal Exposure; Milk, Human; Risk Factors; Schizophrenia; Sulpiride; Weaning | 2011 |
Assessment of infant dose through milk in a lactating woman taking amisulpride and desvenlafaxine for treatment-resistant depression.
Topics: Adult; Amisulpride; Antidepressive Agents; Breast Feeding; Cyclohexanols; Depressive Disorder; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Female; Humans; Infant; Infant, Newborn; Lactation; Milk, Human; Sulpiride | 2010 |
Amisulpride therapeutic dose-induced asymptomatic bradycardia.
Topics: Amisulpride; Antipsychotic Agents; Bradycardia; Humans; Male; Schizophrenia, Paranoid; Sulpiride; Young Adult | 2011 |
Relief from chronic intractable auditory hallucinations after long-term bilateral theta burst stimulation.
Topics: Amisulpride; Antipsychotic Agents; Clozapine; Cognitive Behavioral Therapy; Combined Modality Therapy; Dominance, Cerebral; Follow-Up Studies; Hallucinations; Humans; Middle Aged; Parietal Lobe; Schizophrenia, Paranoid; Sulpiride; Temporal Lobe; Theta Rhythm; Transcranial Magnetic Stimulation; Treatment Outcome | 2010 |
Clock genes and body composition in patients with schizophrenia under treatment with antipsychotic drugs.
Topics: Adult; Age Factors; Alleles; Amisulpride; Anthropometry; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Composition; Body Mass Index; CLOCK Proteins; Clozapine; Dibenzothiazepines; Drug Therapy, Combination; Female; Genetic Association Studies; Genetic Carrier Screening; Genotype; Humans; Long-Term Care; Male; Middle Aged; Mutation, Missense; Olanzapine; Period Circadian Proteins; Piperazines; Polymorphism, Single Nucleotide; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Receptor, Melanocortin, Type 3; Receptors, Glucocorticoid; Receptors, Leptin; Risperidone; Schizophrenia; Sex Factors; Sulpiride; Syndecan-3 | 2011 |
Basic drug analysis by strong cation-exchange liquid chromatography-tandem mass spectrometry: simultaneous analysis of amisulpride, and of metamfetamine and amfetamine in serum/plasma.
Topics: Amisulpride; Amphetamine; Cations; Chromatography, High Pressure Liquid; Chromatography, Ion Exchange; Humans; Least-Squares Analysis; Methamphetamine; Reproducibility of Results; Sensitivity and Specificity; Sulpiride; Tandem Mass Spectrometry | 2011 |
Amisulpride-induced seizurogenic effect: a potential role of opioid receptor-linked transduction systems.
Topics: Amines; Amisulpride; Analysis of Variance; Animals; Anti-Asthmatic Agents; Cromolyn Sodium; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Male; Mice; Mice, Inbred Strains; Naloxone; Receptors, GABA; Receptors, Histamine H1; Receptors, Opioid; Seizures; Sulpiride | 2011 |
Dopamine-mediated reinforcement learning signals in the striatum and ventromedial prefrontal cortex underlie value-based choices.
Topics: Adult; Amisulpride; Choice Behavior; Corpus Striatum; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Female; Humans; Magnetic Resonance Imaging; Male; Models, Neurological; Neuropsychological Tests; Prefrontal Cortex; Psychomotor Performance; Reinforcement Schedule; Reinforcement, Psychology; Reward; Signal Transduction; Sulpiride; Time Factors | 2011 |
The effectiveness of the combination therapy of amisulpride and quetiapine for managing treatment-resistant schizophrenia: a naturalistic study.
Topics: Adult; Amisulpride; Dibenzothiazepines; Disease Management; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Quality of Life; Quetiapine Fumarate; Schizophrenia; Sulpiride; Treatment Outcome | 2011 |
Beta-glucan from Saccharomyces cerevisiae reduces plasma lipid peroxidation induced by haloperidol.
Topics: Adult; Amisulpride; Analysis of Variance; Antipsychotic Agents; beta-Glucans; Female; Haloperidol; Humans; Lipid Peroxidation; Male; Saccharomyces cerevisiae; Schizophrenia; Sulpiride; Thiobarbituric Acid Reactive Substances | 2011 |
Hyperprolactinaemia with amisulpride.
Topics: Amisulpride; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Anxiety Disorders; Borderline Personality Disorder; Depressive Disorder; Dose-Response Relationship, Drug; Drug Substitution; Drug Therapy, Combination; Female; Galactorrhea; Humans; Hyperprolactinemia; Middle Aged; Patient Readmission; Somatoform Disorders; Sulpiride | 2011 |
Antiserotonergic antipsychotics are associated with obsessive-compulsive symptoms in schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Comorbidity; Female; Germany; Humans; Male; Matched-Pair Analysis; Obsessive-Compulsive Disorder; Olanzapine; Piperazines; Prevalence; Quinolones; Schizophrenia; Serotonin Antagonists; Severity of Illness Index; Sulpiride | 2011 |
[Amisulpride for the treatment of alcohol dependence].
Topics: Alcoholism; Amisulpride; Anticonvulsants; Antipsychotic Agents; Female; Fructose; Humans; Male; Naltrexone; Narcotic Antagonists; Sulpiride; Topiramate | 2011 |
Differential effects of amisulpride and haloperidol on dopamine D2 receptor-mediated signaling in SH-SY5Y cells.
Topics: Amisulpride; Arrestins; beta-Arrestin 2; beta-Arrestins; Cell Line, Tumor; Dopamine D2 Receptor Antagonists; Haloperidol; Humans; Neurites; Receptors, Dopamine D2; Signal Transduction; Sulpiride | 2011 |
Augmentation treatment with amisulpride in schizophrenic patients partially responsive to olanzapine.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Diagnostic and Statistical Manual of Mental Disorders; Dopamine Antagonists; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Retrospective Studies; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Sulpiride; Young Adult | 2011 |
Prediction of torsade de pointes from the QT interval: analysis of a case series of amisulpride overdoses.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Overdose; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Sulpiride; Torsades de Pointes; Young Adult | 2011 |
Serum creatine kinase elevation associated with olanzapine treatment.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Creatine Kinase; Humans; Male; Olanzapine; Sulpiride | 2008 |
Clozapine-induced salivation: interaction with N-desmethylclozapine and amisulpride in an experimental rat model.
Topics: Abdomen; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Amisulpride; Animals; Antipsychotic Agents; Blood Pressure; Chorda Tympani Nerve; Clozapine; Female; Lingual Nerve; Liver Circulation; Methacholine Chloride; Models, Animal; Muscarinic Agonists; Parasympathectomy; Phentolamine; Propranolol; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M1; Receptor, Muscarinic M3; Saliva; Salivation; Submandibular Gland; Sulpiride; Time Factors | 2011 |
Amisulpride-induced acute akathisia in OCD: an example of dysfunctional dopamine-serotonin interactions?
Topics: Adult; Akathisia, Drug-Induced; Amisulpride; Dopamine; Female; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Serotonin; Sulpiride | 2012 |
Secondary pseudomyopia induced by amisulpride.
Topics: Adult; Amisulpride; Antipsychotic Agents; Diagnosis, Differential; Female; Humans; Myopia; Refraction, Ocular; Schizophrenia; Sulpiride; Vision Tests; Visual Acuity | 2011 |
Identification of photodegradation product of amisulpride by ultra-high-pressure liquid chromatography-DAD/ESI-quadrupole time-of-flight-mass spectrometry.
Topics: Amisulpride; Antipsychotic Agents; Chromatography, High Pressure Liquid; Photochemistry; Sulpiride; Tandem Mass Spectrometry | 2011 |
Amisulpride in the treatment of somatoform disorders.
Topics: Adult; Amisulpride; Female; Humans; Male; Middle Aged; Somatoform Disorders; Sulpiride; Treatment Outcome | 2011 |
Amisulpride augmentation of clozapine in refractory schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Clozapine; Drug Synergism; Humans; Male; Middle Aged; Schizophrenia; Sulpiride | 2011 |
Effects of amisulpride and aripiprazole on progressive-ratio schedule performance: comparison with clozapine and haloperidol.
Topics: Amisulpride; Animals; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Clozapine; Conditioning, Operant; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Haloperidol; Kinetics; Models, Biological; Motor Activity; Motor Skills; Piperazines; Quinolones; Rats; Rats, Wistar; Reaction Time; Reinforcement Schedule; Serotonin Antagonists; Sulpiride | 2012 |
Cost-effectiveness analysis of burning mouth syndrome therapy.
Topics: Amisulpride; Antidepressive Agents; Burning Mouth Syndrome; Clonazepam; Cost-Benefit Analysis; Decision Trees; Dental Care; Drug Costs; Health Care Costs; Humans; Paroxetine; Sertraline; Sulpiride | 2012 |
Effect of the antipsychotic agent amisulpride on glucose lowering and insulin secretion.
Topics: Amisulpride; Animals; Antipsychotic Agents; Blood Glucose; Glucagon-Like Peptide 1; Glucose Tolerance Test; Insulin; Insulin Secretion; Insulin-Secreting Cells; Male; Mice; Mice, Obese; Prolactin; Sulpiride | 2012 |
Safety of amisulpride in combination with antidepressants under common clinical practice conditions.
Topics: Adult; Amisulpride; Antidepressive Agents; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sulpiride | 2011 |
BMP inhibition by DAN in Hensen's node is a critical step for the establishment of left-right asymmetry in the chick embryo.
Topics: Amisulpride; Animals; Avian Proteins; Benzamides; Body Patterning; Bone Morphogenetic Protein 4; Chick Embryo; Chlorocebus aethiops; COS Cells; Dioxoles; Gene Expression Regulation, Developmental; Hedgehog Proteins; In Situ Hybridization; Intracellular Signaling Peptides and Proteins; Left-Right Determination Factors; Mesoderm; Models, Genetic; Nodal Protein; Notochord; Organizers, Embryonic; Protein Binding; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Signal Transduction; Sulpiride; Xenopus | 2012 |
Attentional and emotional functioning in schizophrenia patients treated with conventional and atypical antipsychotic drugs.
Topics: Adult; Amisulpride; Analysis of Variance; Antipsychotic Agents; Attention; Benzodiazepines; Dibenzothiazepines; Emotions; Fluphenazine; Haloperidol; Humans; Memory; Middle Aged; Olanzapine; Perazine; Perphenazine; Quetiapine Fumarate; Recognition, Psychology; Risperidone; Schizophrenia; Sulpiride | 2012 |
Second-generation antipsychotic medications and risk of pneumonia in schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Case-Control Studies; Clozapine; Cohort Studies; Dibenzothiazepines; Dibenzothiepins; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Middle Aged; Olanzapine; Pneumonia; Quetiapine Fumarate; Risk Factors; Risperidone; Schizophrenia; Sulpiride; Taiwan | 2013 |
Changes in sexual function and gonadal axis hormones after switching to aripiprazole in male schizophrenia patients: a prospective pilot study.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Estradiol; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Middle Aged; Olanzapine; Pilot Projects; Piperazines; Prolactin; Prospective Studies; Quinolones; Retreatment; Risperidone; Schizophrenia; Sex Hormone-Binding Globulin; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Sulpiride; Testosterone | 2012 |
Atypical antipsychotics--effects of amisulpride on salivary secretion and on clozapine-induced sialorrhea.
Topics: Amisulpride; Amylases; Animals; Antipsychotic Agents; Autonomic Agents; Bethanechol; Clozapine; Denervation; Female; Isoproterenol; Methacholine Chloride; Parasympathetic Nervous System; Parotid Gland; Raclopride; Rats; Rats, Sprague-Dawley; Saliva; Salivation; Sialorrhea; Submandibular Gland; Substance P; Sulpiride; Sympathetic Nervous System | 2012 |
Effects of drop-out on efficacy estimates in five Cochrane reviews of popular antipsychotics for schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Data Interpretation, Statistical; Dibenzothiazepines; Humans; Olanzapine; Patient Dropouts; Piperazines; Quetiapine Fumarate; Quinolones; Review Literature as Topic; Risperidone; Schizophrenia; Sulpiride | 2012 |
Amisulpride in the treatment of fibromyalgia: an uncontrolled study.
Topics: Adult; Amisulpride; Antipsychotic Agents; Anxiety; Comorbidity; Dopamine Antagonists; Female; Fibromyalgia; Humans; Male; Middle Aged; Severity of Illness Index; Sulpiride; Surveys and Questionnaires; Treatment Outcome | 2012 |
Antipsychotic monotherapy and polypharmacy in the treatment of outpatients with schizophrenia in the European Schizophrenia Outpatient Health Outcomes Study.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Europe; Female; Humans; Logistic Models; Male; Olanzapine; Polypharmacy; Prospective Studies; Quetiapine Fumarate; Risperidone; Schizophrenia; Sulpiride; Time Factors | 2012 |
Risperidone augmentation with amisulpride: the blue-tongue sign.
Topics: Amisulpride; Dopamine Antagonists; Drug Therapy, Combination; Humans; Male; Melanins; Pigmentation; Risperidone; Schizophrenia; Sulpiride; Tongue; Young Adult | 2012 |
Determination of steroid metabolome as a possible tool for laboratory diagnosis of schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Case-Control Studies; Female; Humans; Male; Metabolome; Metabolomics; Middle Aged; Models, Biological; Olanzapine; Schizophrenia; Steroids; Sulpiride; Young Adult | 2013 |
Plasma amisulpride in relation to prescribed dose, clozapine augmentation, and other factors: data from a therapeutic drug monitoring service, 2002-2010.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amisulpride; Antipsychotic Agents; Clozapine; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Female; Humans; Linear Models; Male; Middle Aged; Smoking; Sulpiride; Young Adult | 2012 |
Choline acetyltransferase expression in rat prefrontal cortex and hippocampus after acute and chronic exposure to amisulpride, haloperidol, and risperidone.
Topics: Amisulpride; Animals; Antipsychotic Agents; Choline O-Acetyltransferase; Dose-Response Relationship, Drug; Haloperidol; Hippocampus; Male; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Risperidone; Sulpiride; Time Factors | 2012 |
Charles Bonnet syndrome responding to amisulpride.
Topics: Amisulpride; Antipsychotic Agents; Blindness; Electroencephalography; Hallucinations; Humans; Male; Middle Aged; Sulpiride; Visual Field Tests | 2012 |
Effect of atypical antipsychotics on antioxidant enzyme activities in human erythrocytes (in vitro study).
Topics: Adult; Amisulpride; Antioxidants; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Catalase; Clozapine; Dibenzothiazepines; Enzyme Activation; Erythrocytes; Glutathione Peroxidase; Glutathione Reductase; Humans; Imidazoles; Indoles; Male; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Sulpiride; Superoxide Dismutase; Superoxide Dismutase-1; Thiazoles; Treatment Outcome; Young Adult | 2013 |
Successful treatment of atypical depression with amisulpride: a case report.
Topics: Amisulpride; Antidepressive Agents; Depressive Disorder, Major; Female; Humans; Sulpiride; Young Adult | 2012 |
Attaining and sustaining remission of predominant negative symptoms.
Topics: Adult; Amisulpride; Analysis of Variance; Antipsychotic Agents; Chi-Square Distribution; Double-Blind Method; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Recurrence; Regression Analysis; Schizophrenia; Sulpiride; Time Factors; Treatment Outcome; Young Adult | 2013 |
Improvements in micturition and urinary retention after switching from amisulpiride to paliperidone in a schizophrenic patient.
Topics: Amisulpride; Antipsychotic Agents; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Pyrimidines; Retreatment; Schizophrenia; Sulpiride; Treatment Outcome; Urinary Retention; Urination | 2012 |
[The comparative study on the efficacy of the combination of serotonin reuptake inhibitor antidepressants and antipsychotics in the treatment of recurrent depressive disorders].
Topics: Adolescent; Adult; Amisulpride; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Olanzapine; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Sulpiride; Treatment Outcome; Young Adult | 2012 |
Poisoning: fact or fiction?
Topics: Aconitum; Amisulpride; Antipsychotic Agents; Chloroform; Forensic Toxicology; History, 19th Century; History, 20th Century; History, 21st Century; Homicide; Humans; Infant; Poisoning; Solvents; Sudden Infant Death; Sulpiride | 2012 |
Imaging brain gene expression profiles by antipsychotics: region-specific action of amisulpride on postsynaptic density transcripts compared to haloperidol.
Topics: Amisulpride; Animals; Antipsychotic Agents; Cerebral Cortex; Corpus Striatum; Dopamine Antagonists; Dose-Response Relationship, Drug; Functional Neuroimaging; Gene Expression Profiling; Genes, Immediate-Early; Haloperidol; Limbic System; Male; Organ Specificity; Post-Synaptic Density; Rats; Sulpiride | 2013 |
Spectroscopic investigation on the inclusion complex formation between amisulpride and γ-cyclodextrin.
Topics: Amisulpride; gamma-Cyclodextrins; Models, Molecular; Molecular Conformation; Spectrum Analysis; Sulpiride | 2013 |
Amisulpride-associated acute onset of metabolic syndrome in a schizophrenia patient.
Topics: Adult; Amisulpride; Antipsychotic Agents; Female; Humans; Metabolic Syndrome; Schizophrenia; Sulpiride | 2013 |
Delusional infestation: a clinical profile.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Delusions; Ectoparasitic Infestations; Female; Humans; Male; Middle Aged; Olanzapine; Risperidone; Sulpiride; Treatment Outcome | 2013 |
Safety of the electroconvulsive therapy and amisulpride combination.
Topics: Adult; Amisulpride; Antipsychotic Agents; Case-Control Studies; Combined Modality Therapy; Electroconvulsive Therapy; Female; Humans; Male; Middle Aged; Retrospective Studies; Schizophrenia; Sulpiride; Treatment Outcome | 2013 |
False-positive buprenorphine by CEDIA in patients prescribed amisulpride or sulpiride.
Topics: Adult; Amisulpride; Buprenorphine; Chromatography, High Pressure Liquid; False Positive Reactions; Humans; Immunoassay; Immunoenzyme Techniques; Male; Substance Abuse Detection; Sulpiride | 2013 |
LC-MS/MS of some atypical antipsychotics in human plasma, serum, oral fluid and haemolysed whole blood.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chromatography, Liquid; Clozapine; Dibenzothiazepines; Female; Forensic Toxicology; Hemolysis; Humans; Isoxazoles; Male; Olanzapine; Paliperidone Palmitate; Piperazines; Pyrimidines; Quetiapine Fumarate; Quinolones; Reproducibility of Results; Risperidone; Saliva; Serum; Sulpiride; Tandem Mass Spectrometry | 2013 |
Amisulpride-induced macrocytic anemia.
Topics: Adult; Amisulpride; Anemia, Macrocytic; Antipsychotic Agents; Humans; Male; Schizophrenia, Paranoid; Sulpiride | 2013 |
Lethal neuroleptic malignant syndrome due to amisulpride.
Topics: Adult; Amisulpride; Antipsychotic Agents; Autopsy; Cause of Death; Fatal Outcome; Forensic Pathology; Forensic Toxicology; Humans; Male; Neuroleptic Malignant Syndrome; Sulpiride | 2013 |
[Clinical and experimental research of immunomodulatory effect of amisulpride].
Topics: Adult; Amisulpride; Animals; Antibodies, Anti-Idiotypic; Antipsychotic Agents; Disease Models, Animal; Female; Humans; Immunity, Humoral; Immunoglobulin M; Male; Mice; Mice, Inbred C57BL; Schizophrenia; Sulpiride; T-Lymphocytes; Treatment Outcome | 2012 |
Antipsychotics and torsadogenic risk: signals emerging from the US FDA Adverse Event Reporting System database.
Topics: Adverse Drug Reaction Reporting Systems; Amisulpride; Antipsychotic Agents; Arrhythmias, Cardiac; Benzodiazepines; Cardiotoxins; Cardiovascular Agents; Databases, Pharmaceutical; Death, Sudden, Cardiac; Female; Humans; Male; Olanzapine; Phenothiazines; Risk; Sulpiride; Tachycardia; Torsades de Pointes; United States; United States Food and Drug Administration; Ventricular Fibrillation | 2013 |
Stability of some atypical antipsychotics in human plasma, haemolysed whole blood, oral fluid, human serum and calf serum.
Topics: Amisulpride; Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cattle; Chromatography, Liquid; Clozapine; Dibenzothiazepines; Drug Stability; Female; Forensic Toxicology; Hemolysis; Humans; Isoxazoles; Male; Olanzapine; Paliperidone Palmitate; Piperazines; Pyrimidines; Quetiapine Fumarate; Quinolones; Reproducibility of Results; Risperidone; Saliva; Serum; Sulpiride; Tandem Mass Spectrometry | 2013 |
Amisulpride promotes cognitive flexibility in rats: the role of 5-HT7 receptors.
Topics: Amisulpride; Animals; Antipsychotic Agents; Attention; Cognition Disorders; Disease Models, Animal; Male; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Sulpiride; Tetrahydronaphthalenes | 2013 |
Brain morphology changes in a remitted patient with late-onset, drug-naïve, non-psychotic major depressive disorder after amisulpride monotherapy.
Topics: Amisulpride; Antipsychotic Agents; Brain; Depressive Disorder, Major; Female; Humans; Middle Aged; Sulpiride | 2013 |
Methamphetamine-induced disruption of frontostriatal reward learning signals: relation to psychotic symptoms.
Topics: Adult; Amisulpride; Antipsychotic Agents; Basal Ganglia; Central Nervous System Stimulants; Corpus Striatum; Female; Functional Neuroimaging; Humans; Learning; Magnetic Resonance Imaging; Male; Methamphetamine; Nucleus Accumbens; Prefrontal Cortex; Psychotic Disorders; Reinforcement, Psychology; Reward; Sulpiride | 2013 |
Clozapine augmented with amisulpride in 3 cases of treatment-resistant early- and very early-onset schizophrenia.
Topics: Adolescent; Amisulpride; Antipsychotic Agents; Clozapine; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Schizophrenia, Childhood; Schizophrenic Psychology; Sulpiride; Treatment Outcome | 2013 |
Effects of the selective 5-HT7 receptor antagonist SB-269970 and amisulpride on ketamine-induced schizophrenia-like deficits in rats.
Topics: Amisulpride; Animals; Ketamine; Male; Phenols; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Schizophrenia; Serotonin Antagonists; Sulfonamides; Sulpiride | 2013 |
Effects of cabergoline on hyperprolactinemia, psychopathology, and sexual functioning in schizophrenic patients.
Topics: Adult; Amisulpride; Antipsychotic Agents; Cabergoline; Diagnostic and Statistical Manual of Mental Disorders; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Female; Haloperidol; Humans; Hyperprolactinemia; Longitudinal Studies; Maintenance Chemotherapy; Male; Middle Aged; Prolactin; Prospective Studies; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Sexual Dysfunction, Physiological; Sulpiride | 2013 |
[Effect of antipsychotic amisulpride on immune reactivity].
Topics: Amisulpride; Animals; Antigens, CD; Antipsychotic Agents; Humans; Immune Tolerance; Male; Mice; Mice, Inbred CBA; Receptors, Dopamine D3; Schizophrenia; Sheep; Stress, Physiological; Sulpiride | 2013 |
Hypochondriasis and obsessive-compulsive disorder in schizophrenic patients treated with clozapine vs other atypical antipsychotics.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Comorbidity; Female; Humans; Hypochondriasis; Male; Middle Aged; Obsessive-Compulsive Disorder; Olanzapine; Paliperidone Palmitate; Prevalence; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride | 2014 |
Implication of the ERK/MAPK pathway in antipsychotics-induced dopamine D2 receptor upregulation and in the preventive effects of (±)-α-lipoic acid in SH-SY5Y neuroblastoma cells.
Topics: Amisulpride; Antipsychotic Agents; Cell Line, Tumor; Cell Survival; Haloperidol; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neurons; Neuroprotective Agents; Receptors, Dopamine D2; RNA, Messenger; Sulpiride; Thioctic Acid; Up-Regulation | 2014 |
The antipsychotic amisulpride: ultrastructural evidence of its secretory activity in salivary glands.
Topics: Amisulpride; Animals; Antipsychotic Agents; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Rats; Rats, Wistar; Salivary Glands; Sulpiride | 2014 |
Decreased prefrontal cortex dopamine activity following adolescent social defeat in male rats: role of dopamine D2 receptors.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amisulpride; Animals; Catheters, Indwelling; Dominance-Subordination; Dopamine; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Male; Microdialysis; Prefrontal Cortex; Quinpirole; Rats, Sprague-Dawley; Receptors, Dopamine D2; Stress, Psychological; Sulpiride | 2014 |
Augmentation of clozapine with amisulpride: an effective therapeutic strategy for violent treatment-resistant schizophrenia patients in a UK high-security hospital.
Topics: Adult; Aggression; Amisulpride; Antipsychotic Agents; Blood Glucose; Body Mass Index; Cholesterol; Cholesterol, HDL; Clozapine; Cohort Studies; Drug Therapy, Combination; Hospitals, Psychiatric; Humans; Male; Retrospective Studies; Schizophrenia; Schizophrenic Psychology; Security Measures; Sulpiride; Treatment Outcome; United Kingdom; Violence; Young Adult | 2014 |
A validated GC/MS method for the determination of amisulpride in whole blood.
Topics: Adult; Aged; Amisulpride; Antipsychotic Agents; Female; Gas Chromatography-Mass Spectrometry; Humans; Male; Middle Aged; Sensitivity and Specificity; Sulpiride | 2014 |
Case report of a patient presenting both schizophrenia and Charcot-Marie-Tooth disease.
Topics: Adult; Amisulpride; Antipsychotic Agents; Charcot-Marie-Tooth Disease; Humans; Male; Schizophrenia; Sulpiride | 2013 |
Towards a therapeutic window of D2/3 occupancy for treatment of psychosis in Alzheimer's disease, with [18F]fallypride positron emission tomography.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amisulpride; Antipsychotic Agents; Benzamides; Brain Mapping; Female; Humans; Male; Positron-Emission Tomography; Psychotic Disorders; Receptors, Dopamine D2; Sulpiride | 2014 |
Detecting potential adverse reactions of sulpiride in schizophrenic patients by prescription sequence symmetry analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amisulpride; Antipsychotic Agents; Child; Cohort Studies; Databases, Factual; Drug Prescriptions; Female; Humans; Male; Middle Aged; Schizophrenia; Sulpiride; Taiwan; Young Adult | 2014 |
Quantitative determination of amisulpride in rat plasma by HPLC-MS/MS.
Topics: Administration, Oral; Amisulpride; Animals; Chromatography, High Pressure Liquid; Drug Stability; Rats; Sulpiride; Tandem Mass Spectrometry | 2015 |
Spectrofluorimetric determination of amisulpride and bumidazone in raw materials and tablets.
Topics: Amisulpride; Calibration; Hydrogen-Ion Concentration; Limit of Detection; Methanol; Nitro Compounds; Reproducibility of Results; Solvents; Spectrometry, Fluorescence; Sulpiride; Tablets | 2014 |
[The role of zolpidem in improving catatonic schizophrenia. Case report].
Topics: Amisulpride; Antipsychotic Agents; Female; Humans; Hypnotics and Sedatives; Pyridines; Schizophrenia, Catatonic; Sulpiride; Young Adult; Zolpidem | 2014 |
(S)-amisulpride as a discriminative stimulus in C57BL/6 mice and its comparison to the stimulus effects of typical and atypical antipsychotics.
Topics: Amisulpride; Animals; Antipsychotic Agents; Discrimination, Psychological; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred C57BL; Reward; Stereoisomerism; Sulpiride; Time Factors | 2014 |
The effectiveness of high-dosage amisulpride combined with moderate-dosage sodium valproate treatment for an overweight patient with psychotic bipolar disorder.
Topics: Amisulpride; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Drug Therapy, Combination; Female; Humans; Overweight; Sulpiride; Valproic Acid | 2014 |
Influence of aripiprazole, risperidone, and amisulpride on sensory and sensorimotor gating in healthy 'low and high gating' humans and relation to psychometry.
Topics: Acoustic Stimulation; Amisulpride; Antipsychotic Agents; Aripiprazole; Auditory Perception; Benzhydryl Compounds; Brain; Double-Blind Method; Electroencephalography; Electromyography; Humans; Lorazepam; Male; Modafinil; Piperazines; Prepulse Inhibition; Psychometrics; Psychotropic Drugs; Quinolones; Risperidone; Sensory Gating; Sulpiride; Valproic Acid; Young Adult | 2014 |
Effects of dopamine D2/D3 blockade on human sensory and sensorimotor gating in initially antipsychotic-naive, first-episode schizophrenia patients.
Topics: Acoustic Stimulation; Adult; Amisulpride; Analysis of Variance; Case-Control Studies; Dopamine Antagonists; Electroencephalography; Electromyography; Evoked Potentials, Auditory; Female; Gait Disorders, Neurologic; Humans; Italy; Longitudinal Studies; Male; Prepulse Inhibition; Psychiatric Status Rating Scales; Psychophysics; Schizophrenia; Statistics as Topic; Sulpiride; Young Adult | 2014 |
The relief of leukocytopenia within 1 month after switching risperidone to amisulpride.
Topics: Amisulpride; Antipsychotic Agents; Drug Substitution; Humans; Leukopenia; Male; Risperidone; Sulpiride; Young Adult | 2014 |
Differential effects of dopamine D1 and D 2/3 receptor antagonism on motor responses.
Topics: Amisulpride; Animals; Benzazepines; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Male; Motor Activity; Random Allocation; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Sulpiride; Zebrafish | 2015 |
The poorly membrane permeable antipsychotic drugs amisulpride and sulpiride are substrates of the organic cation transporters from the SLC22 family.
Topics: Amisulpride; Antipsychotic Agents; Biological Transport; Blood-Brain Barrier; Cell Membrane Permeability; Endothelial Cells; HEK293 Cells; Humans; Membranes, Artificial; Microvessels; Models, Biological; Organic Cation Transport Proteins; Substrate Specificity; Sulpiride; Transfection | 2014 |
Persistent hiccups associated with switching from paliperidone to amisulpride.
Topics: Amisulpride; Antipsychotic Agents; Drug Substitution; Hiccup; Humans; Male; Paliperidone Palmitate; Schizophrenia; Sulpiride; Young Adult | 2015 |
Differential modulation of reinforcement learning by D2 dopamine and NMDA glutamate receptor antagonism.
Topics: Adult; Amisulpride; Avoidance Learning; Conditioning, Operant; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Humans; Male; Memantine; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Reward; Sulpiride | 2014 |
Therapeutic occupation of dopamine D2 antipsychotic receptors in Alzheimer's disease.
Topics: Alzheimer Disease; Amisulpride; Antipsychotic Agents; Benzamides; Brain Mapping; Female; Humans; Male; Positron-Emission Tomography; Psychotic Disorders; Receptors, Dopamine D2; Sulpiride | 2014 |
Increased orbitofrontal cortex activation associated with "pro-obsessive" antipsychotic treatment in patients with schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brain Mapping; Clozapine; Executive Function; Female; Humans; Inhibition, Psychological; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Obsessive Behavior; Olanzapine; Piperazines; Prefrontal Cortex; Psychiatric Status Rating Scales; Psychomotor Performance; Quinolones; Schizophrenia; Sulpiride | 2015 |
Amisulpride for older patients with long-standing schizophrenia.
Topics: Aged; Aged, 80 and over; Amisulpride; Antipsychotic Agents; Cohort Studies; Female; Humans; Male; Middle Aged; Patient Readmission; Retrospective Studies; Schizophrenia; Sulpiride; Time Factors | 2014 |
Clozapine augmentation with amisulpride.
Topics: Adult; Amisulpride; Antipsychotic Agents; Clozapine; Drug Synergism; Humans; Male; Schizophrenia; Sulpiride | 2014 |
Augmentation with amisulpride for schizophrenic patients non-responsive to risperidone monotherapy.
Topics: Administration, Oral; Adult; Aged; Amisulpride; Antipsychotic Agents; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Sulpiride; Young Adult | 2015 |
Amisulpride-associated mania in a young adult with schizophrenia and cerebral disease.
Topics: Amisulpride; Antipsychotic Agents; Bipolar Disorder; Cerebral Palsy; Drug Administration Schedule; Humans; Male; Risperidone; Schizophrenia; Sulpiride; Taiwan; Young Adult | 2014 |
[Association of atypical neuroleptics with anticonvulsants and malignant syndrome. Report of 2 cases].
Topics: Adolescent; Adult; Amisulpride; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Drug Therapy, Combination; Female; Humans; Male; Neuroleptic Malignant Syndrome; Olanzapine; Sulpiride; Valproic Acid | 2014 |
Accounting for uncertainty due to 'last observation carried forward' outcome imputation in a meta-analysis model.
Topics: Amisulpride; Antipsychotic Agents; Bayes Theorem; Bias; Biostatistics; Humans; Markov Chains; Meta-Analysis as Topic; Models, Statistical; Monte Carlo Method; Odds Ratio; Randomized Controlled Trials as Topic; Schizophrenia; Sulpiride; Uncertainty | 2015 |
Prolonged QT Risk Assessment in Antipsychotic Overdose Using the QT Nomogram.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Drug Overdose; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Middle Aged; Nomograms; Retrospective Studies; Risk Assessment; Sulpiride; Tachycardia; Thioridazine; Torsades de Pointes; Young Adult | 2015 |
DRD2 genotypic and haplotype variation is associated with improvements in negative symptoms after 6 weeks' amisulpride treatment.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; DNA; Dopamine Antagonists; Female; Genotype; Haplotypes; Humans; Male; Middle Aged; Polymorphism, Genetic; Psychiatric Status Rating Scales; Receptors, Dopamine D2; Schizophrenia; Sulpiride; Treatment Outcome; Young Adult | 2015 |
Striatal D(2/3) Binding Potential Values in Drug-Naïve First-Episode Schizophrenia Patients Correlate With Treatment Outcome.
Topics: Adolescent; Adult; Amisulpride; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Female; Humans; Male; Middle Aged; Receptors, Dopamine D2; Receptors, Dopamine D3; Schizophrenia; Sulpiride; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Young Adult | 2015 |
Improvement of ketamine-induced social withdrawal in rats: the role of 5-HT7 receptors.
Topics: Amisulpride; Animals; Antipsychotic Agents; Behavior, Animal; Disease Models, Animal; Excitatory Amino Acid Antagonists; Ketamine; Male; Phenols; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Receptors, Serotonin; Schizophrenia; Serotonin Antagonists; Social Behavior Disorders; Sulfonamides; Sulpiride | 2015 |
Amisulpride monotherapy may be a choice of maintenance treatment for patients with both bipolar I disorder and metabolic syndrome.
Topics: Amisulpride; Antipsychotic Agents; Bipolar Disorder; Humans; Male; Metabolic Syndrome; Sulpiride; Young Adult | 2015 |
Reversible Amisulpride-induced Elevation of Creatine Kinase (CK): A Case Series from the German AMSP Pharmacovigilance Project.
Topics: Adult; Amisulpride; Antipsychotic Agents; Creatine Kinase; Female; Humans; Male; Middle Aged; Myalgia; Schizophrenia; Sulpiride | 2015 |
Photolysis of the antidepressants amisulpride and desipramine in wastewaters: Identification of transformation products formed and their fate.
Topics: Amisulpride; Antidepressive Agents; Desipramine; Environmental Monitoring; Photolysis; Sulpiride; Wastewater; Water Pollutants, Chemical | 2015 |
Skating on thin ice: pragmatic prescribing for medication refractory schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Drug Prescriptions; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Schizophrenia; Schizophrenic Psychology; Sulpiride; Valproic Acid | 2015 |
Dopamine D2/3 receptor antagonism reduces activity-based anorexia.
Topics: Amisulpride; Animals; Anorexia Nervosa; Benzodiazepines; Disease Models, Animal; Dopamine D2 Receptor Antagonists; Eating; Female; Indoles; Mice; Mice, Inbred BALB C; Motor Activity; Nitriles; Olanzapine; Piperidines; Receptors, Dopamine D3; Salicylamides; Sulpiride; Tetrahydroisoquinolines; Weight Loss | 2015 |
Effects of Blocking D2/D3 Receptors on Mismatch Negativity and P3a Amplitude of Initially Antipsychotic Naïve, First Episode Schizophrenia Patients.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Brain; Dopamine D2 Receptor Antagonists; Electroencephalography; Electromyography; Female; Humans; Male; Neuropsychological Tests; Psychiatric Status Rating Scales; Receptors, Dopamine D2; Schizophrenia; Schizophrenic Psychology; Sulpiride; Treatment Outcome; Young Adult | 2015 |
Pramipexole at a Low Dose Induces Beneficial Effect in the Harmaline-induced Model of Essential Tremor in Rats.
Topics: Amisulpride; Animals; Anti-Dyskinesia Agents; Benzothiazoles; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Essential Tremor; Haloperidol; Harmaline; Imidazoles; Male; Movement; Nitriles; Pramipexole; Pyridines; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Sulpiride; Tetrahydroisoquinolines; Tetrahydronaphthalenes; Treatment Outcome | 2016 |
Heat stroke during treatment with olanzapine, trihexyphenidyl, and trazodone in a patient with schizophrenia.
Topics: Amisulpride; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Body Temperature Regulation; Critical Care; Diagnosis, Differential; Drug Interactions; Heat Stroke; Humans; Male; Middle Aged; Olanzapine; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Suicide, Attempted; Sulpiride; Trazodone; Trihexyphenidyl | 2015 |
Comparative risk of oral ulcerations among antipsychotics users - population-based retrospective cohort study.
Topics: Adult; Aged; Amisulpride; Antipsychotic Agents; Benzodiazepines; Cohort Studies; Databases, Factual; Female; Humans; Male; Middle Aged; Olanzapine; Oral Ulcer; Population Surveillance; Quetiapine Fumarate; Retrospective Studies; Sulpiride; Taiwan; Young Adult | 2016 |
Treatment-Resistant Schizophrenia in a Patient With 17q12 Duplication.
Topics: Amisulpride; Antipsychotic Agents; Chromosomes, Human, Pair 17; Drug Resistance; Humans; Male; Mosaicism; Psychiatric Status Rating Scales; Schizophrenia; Sulpiride; Trisomy; Young Adult | 2016 |
Frontal fasciculi and psychotic symptoms in antipsychotic-naive patients with schizophrenia before and after 6 weeks of selective dopamine D2/3 receptor blockade.
Topics: Acute Disease; Adult; Amisulpride; Anisotropy; Antipsychotic Agents; Brain; Diffusion Magnetic Resonance Imaging; Diffusion Tensor Imaging; Dopamine Antagonists; Female; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Male; Psychiatric Status Rating Scales; Psychotic Disorders; Receptors, Dopamine D2; Receptors, Dopamine D3; Schizophrenia; Schizophrenic Psychology; Sulpiride; Treatment Outcome; White Matter | 2016 |
Catechol-O-methyltransferase gene variants may associate with negative symptom response and plasma concentrations of prolactin in schizophrenia after amisulpride treatment.
Topics: Adult; Amisulpride; Antipsychotic Agents; Case-Control Studies; Catechol O-Methyltransferase; Female; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Prolactin; Psychiatric Status Rating Scales; Schizophrenia; Sulpiride; Treatment Outcome | 2016 |
Striatal Reward Activity and Antipsychotic-Associated Weight Change in Patients With Schizophrenia Undergoing Initial Treatment.
Topics: Adolescent; Adult; Amisulpride; Anticipation, Psychological; Antipsychotic Agents; Dopamine D2 Receptor Antagonists; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Putamen; Reward; Schizophrenia; Sulpiride; Treatment Outcome; Weight Gain; Young Adult | 2016 |
[Aripiprazole, gambling disorder and compulsive sexuality].
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Compulsive Behavior; Gambling; Humans; Male; Schizoid Personality Disorder; Schizophrenia; Sexual Behavior; Sexual Dysfunctions, Psychological; Sulpiride | 2016 |
Adjunctive ondansetron in schizophrenia--A pilot study.
Topics: Adult; Amisulpride; Antipsychotic Agents; Clozapine; Drug Therapy, Combination; Feasibility Studies; Humans; Ondansetron; Pilot Projects; Schizophrenia; Sulpiride; Treatment Outcome | 2016 |
Use of amisulpride in treating adolescent onset schizophrenia associated with stuttering priapism induced by multiple antipsychotics.
Topics: Adolescent; Amisulpride; Antipsychotic Agents; Humans; Male; Priapism; Schizophrenia; Sulpiride; Treatment Outcome | 2016 |
Antipsychotic Drugs Differentially Affect mRNA Expression of Genes Encoding the Neuregulin 1-Downstream ErbB4-PI3K Pathway.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Cell Line, Tumor; Cell Survival; Clozapine; Gene Expression Regulation; Haloperidol; Humans; Neuregulin-1; Olanzapine; Phosphatidylinositol 3-Kinases; Quetiapine Fumarate; Receptor, ErbB-4; RNA, Messenger; Schizophrenia; Sulpiride | 2016 |
A Liquid Chromatography-Tandem Mass Spectrometry Method for Quantifying Amisulpride in Human Plasma and Breast Milk, Applied to Measuring Drug Transfer to a Fully Breast-Fed Neonate.
Topics: Adult; Amisulpride; Antipsychotic Agents; Breast Feeding; Chromatography, Liquid; Drug Monitoring; Female; Humans; Infant, Newborn; Lactation; Male; Milk, Human; Plasma; Reproducibility of Results; Sulpiride; Tandem Mass Spectrometry | 2016 |
Amisulpride induced agranulocytosis: a case report.
Topics: Agranulocytosis; Amisulpride; Antipsychotic Agents; Female; Humans; Middle Aged; Sulpiride | 2016 |
Asymptomatic bradycardia and hypotension associated with amisulpride: A case report.
Topics: Adult; Amisulpride; Antipsychotic Agents; Bradycardia; Female; Humans; Hypotension; Schizophrenia; Sulpiride | 2016 |
Switching antipsychotics: Imaging the differential effect on the topography of postsynaptic density transcripts in antipsychotic-naïve vs. antipsychotic-exposed rats.
Topics: Amisulpride; Animals; Antipsychotic Agents; Cerebral Cortex; Corpus Striatum; Cytoskeletal Proteins; Disks Large Homolog 4 Protein; Drug Resistance; Drug Substitution; Gene Expression; Haloperidol; Homer Scaffolding Proteins; Injections, Intraperitoneal; Intracellular Signaling Peptides and Proteins; Male; Membrane Proteins; Nerve Tissue Proteins; Post-Synaptic Density; Random Allocation; Rats, Sprague-Dawley; RNA, Messenger; Sulpiride | 2016 |
Stability of the Effect of a Standardized Meal on QTc.
Topics: Amisulpride; Antipsychotic Agents; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Eating; Electrocardiography; Healthy Volunteers; Heart Conduction System; Heart Rate; Humans; Morpholines; Postprandial Period; Pyrazoles; Randomized Controlled Trials as Topic; Reproducibility of Results; Research Design; Sensitivity and Specificity; Sulpiride | 2017 |
A population approach to characterise amisulpride pharmacokinetics in older people and Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amisulpride; Antipsychotic Agents; Female; Healthy Volunteers; Humans; Male; Sulpiride | 2016 |
Occurrence and fate of amisulpride, sulpiride, and lamotrigine in municipal wastewater treatment plants with biological treatment and ozonation.
Topics: Amisulpride; Central Nervous System Agents; Groundwater; Lamotrigine; Ozone; Sulpiride; Triazines; Wastewater; Water Pollutants, Chemical; Water Purification | 2016 |
Simultaneous Use of Intravenous Lipid Emulsion and Plasma Exchange Therapies in Multiple Drug Toxicity.
Topics: Amisulpride; Antihypertensive Agents; Antipsychotic Agents; Aripiprazole; Diazepam; Drug-Related Side Effects and Adverse Reactions; Fat Emulsions, Intravenous; Female; Humans; Hypnotics and Sedatives; Hypotension; Middle Aged; Paliperidone Palmitate; Plasma Exchange; Suicide, Attempted; Sulpiride; Treatment Outcome; Turkey; Valsartan | 2016 |
Level of serum thioredoxin and correlation with neurocognitive functions in patients with schizophrenia using clozapine and other atypical antipsychotics.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Cognition; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Olanzapine; Psychotic Disorders; Risperidone; Schizophrenia; Sulpiride; Thioredoxins; Young Adult | 2017 |
Application of an Untargeted Chemometric Strategy in the Impurity Profiling of Pharmaceuticals: An Example of Amisulpride.
Topics: Amisulpride; Chromatography, High Pressure Liquid; Drug Contamination; Least-Squares Analysis; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Sulpiride | 2017 |
Dopamine Modulates the Functional Organization of the Orbitofrontal Cortex.
Topics: Amisulpride; Dopamine; Dopamine Antagonists; Double-Blind Method; Humans; Magnetic Resonance Imaging; Male; Nerve Net; Prefrontal Cortex; Random Allocation; Receptors, Dopamine D2; Sulpiride | 2017 |
Measurement of Clozapine, Norclozapine, and Amisulpride in Plasma and in Oral Fluid Obtained Using 2 Different Sampling Systems.
Topics: Adult; Aged; Amisulpride; Antipsychotic Agents; Body Fluids; Chromatography, Liquid; Clozapine; Drug Monitoring; Female; Humans; Male; Middle Aged; Mouth; Plasma; Sulpiride; Tandem Mass Spectrometry; Young Adult | 2017 |
Crystal structures and physicochemical properties of amisulpride polymorphs.
Topics: Amisulpride; Calorimetry, Differential Scanning; Crystallography, X-Ray; Molecular Conformation; Solubility; Sulpiride | 2017 |
Sulpiride, Amisulpride, Thioridazine, and Olanzapine: Interaction with Model Membranes. Thermodynamic and Structural Aspects.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Calorimetry; Dynamic Light Scattering; Electron Spin Resonance Spectroscopy; Membranes, Artificial; Models, Chemical; Molecular Structure; Olanzapine; Phosphatidylcholines; Phosphatidylglycerols; Protons; Sulpiride; Thermodynamics; Thioridazine; Water | 2017 |
Development of novel amisulpride-loaded liquid self-nanoemulsifying drug delivery systems via dual tackling of its solubility and intestinal permeability.
Topics: Administration, Oral; Amisulpride; Biological Availability; Chemistry, Pharmaceutical; Drug Delivery Systems; Drug Liberation; Emulsions; Ethylene Glycols; Excipients; Intestinal Absorption; Particle Size; Permeability; Polyethylene Glycols; Solubility; Sulpiride; Surface-Active Agents | 2017 |
Development of novel amisulpride-loaded solid self-nanoemulsifying tablets: preparation and pharmacokinetic evaluation in rabbits.
Topics: Administration, Oral; Amisulpride; Animals; Biological Availability; Chemistry, Pharmaceutical; Drug Carriers; Drug Delivery Systems; Emulsions; Ethylene Glycols; Particle Size; Polyethylene Glycols; Rabbits; Sulpiride; Surface-Active Agents; Tablets | 2017 |
A Population Approach to Guide Amisulpride Dose Adjustments in Older Patients With Alzheimer's Disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amisulpride; Basal Ganglia Diseases; Brain; Delusions; Dose-Response Relationship, Drug; Female; Humans; Male; Prolactin; Psychotic Disorders; Receptors, Dopamine D2; Receptors, Dopamine D3; Reference Values; Risk Factors; Sulpiride | 2017 |
Polymorphism of the SNAP25 gene is associated with symptom improvement in schizophrenic patients treated with amisulpride.
Topics: Adult; Amisulpride; Antipsychotic Agents; Female; Genotype; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Schizophrenia; Sulpiride; Synaptosomal-Associated Protein 25; Treatment Outcome; Young Adult | 2017 |
[Neuroleptic malignant syndrome under amisulpride in a patient during a second acute psychotic episode].
Topics: Acute Disease; Adult; Amisulpride; Antipsychotic Agents; Female; Humans; Neuroleptic Malignant Syndrome; Psychotic Disorders; Recurrence; Sulpiride | 2018 |
Resolution V fractional factorial design for screening of factors affecting weakly basic drugs liposomal systems.
Topics: Amisulpride; Ammonium Sulfate; Chemistry, Pharmaceutical; Cholesterol; Hydrogen-Ion Concentration; Liposomes; Phosphatidylcholines; Sulpiride; Zinc | 2018 |
[Aripiprazole for drug-induced sexual dysfunction in schizophrenic males].
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Drug Administration Schedule; Humans; Male; Prolactin; Risperidone; Schizophrenia; Sexual Behavior; Sexual Dysfunction, Physiological; Sulpiride; Testosterone; Treatment Outcome | 2017 |
Amisulpride-CD-Loaded Liposomes: Optimization and In Vivo Evaluation.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Amisulpride; Animals; Antipsychotic Agents; beta-Cyclodextrins; Biological Availability; Drug Carriers; Drug Evaluation, Preclinical; Drug Liberation; Liposomes; Male; Particle Size; Rats; Rats, Wistar; Sulpiride; Tablets | 2018 |
Involvement of vascular endothelial growth factor (VEGF) and mitogen-activated protein kinases (MAPK) in the mechanism of neuroleptic drugs.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Cell Line, Tumor; Haloperidol; Humans; Mitogen-Activated Protein Kinases; Neuroprotective Agents; Olanzapine; Pituitary Adenylate Cyclase-Activating Polypeptide; Signal Transduction; Sulpiride; Vascular Endothelial Growth Factor A | 2018 |
Antipsychotics and pituitary tumors: an analysis of the European pharmacovigilance database (EudraVigilance).
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Child; Databases, Factual; Female; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Paliperidone Palmitate; Pharmacovigilance; Pituitary Neoplasms; Pregnancy; Quetiapine Fumarate; Retrospective Studies; Risperidone; Sulpiride; Young Adult | 2019 |
Identification and Quantification of Antipsychotics in Blood Samples by LC-MS-MS: Case Reports and Data from Three Years of Routine Analysis.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chromatography, Liquid; Clozapine; Dibenzothiazepines; Female; Forensic Toxicology; Humans; Male; Olanzapine; Paliperidone Palmitate; Piperazines; Quetiapine Fumarate; Retrospective Studies; Risperidone; Schizophrenia; Substance Abuse Detection; Suicide; Sulpiride; Tandem Mass Spectrometry; Thiazoles | 2020 |
Prediction of the significance in the improvement of depression symptoms of amisulpride in the treatment of schizophrenia: an 8-week case-control study.
Topics: Amisulpride; Antipsychotic Agents; Case-Control Studies; Depression; Humans; Psychiatric Status Rating Scales; Schizophrenia; Sulpiride; Treatment Outcome | 2020 |
Study on the relationship among dose, concentration and clinical response in Chinese schizophrenic patients treated with Amisulpride.
Topics: Amisulpride; Antipsychotic Agents; China; Female; Humans; Male; Psychiatric Status Rating Scales; Schizophrenia; Sulpiride; Treatment Outcome | 2021 |
Going the extra mile? The influence of Amisulpride on effort-based decisions.
Topics: Amisulpride; Humans; Sulpiride | 2022 |
Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
Topics: Adenosine Monophosphate; Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chlorpromazine; Clopenthixol; Clozapine; Flupenthixol; Fluphenazine; Haloperidol; Humans; Olanzapine; Paliperidone Palmitate; Pharmaceutical Preparations; Pimozide; Quetiapine Fumarate; Risperidone; Sulpiride; Trifluoperazine | 2022 |
Persistence of N-oxides transformation products of tertiary amine drugs at lab and field studies.
Topics: Amisulpride; Desvenlafaxine Succinate; Oxides; Pharmaceutical Preparations; Sulpiride; Tramadol; Venlafaxine Hydrochloride; Water; Water Pollutants, Chemical | 2022 |
Age, Sex, and Comedication Effects on the Steady-State Plasma Concentrations of Amisulpride in Chinese Patients with Schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; East Asian People; Female; Humans; Male; Retrospective Studies; Schizophrenia; Sulpiride | 2023 |